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Abstract 
 
The research presented herein is concerned with the exploration of tandem processes 
initiated by the conjugate reduction of Michael acceptors, encompassing the asymmetric 
reductive Dieckmann reaction and the two-carbon homologation of aldehydes by two 
complementary methodologies. 
 
Chapter 1 introduces the area of transition metal catalysed tandem reductive processes as a 
tool for carbon-carbon bond formation. An extensive discussion of this methodology is 
included and recent advances in the area are highlighted.  
 
Chapter 2 discusses the initial study into the asymmetric reductive Dieckmann 
condensation. 3,3’-Disubstituted 4-oxopyrrolidines were synthesised in up to 93% ee using 
both molybdenum and copper catalysis.  
 
Chapter 3 describes the novel molybdenum-catalysed two-carbon homologation of 
aldehydes by the reduction of alkylidene Meldrum’s acid derivatives. No over reduction to 
the corresponding alcohol is observed, as the aldehyde functionality remains protected until 
hydrolysis. 
 
Chapter 4 discusses the mild, expeditious amine promoted reduction of cyclic malonates to 
β-substituted propionaldehydes. The synthetic utility of the methodology is demonstrated 
by the synthesis of γ-substituted propylamines in a one-pot hydrosilylation/reductive 
amination process. 
 
Chapter 5 describes the synthesis and characterisation for the compounds discussed in 
chapters 2, 3 and 4. 
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Chapter 1 
Chapter 1 - Tandem Catalytic Reductive Processes 
 
1.1 Introduction 
 
The formation of new carbon-carbon bonds is one of the most important challenges within 
organic synthesis. Of the numerous methods of carbon-carbon bond formation available to 
the modern synthetic organic chemist, those involving the nucleophilic attack of silyl enol 
ethers or silyl ketene acetals on electrophilic carbon centres has proved to be of great 
importance, especially the Mukaiyama aldol reaction.1 The 2009 review by Kalesse et al. 
on the use of highly stereoselective aldol reactions in the total synthesis of natural products 
highlights the recent progress and applications of the aldol reaction.2
 
Despite being a methodological cornerstone of organic synthesis, enolate chemistry has its 
limitations. For example, formation of the desired enolate requires either a completely 
separate synthetic step or the chemo- and regioselective deprotonation of pro-nucleophiles. 
A particularly attractive method of efficient in situ generation of enolates is the use of 
enones as “latent enolates”.3 The use of enones as latent enolates enables regioselective 
enolate formation from relatively robust precursors. These enolates can then react with the 
desired electrophilic partner (Scheme 1). 
 
R
O
R' R
O
R'
H
R
O
R'
H
E
M
E+
1 2 3
M-H
 
Scheme 1 Tandem processes initiated by the conjugate reduction of enones 
 
Development of catalytic variations of this tandem methodology has greatly focused on the 
formation of enolates from enones by hydrometallation and has been addressed in a number 
of reviews.3-7 Efficient and highly selective processes have been developed using transition 
metal salt precatalysts, chiral ligands and stoichiometric reductants. A range of different 
stoichiometric reductants has been used such as silanes, molecular hydrogen, stannanes and 
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boranes. The use of chiral ligands results in the formation of chiral metal enolates which 
allow for the stereoselective nucleophilic attack of the enolate on the carbon electrophile 
resulting in the formation of new stereogenic centres (Scheme 2). 
 
R
O
R' R
O
R'
H
R
O
R'
H
E
[M]*
M (cat.)
Ligand*
H- E+
1 2 3  
Scheme 2 Enantioselective tandem reductive processes 
 
This review will map the recent progress made in tandem reductive processes focusing on 
those processes initiated by the hydrometallation and hydrosilylation of Michael acceptors. 
 
1.2 Reductive Aldol Reactions 
 
1.2.1 Rhodium-Catalysed Reductive Aldol Reactions 
 
1.2.1.1 Initial Studies 
 
Revis and Hilty reported the first reductive aldol reaction.8 Catalysed by rhodium chloride, 
methyl methacrylate 4 was coupled with excess acetone 5 using trimethylsilane as a 
hydride source giving the β-siloxy ester 6 in a 95% yield (Scheme 3). No aldol product was 
observed on reacting silyl ketene acetal 7 (synthesised independently) with acetone in the 
presence of rhodium chloride, suggesting the reaction proceeded via a rhodium ketene 
acetal (Scheme 3).  
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O
MeO
O
+
RhCl3.H2O (9 mol%)
Me3SiH (1.3 equiv.) O
MeO
OSiMe3
95%
4 5 6
OSiMe3
MeO
7  
Scheme 3 The first example of a reductive aldol reaction 
 
Matsuda  et al. formed β-siloxy ketone aldols by the reductive coupling of α,β-unsaturated 
ketones with aldehydes in the presence of Rh4(CO)12 and Et2MeSiH; syn-selectivity was 
observed for this transformation (Scheme 4).9 It was also found that the addition of MePh2P 
enabled the reductive coupling of enolisable aldehydes such as hexanal (Scheme 5). 
 
O
O
PhH
+
O OSiMeEt2
Ph
O OSiMeEt2
Ph
Ph
O OSiMeEt2
Ph
10
80% (syn:anti = 87:13)
11
88% (syn:anti = 55:45)
12
75% (syn:anti = 73:27)
Rh4(CO)10 (0.5 mol%)
Et2MeSiH (2 equiv.)
toluene, -15 oC, 7 h
8 9
 
Scheme 4 Rhodium-catalysed reductive aldol reaction between enones and benzaldehyde 
 
O
+
O
nHexH
Rh4(CO)10 (0.5 mol%)
MePh2P (1.0 mol%)
Et2MeSiH (2 equiv.)
toluene, -15 oC, 7 h
O OSiMeEt2
15
80% (syn:anti = 68:32)
13 14
 
Scheme 5 Rhodium-catalysed reductive aldol reaction between methyl vinyl ketone and hexanal 
 
Motherwell and Whitehead reported the rhodium-catalysed intramolecular reductive aldol 
reaction, it was found that by simply changing the catalyst precursor a switch between cis- 
and trans-selectivity could be achieved.10,11 On using RhCl(PPh3)3 cis-selectivity was 
observed and using RhH(PPh3)4 trans-selectivity was achieved (Scheme 6). Five-, six- and 
seven-membered ring products were accessed with substitution on the carbon backbone 
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being tolerated. This method also allowed for the synthesis of bicyclic systems. It was also 
observed that the selectivity of the catalytic precursors was a general, not absolute, trend.11 
Motherwell and Whitehead applied this methodology to the formal enantioselective 
synthesis of (–)-carbovir 20 and (–)-abacavir 21.12 Exposure of protected diol containing 6-
oxohexanoate 18 to the reductive conditions gave a separable mixture of diastereomers, 
which, through further manipulations, led to the synthesis of these biologically active 
targets (Scheme 7). 
 
O
MeO
O
H
[Rh] (1 mol%)
Et3SiH (2.1 equiv.)
toluene, 50 oC, 18 h
CO2Me
Et3SiO
[Rh] = RhCl(PPh3)3 81% (cis:trans = 2.0:1.0)
RhH(PPh3)4 81% (cis:trans = 1.0:11.0)
16 17
 
Scheme 6 Rhodium-catalysed intramolecular reductive aldol reaction 
 
O
MeO
RhH(PPh3)4 (1 mol%)
Et3SiH (2.1 equiv.)
toluene, 50 oC, 16 h
CO2Me
Et3SiO
18
O H
O
O O O
CO2Me
Et3SiO
O
O
CO2Me
Et3SiO
O
O
CO2Me
Et3SiO
O
O
19a 19b 19c 19d
19a:19b:19c:19d 5.4:4.0:2.0:1.0
HO
N
N
N
NH
O
NH2
HO
N
N
N
N
HN
NH2
20 : (-)-carbovir 21 : (-)-abacavir
81%
 
Scheme 7 Key synthetic step towards the synthesis of (-)-carbovir and (-)-abacavir 
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1.2.1.2 Hydrogen Mediated Processes 
 
Often, transition metal catalysed reduction of Michael acceptors are mediated by a 
stoichiometric hydride source, such as a silane. The use of molecular hydrogen offers a 
convenient, atom-economic solution to the use of a stoichiometric reductant, bypassing the 
removal of undesirable byproducts from the reaction mixture.13,14
 
Krische has pioneered the reductive aldol reaction mediated by molecular hydrogen, with 
both syn-selective inter- and intramolecular transformations being carried out.5,15 
Competitive alkene hydrogenation of the Michael acceptor was suppressed by the use of a 
cationic rhodium precatalyst and an inorganic base (typically KOAc or Li2CO3).16 
Mechanistic studies revealed the base converts the rhodium(III)-dihydride species, 
responsible for alkene hydrogenation via the dihydride cycle (Scheme 8), into the desired 
rhodium(I)-monohydride species which catalyses the reductive aldol process via the 
monohydride cycle  (Scheme 8).5
 
MeO
O
CH2D
MeO
O
CH2D
R'
OH
MeO
O
R'
O
MeO
ORhIII(D)(X)Ln
D
LnRhIX
dihydride
cycle LnRh
III(X)(D2) LnRhID
- DX (base)
DX
O RhILn
O
R'
CH2D
OMe
O RhILn
O
R'
CH2D
OMe
O RhI(D2)Ln
O
R'
CH2D
OMe
monohydride
cycle
D2
D2
 
Scheme 8 Competitive alkene hydrogenation and reductive aldol reactions 
 
Early research focused on the intramolecular reductive aldol cyclisation of aldo-enones16 
and keto-enones17,18 with five- and six-membered rings being formed in high yields and 
with excellent syn-selectivity (syn:anti >95:5 for all keto-enones). Reactions involving 
aldo-enones under optimised conditions show trace amounts of alkene hydrogenation 
product (Scheme 9). However, on moving to keto-enones, increased amounts of alkene 
hydrogenation occurs due to the decreased electrophilicity of the ketone (Scheme 10).17 
The efficient reductive aldol cyclisation of keto-enones was achieved using the more 
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electrophilic 1,3-diones 30 (Scheme 11); no conjugate reduction product was observed for 
these keto-enones except in the formation of the strained cis-decalone 33.18
 
O
R
H O
22
Rh(cod)2OTf (10 mol%)
(4-F3CC6H4)3P (24 mol%)
H2 (1 atm)
KOAc (30 mol%)
DCE, 25 oC, 3 hn
O
Ph
OH
23 : 89%
(syn:anti 10:1)
O OH
24 : 76%
(syn:anti 19:1)
O
Ph
OH
25 : 71%
(syn:anti 24:1)
S
 
Scheme 9 Reductive aldol cyclisation of aldo-enones under hydrogenation conditions 
 
O
R
Me O
26
Rh(cod)2OTf (10 mol%)
Ph3P (24 mol%)
H2 (1 atm)
K2CO3 (80 mol%)
DCE, 80 oCn
O
Ph
n = 1 27a : 75%
(8% hydrogenation)
n = 2 27b : 72%
(20% hydrogenation)
OHMe
n
O
n = 1 28a : 70%
(24% hydrogenation)
n = 2 28b : 83%
(8% hydrogenation)
OHMe
n
O
n= 1 29a : 74%
(8% hydrogenation)
n = 2 29b : 72%
(17% hydrogenation)
OHMe
n
O HN
 
Scheme 10 Reductive aldol cyclisation of keto-enones via catalytic hydrogenation 
 
O
R
30
Rh(cod)2OTf (10 mol%)
Ph3P (24 mol%)
H2 (1 atm)
K2CO3 (80 mol%)
DCE, 80 oCn
31 : 88% 32 : 86% 33 : 65%
(15% hydrogenation)
O
O
m
O
OH
O
Me
O
HO
PhO
OH
O
PhO
 
Scheme 11 Reductive aldol cyclisation of enone-diones via catalytic hydrogenation 
 
Krische et al. also described the challenging intramolecular reductive aldol reaction of enal-
ketones (Scheme 12).18 Low yields were observed with triphenylphosphine, however, π-
acidic ligand tri(2-furyl)phosphine increased yields. Poor to moderate syn-selectivity was 
observed along with varying quantities of undesirable conjugate reduction product. 
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O
H
O
Rh(cod)2OTf (10mol%)
(2-furyl)3P (24mol%)
H2 (1 atm)
K2CO3 (80 mol%)
DCE, 80 oC
35 : 72% (syn:anti 2:1)
(16% hydrogenation)
O
OH
O
H
36 : 61% (syn:anti 5:1)
(20% hydrogenation)
OH
O
H
BzO
37 : 67% (syn:anti 2:1)
(20% hydrogenation)
N
O
OH
O
H
Bn
34
 
Scheme 12 Reductive aldol cyclisation of enal-ketones via catalytic hydrogenation 
 
The intermolecular reductive aldol couplings of vinyl ketones with aryl aldehydes was 
investigated in Krische’s original paper, however, only poor syn-selectivity was observed 
(typically syn:anti 2:1).16 Further investigation showed that excellent syn-selectivity could 
be achieved when using the π-acid phosphine ligand tri(2-furyl)phosphine and Li2CO3.19  
 
Hydrometallation is thought to result in a Z-(O)-enolate which undergoes aldolisation via a 
Zimmerman-Traxler-type transition structure (Scheme 13). The addition of tri(2-
furyl)phosphine increases the Lewis acidity of the rhodium centre, therefore promoting the 
formation of the kinetically favourable syn-diastereomer by the tightening of the chair like 
transition state and favouring the kinetic pathway by mitigating retro-aldol cyclisation. 
 
O
Rh
H
Ln
O
Rh
H
Ln
O RhLn
OR
O OH
R
O
Rh
O
Ln
R
hydride delivery to
s-cis-conformer
Z-(O)-enolate Zimmerman-Traxler
transition structure
syn-aldolate kinetic product
 
Scheme 13 Postulated route to syn-aldol product 
 
Under these conditions, it was found that reduction of normally hydrogen-labile 
functionalities did not occur; alkynes, alkenes, benzylic ethers and nitroarenes remained 
intact (Scheme 14).19 This reductive coupling was extended from methyl- and ethyl vinyl 
ketone to the divinyl ketone 41 with chemoselective reduction occurring only at the less 
substituted alkene; no further reduction of the aldol product was observed (Scheme 15).20
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O
Et
O
R
Rh(cod)2OTf (5mol%)
(2-fur)3P (12 mol%)
Li2CO3 (10 mol%)
H2 (1 atm)
DCM, 25 oC
+
H
O
Et
Me
OH
NO2
O
Et
Me
OH
OBn
O
Et
Me
OH
Ph
38 39 40a : 90% (28:1 dr) 40b : 90% (18:1 dr) 40c : 70% (10:1 dr)  
Scheme 14 Reductive coupling of vinyl ketones and aldehydes containing hydrogen-labile groups 
 
O
Me
O
RH
Rh(cod)2SbF6 (5 mol%)
(2-fur)3P (12 mol%)
Li2CO3 (10 mol%)
H2 (1 atm)
DCM, 25 oC
+
O
Me
OH
NO2
O
Me
OH
N Br
41 39 42a : 82% (13:1 dr) 42b : 94% (11:1 dr)  
Scheme 15 Regioselective reductive aldol reaction between aldehydes and divinyl ketones 
 
These neutral conditions also allow for the reductive aldol reaction between α,β-unsaturated 
ketones and chiral N-Boc-α-amino aldehydes without any deprotection of the amine 
functionality or racemisation of the chiral centre (Scheme 16).21 In this study Krische et al. 
attribute the excellent levels of syn-aldol diastereoselectivity and anti-Felkin-Ahn control to 
the intramolecular hydrogen bonding in the amino aldehyde. 
 
O
R
O
Rh(cod)2OTf (5 mol%)
(2-fur)3P (12 mol%)
Li2CO3 (10 mol%)
H2 (1 atm)
DCM, 25 oC
+ H
O
Me
Me
OH
NHBoc
Ph
13 R= Me
38 R= Et
44 45 : 84% (>20:1 dr)
>20:1 anti-Felkin-Anh
NBoc
H
R'
O
Et
Me
OH
NHBoc
OTBDPS
46 : 91% (>20:1 dr)
>20:1 anti-Felkin-Anh  
Scheme 16 syn-Diastereoselective hydrogenative aldol coupling between vinyl ketones and α-amino 
aldehydes 
 
1.2.1.3 Asymmetric Rhodium-Catalysed Reductive Aldol Reactions 
 
Morken et al., in 1999, carried out a catalyst evaluation, screening metal precatalysts, 
hydride sources and phosphine ligands in an array format.22 The study revealed that 
[Rh(cod)Cl]2, (R,R)-Me-DuPhos 49 and Cl2MeSiH gave the desired product in both high 
yields, up to 82% isolated yield, and diastereoselectivity, up to syn:anti 23:1 (Scheme 17). 
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O
MeO
O
RH
[Rh(cod)Cl]2 (2.5mol%)
49 (5.5 mol%)
Cl2MeSiH
DCE, 16 h, then H3O+
+
O
MeO R
OH
47 39 48a : R = Ph 69% (syn:anti = 23:1)
48b : R = Np 82% (syn:anti = 10:1)
P
P
49 : (R,R)-Me-DuPhos  
Scheme 17 Rhodium-catalysed reductive aldol reaction ligated by bisphosphine 
 
Further studies by Morken et al. into the reductive conditions described above showed that 
excellent diastereoselectivities of >60:1 (syn:anti) could be achieved in a two step process 
in which the required aldehyde was added to the reaction mixture after rhodium-catalysed 
hydrosilylation had occurred.23  
 
In both Morken’s one- and two-step rhodium-catalysed reductive aldol reactions it is the 
silyl ketene acetal, formed after hydrosilylation of the Michael acceptor, which is involved 
in the carbon-carbon bond forming process. Therefore, the chiral rhodium – bisphosphine 
species is not involved in the key step in which chirality is installed. However, using 
Et2MeSiH as the stoichiometric reductant and (R)-BINAP as the bisphosphine ligand 
Morken et al. carried out asymmetric rhodium-catalysed reductive aldol reactions.24 While 
syn:anti selectivities and yields in this study were moderate, good enantioselectivities were 
observed for the major syn-diastereomer (Scheme 18). This asymmetric transformation was 
carried out during the initial arrayed catalyst evaluation, however, a poor yield (4% yield) 
and enantioselectivity (20% ee) was observed. This was attributed to incomplete 
complexation during the microscale reaction. 
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O
PhO
O
RH
[Rh(cod)Cl]2 (2.5 mol%)
(R)-52 (6.5 mol%)
Et2MeSiH
DCE, 24 h, then H3O+
+
O
PhO Ph
OH
50 39
51a : 72% (syn:anti = 3.4:1)
syn 87% ee, anti 34% ee
52 : (R)-BINAP
PPh2
PPh2
O
PhO Np
OH
51c : 82% (syn:anti = 3.8:1)
syn 80% ee, anti 13% ee
O
PhO Et
OH
51b : 59% (syn:anti = 5.1:1)
syn 88% ee, anti 7% ee
O
PhO Cy
OH
51d : 54% (syn:anti = 3.9:1)
syn 84% ee, anti 48% ee
 
Scheme 18 Asymmetric rhodium-catalysed reductive aldol reaction 
 
Although further studies by Morken et al. into this reactivity of the asymmetric rhodium-
catalysed reductive aldol reaction resulted in little improvement in terms of yield and 
selectivity, greater mechanistic insight was achieved.25 The dinuclear µ-hydride bridged 
Rh(I) species, [(BINAP)Rh-H/H-Rh(BINAP)] was postulated to be the active hydride 
species generated in situ from (R-BINAP)Rh(COD)BF4 and PhMe2SiH. Morken et al. also 
showed that without acidic hydrolysis the silyl protected aldol product could be isolated.26 
Reductive aldol product 55 was found to be a precursor to the C10-C24 ketone fragment of 
the inostamycin family of polyether antibiotics 56 (Scheme 19); synthesis of this fragment 
also uses a reductive Claisen rearrangement which will be discussed later (cf. 1.8).27
 
O
PhO
O
H
[Rh(cod)Cl]2 (2.5mol%)
(S)-52 (5.5 mol%)
Et2MeSiH
DCE, 24 h, then H3O+
+
53 54
O
PhO
Et
OH
55 : 76% (syn:anti = 4.3:1)
88% ee
TESO
Et
OH O
TES
Et Pr
56
(S)-52 : (S)-BINAP
PPh2
PPh2
 
Scheme 19 A key step in the synthesis of the C10-C24 ketone fragment of inostamycins 
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Remaining with the group 9 transition metals, Morken et al. used indane-Pybox 58 in the 
asymmetric iridium-catalysed reductive aldol reaction (Scheme 20). This showed greater 
enantio- and diastereocontrol than the previously reported rhodium – BINAP system, 
however, reaction scope was limited to benzaldehyde and α-alkoxy aldehydes.28 The aldol 
product 57b was used by Morken et al. as a precursor in the synthesis of biologically active 
macrocyclic borrelidin 59.29  
 
O
MeO
O
RH
[Ir(cod)Cl]2 (2.5 mol%)
58 (7.5 mol%)
Et2MeSiH
DCE, r.t., 16 h, then H3O+
+
47 39
58 : indane-Pybox
NO
N N
O
O
MeO Ph
OH
57a : 68% (syn:anti = 6.6:1)
syn 94% ee
O
MeO
OH
57c : 47% (syn:anti = 8.2:1)
syn 96% ee
O
MeO
OH
57b : 49% (syn:anti = 9.9:1)
syn 96% ee
O
MeO
OH
57d : 65% (syn:anti = 2.7:1)
syn 82% ee
OBn
OTBS
OBn
OH
O
Me Me Me
OH
O
Me
NC
H
CO2H
H
59 : borrelidin  
Scheme 20 Asymmetric iridium-catalysed reductive aldol reaction 
 
Both Morken’s rhodium- and iridium-catalysed reductive aldol processes are moderately 
syn-diastereoselective. Nishiyama et al. developed conditions, formerly used for conjugate 
reduction,30,31 to allow for a highly anti-selective rhodium-catalysed reductive aldol 
reaction to proceed using Rh(Phebox) catalysts 62a and 62b along with a range of alkoxy- 
and alkylsilanes.32 With very short reaction times (0.5 – 1 hour), a number of different 
aldehydes were coupled with tert-butyl acrylate (Scheme 21). Aromatic aldehydes gave 
consistently high anti-selectivities (up to 98:2) and enantioselectivities (up to 96% ee), 
while cinnamaldehydes and aliphatic aldehydes proved to be more challenging. 
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O
tBuO H R
O
62a or 62b (1 mol%)
(EtO)2MeSiH (1.6 mmol)
toluene, 50 oC
0.5 - 1 h, thenH3O+
+
O
tBuO Ph
OH
61a : cat 62a : 91% (anti:syn 95:5)
anti 91% ee, syn 11% ee
: cat 62b : 98% (anti:syn 98:2)
anti 94% ee, syn 57% ee
O
tBuO Np
OH
61c : cat 62a : 95% (anti:syn 98:2)
anti 95% ee, syn 23% ee
: cat 62b : 97% (anti:syn 98:2)
anti 96% ee, syn -
O
tBuO
OH
61b : cat 62a : 56% (anti:syn 81:19)
anti 93% ee, syn 76% ee
O
tBuO Cy
OH
61d : cat 62a : 58% (anti:syn 95:5)
anti 95% ee, syn 5% ee
: cat 62b : 72% (anti:syn 86:14)
anti 93% ee, syn 57% ee
Ph
O
N N
O
R R
Rh
OH2
AcO OAc
62a : R = iPr : Rh(Phebox-ip)(OAc)2(aq)
62b : R = Bn : Rh(Phebox-bn)(OAc)2(aq)
60 39
 
Scheme 21 Highly anti-selective rhodium-catalysed reductive aldol reaction 
 
Although further modifications of the Phebox skeleton resulted in a detrimental effect on 
the anti-selectivity of the process, it did allow for the synthesis of β-hydroxy carboxylic 
acids by the hydrolysis of the reductive aldol product (Scheme 22).33,34
 
O
TMSO H Ph
O
62a or 62c (1 mol%)
(EtO)2MeSiH (1.6mmol)
toluene, 50 oC
0.5 h, then H3O+
+
O
HO Ph
OH
64 : cat 62a : 98% (anti:syn 86:14)
anti 86% ee, syn 3% ee
: cat 62c : 93% (anti:syn 91:9)
anti 88% ee, syn 37
O
N N
O
R R
Rh
OH2
AcO OAc
62a : R = iPr, X = H : Rh(Phebox-ip)(OAc)2(aq)
62c : R = Bn, X = NO2 : Rh(Phebox-bn)(OAc)2(aq)
X
63 9
 
Scheme 22 Asymmetric synthesis of β-hydroxy carboxylic acids 
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Using Rh(Phebox-Ph) 62d, Nishiyama et al. were able to couple cyclopentenone and aryl 
aldehydes with excellent anti-selectivity as well as high yields and enantioselectivities for 
the favoured anti-product. However, yields and selectivities for this transformation tail 
away on using other cyclic enones and vinyl methyl ketone (Scheme 23).35
 
O O
H
62d (1 mol%)
Ph2MeSiH (1.7 mmol)
toluene, 50 oC
1 h, then H3O+
+
O OH OH
OH OH
O
O
O O
67 : 90% (anti:syn 94:6)
anti 90% ee, syn 85% ee
68 : 31% (anti:syn 93:7)
anti 80% ee, syn -
69 : 68% (anti:syn 94:6)
anti 70% ee, syn -
70 : 32% (anti:syn 80:20)
anti 57% ee, syn -
O
N N
O
Ph Ph
Rh
OH2
AcO OAc
62d : Rh(Phebox-Ph)
65 66
 
Scheme 23 Intermolecular reductive coupling of enones and aldehdyes 
 
Nishiyama et al. also observed high yields and selectivities when applying their 
Rh(Phebox) reductive system to the reductive coupling of acrylates and ketones.36 The 
reductive coupling of acrylates with both aldehydes and ketones enabled Nishiyama et al. 
to access both enantiomers of the α-chiral dihydroxinnamate 74 using the same chiral 
ligand.37 Reductive coupling of 71 with p-anisaldehyde 72 and subsequent dehydroxyation 
gave (S)-74, while reductive coupling of 75 with acetone and subsequent dehydration and 
reduction gave (R)-74 (Scheme 24). 
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O
EtO Me
Me
H
O
OMe
+
Rh(Phebox-ip) 62a (1 mol%)
MePh2SiH (1 equiv)
toluene, 50 oC, 0.5 h
then KF
O
EtO
OH
OMe
O
EtO
OMe
Et3SiH
CF3CO2H
71 72 73 : 20% (S)-74 : 81% (80% ee)
O
EtO
75
OMe
Rh(Phebox-ip) 62a (1 mol%)
MePh2SiH (1 equiv)
acetone
toluene, 50 oC, 0.5 h
then KF
O
EtO
76
OMe
OH
O
EtO
77
OMe
MsCl
Et3N
O
EtO
OMe
(R)-74 : overall 70% (91% ee)
Pd/C, H2 (1 atm)
MeOH
 
Scheme 24 Synthesis of α-chiral dihydrocinnamates 
 
Krische et al. were faced with a number of challenges on attempting asymmetric 
hydrogenative aldol couplings mediated by molecular hydrogen.38 Firstly, only trace 
amounts of product were observed when a chelating phosphine ligand was used. Secondly, 
as seen in prior studies,18-21 π-acidic ligands were required. Finally, commercially available 
chiral π-acidic phosphine ligands, such as phosphites and phosphoramidites derived from 
BINOL, gave only trace quantities of product; these ligands were considered too π-acidic. 
 
By ligand design and structural optimisation, Krische et al. identified TADDOL-based 
phosphonite 82 to be an effective monodentate ligand for the enantioselective 
hydrogenative aldol coupling of vinyl ketones with aldehydes (Scheme 25).38 High yields 
(70-97%) and excellent enantioselectivities (86-96%) were observed for reductive coupling 
of vinyl ketones and α- and β-heteroatom substituted aldehydes as well as α-(hetero)aryl 
substituted aldehydes. When using acrylates only conventional hydrogenation was 
observed. It was also found that less activated aldehydes could not be tolerated in this 
reaction. 
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OEt
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S
Me Me
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R
O OH
Ph
79a : R = Me, 70% yield
(syn:anti 25:1) syn 90% ee
79b : R = Et, 76% yield
(syn:anti 22:1) syn 90% ee
R
O OH
81a : R = Me, 92% yield
(syn:anti 15:1) syn 86% ee
81b : R = Et, 97% yield
(syn:anti 25:1) syn 90% ee
NMe
82 : AbbasPhos-1 (AP-I)
13 R= Me
38 R= Et
39
 
Scheme 25 Asymmetric rhodium-catalysed reductive aldol reaction mediated by molecular hydrogen 
 
1.2.2 Copper-Catalysed Reductive Aldol Reactions 
 
Following a number of studies into the copper-catalysed reductive aldol reaction using the 
phosphine stabilized hexamer Stryker’s reagent, [Ph3PCuH]6,39-45 and encouraged by the 
development of the asymmetric copper-catalysed conjugate reduction reaction,6,46 Lam et 
al. reported the diastereo- and enantioselective synthesis of β-hydroxylactones.47 Lam 
found Cu(OAc)2.H2O to be a convenient copper salt for the transformation along with the 
inexpensive siloxane 1,1,3,3-tetramethylhydrosiloxane (TMDS) and either DPPF or rac-
BINAP. Moderate yields of diastereotopically pure β-hydroxylactones were observed for 
both five- and six-membered rings, despite the former’s 5-(enolendo)-exo-trig cyclisation 
being formally disfavoured by Baldwin’s rules (Scheme 26).48 A range of chiral 
bisphosphines was screened and enantioselectivities of up to 83% ee were observed when 
(R)-3,5-xylyl-MeO-BIPHEP 90 was employed as the ligand (Scheme 27).  
 
 15
Chapter 1 
O
O
R
R'
O
n
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Scheme 26 Copper-catalysed synthesis of β-hydroxylactones 
 
O
O
Me
O
2
Cu(OAc)2.H2O (5 mol%)
90 (5mol%)
TMDS (1 equiv)
THF, r.t., 24 h
88 89 : 71%, 83% ee
O
O
HO
Me
Cl
Cl
MeO
MeO
P(Xylyl)2
P(Xylyl)2
90 : (R)-3,5-xylyl-MeO-BIPHEP  
Scheme 27 Asymmetric copper-catalysed β-hydroxylactone synthesis 
 
Lam proposed a catalytic cycle initiated by the formation of a copper-(I)-bisphosphine 
hydride complex 91 from Cu(OAc)2, TMDS and a bisphosphine ligand. Hydrometallation 
of substrate 83 forms the copper enolate 92, carbon-carbon bond formation then occurs to 
give aldolate 93. Reaction of 93 with TMDS gives copper-(I)-complex 91 and silylated 
product 94 which undergoes protodesilylation on acidic work-up (Scheme 28). 
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Scheme 28 Proposed mechanism for the copper-catalysed reductive aldol reaction 
 
By moving from an intramolecular reductive aldol reaction using keto-acrylates to those 
using keto-acrylamides, Lam et al. synthesised 4-hydroxypiperidin-2-ones.49 Yields of 4-
hydroxpiperidin-2-ones were comparable to those observed for the synthesis of β-
hydroxylacones (Scheme 29). The enantioselective synthesis of highly functionalised 
piperidin-2-ones from enantiomerically enriched substrates was achieved using this 
methodology; reduction of piperidin-2-ones 96 and 94 gave the potentially biologically 
active polyhydroxylated piperidines 98 and 99 (Scheme 29). 
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O
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O OEt
Cu(OAc)2.H2O (5 mol%)
dppf (5 mol%)
TMDS (1 equiv)
THF, r.t., 24 h
N
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HO
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BH3.THF
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N
Me
Me
HO
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N
Me PMP
H
HO
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OH
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Scheme 29 Synthesis of piperidin-2-ones and piperidines 
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Lipshutz et al. reported the asymmetric reductive cyclisation of β,β’-disubstituted keto-
enones, resulting in the generation of 6-membered cyclic products containing three 
contiguous new stereogenic centres as a single diastereomer with enantiomer excesses of up 
to 97% (Scheme 30).50 Yields and selectivities for this impressive transformation were 
found to be uniformly high and unaffected by the geometry of the enone. The added 
stereocontrol comes from the formation of the new stereogenic centre after the initial 
asymmetric conjugate reduction of the enone. 
 
O
Me R
O
Me
Me
O
R
O
Me
Cu(OAc)2 (5 mol%)
103 (1 mol%)
(EtO)2MeSiH (1.5 euiqv)
toluene, 12 h, -10 oC
Me OH
Me
Me
O Ph OH
Me
Me
O
Me OH
Me
Me
O Ph OH
Me
Me
O
Cu(OAc)2 (5 mol%)
103 (1 mol%)
(EtO)2MeSiH (1.5 euiqv)
toluene, 12 h, -10 oC
101a : 91%, 96% ee 101b : 77%, 97% ee
101a : 88%, 96% ee 101b : 98%, 85% ee
100a R= Me
100b R = Ph
102a R = Me
102b R= Ph
Fe PPh2
103 : (S,R)-PPF-P(tBu)2
(tBu)2P
Me
 
Scheme 30 Reductive cyclisation to give three contiguous asymmetric stereogenic centres 
 
Riant et al. used the pre-catalyst [CuF(Ph3P)3].2MeOH for the intermolecular asymmetric 
copper-catalysed reductive aldol reaction; the chiral copper-hydride species was formed 
from chiral bisphosphine ligands and PhSiH3.51 A range of chiral bisphosphines was used 
to couple methyl acrylate and aromatic ketones. Highest diastereo- and enantioselectivities 
were achieved with (R,S)-Cy-TANIAPHOS 106; like all ferrocene based ligands screened, 
erythro-selectivity was observed (Scheme 31). 
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O
MeO
O
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+
[CuF(PPh3)3].2MeOH (1 mol%)
106 (1-3 mol%)
PhSiH3 (1.4 equiv)
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MeO Ph
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O
MeO
OH
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70% (erythro:threo 88:12)
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O
MeO
OH
105b
88% (erythro:threo 91:9)
e 92% ee, t 73% ee
O
MeO
OH
105d
95% (erythro:threo 95:5)
e 95% ee, t 65% ee
F
Cl
S
47 104
FeCy2P
NMe2
Cy2P
106 : (R,S)-Cy-TANIAPHOS  
Scheme 31 Reductive coupling of acrylates and aromatic ketones 
 
Further development of this reductive process led to the asymmetric reductive coupling of 
methyl acrylate and a range of aromatic and aliphatic aldehydes; excellent yields and high 
enantioselectivities were observed for this syn-selective process (Scheme 32).52 Riant also 
showed that anti-selectivity could be achieved for the same transformation by using the N-
heterocyclic carbene-copper catalyst 110 (Scheme 33).53 This process was not limited to 
methyl acrylate as methyl vinyl ketone and acrylonitrile gave comparable results. 
 
O
MeO
O
CyH
+
[CuF(PPh3)3].2EtOH (0.1 mol%)
109 (0.1 mol%)
PhSiH3 (1.4 equiv)
toluene, 0 oC, 16 h
then NH4F, MeOH47 107
FePh2P
NMe2
Ph2P
109 : (R,S)-Ph-TANIAPHOS
O
MeO
108 : 99% (syn:anti 77:23)
syn 95% ee, anti 74% ee
OH
Cy
 
Scheme 32 Riant's syn-selective coupling of acrylates and aldehydes 
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O
MeO
O
CyH
+
110 (1.0 mol%)
PhSiH3 (1.4 equiv)
toluene, -20 oC, 16 h
then NH4F, MeOH47 107
O
MeO
108 : 90% (syn:anti 26:74)
OH
Cy
N NR R
Cu
OO
Ph Ph
110 : Cu(DBM)(IMes)
R = 2,4,6-Me3Ph  
Scheme 33 Riant's syn-selective coupling of acrylates and aldehydes 
 
By using pinacolborane as a stoichiometric reductant and switching copper precatalysts and 
bisphosphine ligands, Shibasaki et al. were able to selectively couple allenic esters and 
ketones either from the α-carbon of the allene, giving the branched product, or the γ-carbon 
of the allene, giving the linear product (Scheme 34).54,55 Cu(OAc)2 and (R)-DTBM-
SEGPHOS 116 gave the γ-aldol product 113 with cis-olefin configuration, high 
enantioselectivities and excellent yields. [CuF(Ph3P)3]•2EtOH and TaniaPhos 115 gave the 
α-aldol product 114 with high diastereoselectivity and moderate to high yields with 
aromatic ketones. 
 
O
MeO
O
Ph
+
Cu(OAc)2 (2.5 mol%)
(R)-DTMB-SEGPHOS (5 mol%)
PCy3 (5 mol%)
pinacolborane (1.6 equiv)
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then H2O
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THF, -20 oC, 16 h
then H2O
OH
CO2Me
Ph
OH
CO2MePh
114 : 96% (γ:α 25:1)
99% ee
111 112 113 : 90% (10:1 d.r.)
84% ee
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PAr2
tBu
OMe
tBu
Ar =
116 : (R)-DTBM-SEGPHOS  
Scheme 34 Enantio- and regioselective reductive coupling of allenic esters and ketones 
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1.2.3 Cobalt-Catalysed Reductive Aldol Reactions 
 
Shortly after Revis and Hilty’s original paper on the rhodium-catalysed reduction-aldol 
reaction,8 Isayama and Mukaiyama reported a cobalt-catalysed reductive aldol reaction 
using α,β-unsaturated nitriles, amides and esters.56 Phenylsilane was used as a hydride 
source and Co(II)(dpm) was used as a precatalyst, although high yields were observed, 
selectivity was poor with a syn:anti of 72:28 being achieved at best (Scheme 35). 
 
X
O
PhH
+
Co(dpm)2 (5mol%)
PhSiH3 (2 equiv)
DCE, 20 oC, 12 h
then H3O+
X
Me
Ph
OH
117 : X = CN
118 : X = C(O)NMe2
47 : X = CO2Me
9 119 : X = CN : 93% (syn:anti 1:1)
120 : X = C(ONMe2 : 96% (syn:anti 1:1)
57a : X = CO2Me : 80% (syn:anti 72:28)  
Scheme 35 Cobalt-catalysed reductive aldol reaction 
 
Later, Krische et al. employed Isayama and Mukaiyama’s cobalt-catalysed reductive 
conditions in an intramolecular reductive aldol reaction giving five-, six- and seven 
membered cycloreduction products.57,58 In contrast to the intermolecular reductive aldol 
reactions reported by Isayama and Mukaiyama, exceptional syn-selectivities (>99:1 for all 
examples) were reported by Krische et al. (Scheme 36). This has been explained on the 
basis of a Zimmerman-Traxler type transition state.  
 
Co(dpm)2 (5 mol%)
PhSiH3 (2 equiv)
DCE, 25 oC, 12 h
then H3O+
O
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OH
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OH
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O
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n
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121a : n = 1
121b : n = 2
121c : n = 3
122a : n = 1 : 70%
122b : n = 2 : 87%
122c : n = 3 : 35%
 
Scheme 36 Intramolecular cobalt-catalysed reductive aldol reaction 
 
 21
Chapter 1 
Lam et al. investigated a cobalt-catalysed alternative to their diastereo- and enantioselective 
copper-catalysed synthesis of β-hydroxylactones and β-hydroxylactams.59 A variety of 
stoichiometric reductants were screened, hydrosilanes gave complex reaction mixtures 
while, after investigating organometallic reagents with β-hydride-containing alkyl groups 
(Et3B and Et2Zn),60-65 efficient reductive cyclisation occurred with the use of diethylzinc. 
High yields and diastereoselectivities were observed with Co(acac)2 hydrate when forming 
4-hydroxypiperidin-2-ones and CoCl2 ligated with Cy2PPh was found to be an effective 
catalyst system with substrates 123a and 123b; these showed incomplete conversion with 
Co(acac)2 hydrate (Scheme 37). 
 
O
NR
R'
R''
O
n
Co (cat.)
ligand (cat.)
Et2Zn (2 equiv)
THF, hexane
0 oC to r.t.
Method A : Co(acac)2.H2O (5 mol%)
Method B : CoCl2 (5.5 mol%), Cy2PPh (5.5 mol%)
N
O
PMP
Ph
Me
HO
124 : MethodA
89%, 12:1 dr
N
O
Bn
Me
Ph
HO
125 : Method A
94%, >19:1 dr
N
O
PMP
Me
126 : Method B
80%, >19:1 dr
O
127 : Method B
74%, 14:1 dr
Ph
CO2Et
N PMP
OMe
HO
Me
123a n = 1
123b n = 2
 
Scheme 37 Cobalt-catalysed reductive aldol reaction mediated by Et2Zn 
 
This cobalt-catalysed reductive aldol reaction was not found to be limited to intramolecular 
transformations, both N,N’-dimethylacrylamide 118 and 4-acryloylmorpholine 128 were 
coupled with aliphatic, aromatic and heteroaromatic ketones.66 Moderate diastero-
selectivities were observed, however, ortho-substitution on acetophenone derivatives 
promoted selectivity to 9:1 (Scheme 38). β-Substitution on the olefin resulted in a large 
elevation in the diastereoselectivity, with 135 and 136 being accessed with 
diastereoselectivities of >19:1 (Scheme 39). 
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O
R2N
O
R'Me
+
Co(acac)2.H2O (5 mol%)
Et2Zn (2 equiv)
THF, hexane, 0 oC
O
N
Me OH
130 : 75% (5:1 dr)
O
N
Me OH
132 : 80% (5.5:1 dr)
O
N
Me OH
O
N
Me OH
133 : 84% (9:1 dr)
131 : 68% (9:1 dr)
118 NMe2
128 morpholine
129
O O
 
Scheme 38 Intermolecular cobalt-catalysed reductive aldol reaction 
 
O
N
O
PhMe
+
Co(acac)2.H2O (5 mol%)
Et2Zn (2 equiv)
THF, hexane, 0 oC
O
N Ph
Me OH
135 : 76% (>19:1 dr)
O
N Ph
Me OH
136 : 71% (>19:1 dr)134 112
R'
OO
Me PhO
 
Scheme 39 Reductive aldol reaction using β-substituted acrylamides 
 
To develop an asymmetric variant of this reaction Lam turned to a chiral auxiliary strategy; 
ligation of cobalt was not an option for asymmetric induction due to it being a zinc-, not a 
cobalt-, enolate involved in the key carbon-carbon bond forming step.67  N-
Acryloyloxazolidine 137 was identified as a suitable substrate reacting with acetophenone 
to give the aldol product 138 in 73% yield and with a 11:1 diastereoselectivity. A range of 
aromatic and heteroaromatic ketones revealed the aldol product in moderate yields (58-
76%) and good diastereoselectivities (up to 13:1); as with α,β-unsaturated morpholine 
amides (Scheme 39), substitution on the β-carbon improved reaction yields and selectivities 
(Scheme 40). 
 
O
PhMe
+
Co(acac)2.H2O (5 mol%)
Et2Zn (2 equiv)
THF, hexane, 0 oC
138 : 73% (11:1 dr) 139 : 86% (>19:1 dr)137 112
O N
O
R O N
O
Ph
Me
Me OH
Ph
Me Me Me Me
Ph
O N
O
Ph
Me OHMe Me
Ph Ph
 
Scheme 40 Cobalt-catalysed reductive aldol reaction controlled by a chiral auxiliary 
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1.2.4 Nickel-Catalysed Reductive Aldol Reactions 
 
Alongside the cobalt catalysis described above, Lam developed a complementary nickel 
catalysed intramolecular reductive aldol reaction forming β-hydroxylactams and β-
hydroxylactones, again using a diethylzinc as a stoichiometric reductant.68 This nickel-
catalysed reductive aldol reaction showed higher reactivity than the cobalt system; 
substrates which had previously shown little or no reactivity now gave the desired products 
(Scheme 41). 
 
N
O
R''
O Et2Zn (2 equiv)Ni(acac)2 (5 mol%)
THF, hexane
0 oC to r.t.R'
123b
R
N
O
HO
Me
Bn
Me
125 : 97% (>19:1)
N
O
HO
Me
Bn
141 : >99% (>19:1)
N
O
HO
Me
Bn
Ph
140 : 97% (>19:1)
N
O
Bn
Me
142 : 62% (>19:1)
O HO
CO2Et
 
Scheme 41 Nickel-catalysed reductive aldol reaction mediated by Et2Zn 
 
A problem encountered with this nickel system is that of competitive alkylative aldol 
reaction, a side reaction which is not observed under cobalt catalysis. Substrate 143 gave 
reductive aldol product 144 in 17% yield and alkylative aldol product 145 in 51% yield 
(Scheme 42). Lam found that this competitive alkylation is eliminated by the addition of α- 
or β-substituents on the acrylamide.  
 
N
O
Me
O Et2Zn (2 equiv)Ni(acac)2 (5 mol%)
THF, hexane
0 oC to r.t.Bn
N
O
Me
HO
Me
N
O
iPr
HO
Me
143 144 : 17%
>19:1 dr
145 : 51%
>19:1 dr
+
Bn Bn
 
Scheme 42 Competative alkylative aldol reaction 
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The synthesis of six-membered β-hydroxylactones was also successful under nickel 
catalysis, a transformation which was found not to be possible under the comparable cobalt 
reductive conditions; the results observed were comparable to those shown with the keto-
acrylamides (Scheme 43). However, a significant quantity of the alkylative aldol product 
was observed with electron-deficient substrates. 
 
R O
O
Me
O
Et2Zn (2 equiv)
Ni(acac)2 (5 mol%)
THF, hexane
0 oC to r.t.
O
O
HO
Me
MeO
O
O
HO
Me
O
147a : 76% (>19:1) 147b : 81% (>19:1)146  
Scheme 43 β-Hydroxy lactone synthesis 
 
In this initial study into nickel catalysis, Lam et al. observed the formation of bicyclic 
product 150, a product of the zinc alkoxy aldol product 149 undergoing lactonisation 
(Scheme 44). Following this observation Lam et al. carried out a formal synthesis of 
salinosporamide A 154, a potent 20S proteasome inhibitor and anti-cancer compound.69 
Formation of the β-hydroxy-γ-lactam core of 154 required the reductive cyclisation-
lactonisation of 151, a much more highly functionalised precursor than previously used. 
Bicyclic 153a was isolated in 42% yield and was transformed, in a number of steps, to 
salinosporamide A 154 (Scheme 45). 
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0 oC to r.t.Bn
148
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N
O
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O
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O
O
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149 150 : 89% (>19:1)  
Scheme 44 Reductive aldol-lactonisation 
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Scheme 45 Nickel-catalysed reductive aldol-lactonisation reaction, a key step in the synthesis of 154 
 
Prior to work done by Lam et al. on the nickel-catalysed reductive aldol cyclisation, 
Chrovian and Montgomery reported a similar system in which triethylborane was used as 
the terminal reductant.70 The reaction was found to be initiated by phenyl iodide and only 
5% of the Michael aldol side-product was observed. High yield and syn-selectivity was 
observed for this process with a range of aldehydes (Scheme 46). 
 
O
tBuO
O
RH
+
Ni(cod)2 (10mol%)
PhI (1.0 equiv)
Et3B (2.0 equiv)
THF, 65 oC
O
tBuO
Me
Ph
OH
61a : 87%
(syn:anti 88:12)
O
tBuO
Me
OH
61e : 91%
(syn:anti 88:12)
O
tBuO
Me
OH
61f : 86%
(syn:anti 90:10)
O
tBuO
Me
OH
61g : 68%
( syn:anti 96:4)
O
CN
Et
Et
60 39
 
Scheme 46 Nickel-catalysed reductive aldol reaction mediated by BEt3
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1.2.5 Palladium-Catalysed Reductive Aldol Reactions 
 
Little work has been carried out on tandem reductive processes initiated by a palladium-
catalysed conjugate reduction. In a rare example, Kiyooka et al. illustrated the substrate 
dependence of the palladium-catalysed reductive aldol reaction. Anti-selectivity (syn:anti 
32:68) was observed in the coupling of N,N’-dimethylacrylamide 118 with benzaldehyde 9, 
whereas, syn-selectivity (syn:anti 72:28) was observed when using tert-butyl acrylate 60 
with a significant depletion of yield (Scheme 47).71
 
O
X
O
PhH
+
Pd(PPh3)4 (5 mol%)
Cl3SiH (1.3 equiv)
DCM, r.t. 45 h
thenH3O+
O
Me2N Ph
OH O
tBuO Ph
OH
118 X = NMe2
60 X = OtBu
9 120 : 87% (syn:anti 32:68) 61a : 37% (syn:anti 72:28)
 
Scheme 47 Palladium-catalysed reductive aldol reaction 
 
A further example comes from an investigation into the application of dehydroamino acid 
derivatives in tandem processes. A palladium-catalysed reductive aldol reaction was 
achieved using n-Bu3SnH as a hydride donor, N-phthaloyl dehydroalanine 155 and 
benzaldehyde 9 gave a mixture of 156 and 157 (Scheme 48).72  
 
O
NPhth
EtO
155
O
PhH
+
9
Pd(PPh3)4 (10 mol%)
nBu3SnH (1.2 equiv)
DCM, r.t. 2 h
thenH3O+
O
EtO
156 : 65% (9:1 dr)
Me NPhth
Ph
OH O
Me
NPhth
EtO
157 : 16%
+
 
Scheme 48 Reductive coupling of N-phthaloyl dehydroalanine and benzaldehyde 
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1.2.6 Indium-Catalysed Reductive Aldol Reactions 
 
As with palladium-catalysis, there are few reports of indium-catalysed reductive aldol 
reactions; however, those few reports disclose highly selective processes. Baba et al. used 
stoichiometric amounts of InBr3 with n-Bu3SnH for the reductive aldol reaction between 
enones and aromatic aldehydes.73 Interestingly, selectivity could be switched by the 
addition of water to the solvent system (Scheme 49). When carried out in anhydrous THF 
the thermodynamically favourable product was observed (syn:anti 4:96); addition of water 
to the solvent system (THF/H2O : 9/1) led to the kinetically favourable product (syn:anti 
95:5). 
 
O
Ph Me
O
H
Me
InBr3 (1.2 equiv)
nBu3SnH (1.2 equiv)
THF
-78 oC to r.t., 1 h
O
Ph
Me
OH
Me
InBr3 (1.2 equiv)
nBu3SnH (1.2 equiv)
THF/H2O (9/1)
-78 oC to r.t., 1 h
O
Ph
Me
OH
Me
160 : 77% (syn:anti 95:5) 158 159 160 : 89% (syn:anti 4:96)
+
 
Scheme 49 Indium-promoted reductive aldol reaction 
 
Baba et al. showed that sub-stoichiometric amounts of InBr3 could be used in conjuction 
with triethylsilane; this led to excellent syn-selectivity (typically syn:anti >99:1) with 
aromatic aldehydes and enones.74 This high syn-selectivity can be attributed to the 
formation of a (Z)-indium enolate as conjugate reduction occurs to the s-cis configured 
enone. 
 
O
Ph Me
O
H
InBr3 (10 mol%)
Et3SiH (1.2 equiv)
EtCN
0 oC, 4 h
O
Ph
OH
Me
158 9 162 : 78% (syn:anti 92:8)
+ O
InBr2O
Ph
H
Ph
H
Me
161  
Scheme 50 Indium-catalysed reductive aldol reaction 
 
Adding to the findings of Baba et al., Miura and Hosomi reported the indium-catalysed 
conjugate reduction and reductive aldol reaction using In(OAc)3 and PhSiH3.75 Reported 
yields were comparable to those reported by Baba while selectivity was lower for the 
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reductive coupling of aryl aldehydes and enones. However, these conditions were adapted 
for the intramolecular reductive aldol reaction of 163a and 163b. Complete stereocontrol 
was observed with the six-membered product 164b, while 163a gave five-membered 164a 
as a 62:38 ratio of the cis:trans isomers (Scheme 51). 
 
O
Ph
O
In(OAc)3 (10 mol%)
PhSiH3 (1.0 equiv)
THF/EtOH
0 oC, 4h
Me
163a : n = 1
163b : n = 2
n
Ph
O Me OH
Ph
O Me OH
164a : 85%
(cis:trans 62:38)
164b : 90%
(cis:trans >99:1)  
Scheme 51 Indium-catalysed intramolecular reductive aldol reaction 
 
1.3 Reductive Mannich Reactions 
 
Reductive Mannich reactions offer an efficient route to β-amino esters, which are excellent 
intermediates in the synthesis of β-amino acids and β-lactams. This challenging 
transformation requires anhydrous conditions and needs to avoid competitive imine 
reduction. The majority of examples of reductive Mannich reactions involve the reductive 
coupling of Michael acceptors to aldimines. 
 
Following a two-step synthesis of β-lactams via a reductive Mannich reaction reported by 
Isayama,56 Morken et al. reported the synthesis of β-lactams via an iridium-catalysed 
reductive Mannich reaction.76 Under the reductive conditions the Mannich product is 
cyclised to give the β-lactam in high yields and trans-selectivity. Yields were significantly 
higher with pentafluorophenyl acrylate; a yield of only 13% was observed with phenyl 
acrylate (Scheme 52).  
 
O
C6F5O
N
H R'
PMP
+
[Ir(cod)Cl]2 (2.5. mol%)
P(OPh)3 (10 mol%)
Et2MeSiH (2.5 equiv)
DCE, 60 oC, 6 h
N
PMP O
N
PMP O
Ph
N
PMP O
C5H11
165 166 167 : 80%
(trans:cis >20:1)
168 : 71%
(trans:cis 5.2:1)
169 : 58%
(trans:cis >20:1)  
Scheme 52 Iridium-catalysed β-lactam synthesis 
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Aldimines were coupled with methyl acrylate using a cationic rhodium complex 
[Rh(COD){P(OPh)3}2]OTf and Et2MeSiH by Matsuda.77 This synthesis of β-amino esters 
occurs with slight anti-selectivity and high to excellent yields; highest yields were observed 
with N-tosylaldimines. Greater diastereoselectivity was achieved by Nishiyama et al. who 
applied their Rh(Phebox) ligands to the reductive Mannich reaction which, although gave 
high yields and moderate diastereoselectivities, did not result in any enantioselectivity 
being observed when a chiral Rh(Phebox) complex was used.78 Excellent anti-selectivity 
was achieved when coupling cinnamate 170 and aldimine 171; such high selectivity was 
not observed with tert-butyl acrylate 60 (Scheme 53). 
 
O
RO R'
+ N
PhH
Ph
Rh(Phebox) 62e (1 mol%)
(EtO)2MeSiH (2 equiv)
THF, 50 oC, 1 h
then H2O
O
EtO Ph
HN
Ph
Ph
O
tBuO Ph
HN
Me
Ph
170 R= Et,
R' = Ph
60 R= tBu,
R' =H
171 172 :71%
(anti:syn>99:1)
173 :79%
(anti:syn 82:18)
O
N N
O
Rh
OH2
AcO OAc
tBu
6e  
Scheme 53 Rh(Phebox)-catalysed reductive Mannich reaction 
 
Lam applied the cobalt-catalysed conditions developed for the reductive aldol reaction, 
using diethylzinc as a stoichiometric reductant,59,66 to the coupling N-tosylaldimines 174 
with 4-acryloylmorpholine 128.79 Moderate to good yields and diastereomeric ratios of up 
to 88:12 (anti:syn) were observed for the transformation which proceeds via a zinc enolate 
(Scheme 54). 
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N +
N
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0 oC to r.t.
O
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72% yield of anti
175b : 88:12 dr
67% yield of anti
O O Me
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O
 
Scheme 54 Cobalt-catalysed reductive Mannich reaction 
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After the success of the molecular hydrogen mediated reductive aldol reaction (cf. 1.2.1.2),5 
Krische reported the rhodium-catalysed reductive Mannich coupling of vinyl ketones to N-
sulfonylimines mediated by hydrogen.80 Using the same conditions as the reductive aldol 
chemistry the reductive coupling of methyl vinyl ketone and N-arylaldimides gave the 
Mannich products in excellent yields (88-99%) but with poor diastereoselectivity (<2:1 dr). 
To overcome the problem of poor selectivity, caused by the facile geometrical 
isomerisation of the N-arylaldimine in the presence of rhodium,81,82 N-sulfonylimines were 
employed as the reaction electrophile as they are conformationally more stable. Attention 
was turned to the coupling of vinyl ketones and N-(o-nitrobenzenesulfonyl)imines 176 due 
to the ease of deprotection of the Mannich adducts. Good yields and excellent syn-
diastereoselectivities were observed (Scheme 55). 
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O
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Scheme 55 Diastereoselective hydrogen-mediated reductive Mannich reaction 
 
The only example of transition metal catalysed reductive Mannich reactions to ketimines 
comes from Shibasaki et al. who coupled acrylates with N-diphenylphosphinoyl ketimines 
179 under copper catalysis.83 Initial efforts focused on diastereoselective reductive 
Mannich reactions. Pinacolborane was used as a stoichiometric reductant and 
triphenylphosphine as a ligand; excellent yields (up to 94%) and diastereoselectivities (up 
to 99:1) were observed. The high yields and diastereoselectivities remained on addition of 
(R)-DIFLUORPHOS 181 which, with (EtO)3SiH, gave the β-amino acids with high 
enantiomeric excess (Scheme 56). Acid hydrolysis of the diphenylphosphinoyl group gave 
the free amine with no racemisation or epimerisation. 
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Scheme 56 Reductive Mannich reaction of acrylates and ketimines 
 
1.4 Reductive Michael Reactions 
 
Only two reductive systems have been applied to the reductive Michael reaction, both these 
intramolecular transformations observe complete trans-selectivity of the cyclic products 
from bis-enones. 
 
Krische et al. reported the cobalt-catalysed intramolecular reductive Michael reaction of 
bis(enones).3,57,58 Interestingly, this reaction gave only the trans-cyclic products in 
moderate to high yields, a switch in selectivity compared to the related intramolecular 
reductive aldol reaction. This reaction worked well for symmetrical bis-enones and 
tolerated heteroatoms in the carboskeleton, which led to the synthesis of cyclic ether 185 
(Scheme 57); however, chemoselectivity was poor using non-symmetrical substrates. 
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O
O
Ph
O
O
182
183 : 73% 184 : 62%
185 : 63% 186 : 52%  
Scheme 57 Cobalt-catalysed reductive Michael reaction 
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Miura and Hosomi’s conditions for the indium-catalysed intramolecular reductive aldol 
reaction (cf. 1.2.6) also were applicable to the related reductive Michael reaction.75 Like 
Krische, Miura and Hosomi observed complete trans-selectivity, with products being 
isolated in high yields (Scheme 58). 
 
O
Ph
n
182
In(OAc)3 (10mol%)
PhSiH3 (1 equiv)
THF, EtOH, reflux
O
Ph Ph
O
n
n = 1 184 : 89%
n= 2 183 : 75%
PhO
 
Scheme 58 Indium-catalysed reductive Michael reaction 
 
 
1.5 Morita-Baylis-Hillman Type Reactions 
 
Matsuda et al. reported the synthesis of Morita-Baylis-Hillman type products from Michael 
acceptors and aldehydes.84-86 The process, catalysed by 1 mol% of either RhH(PPh3)4 or 
RuH2(PPh3)4, involves the formation of metal-aldolate 187. 187 undergoes tautomerisation 
to 188 and subsequent β-hydride elimination, regenerating the metal-hydride species, to 
give the Morita-Baylis-Hillman type product 186 (Scheme 59). 
 
O O
EtH
+
M-H (1 mol%)
40 oC, 40 h
O OH
Et
O O
M
Et
O OH
Et
M
187 188
13 185 186 : 78% RhH(PPh3)4
82% RuH2(PPh3)4
 
Scheme 59 Synthesis of Morita-Baylis-Hillman type products initiated by conjugate reduction 
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1.6 Hydrocarbamoylation Reactions 
 
Matsuda et al. showed aryl isocyanates to be useful coupling partners for rhodium-enolates 
formed from the hydrometallation of α,β-unsatrurated esters.87 The hydrocarbamoylation 
products were formed in high yields regardless of substitution of the Michael acceptor or 
the aryl isocyanate (Scheme 60). No isocyanate reduction was observed. 
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Scheme 60 Rhodium-catalysed hydrocarbamoylation 
 
1.7 Hydroallylations 
 
Matsuda et al. carried out the rhodium-catalysed hydroallylation of Michael acceptors to 
give γ,δ-unsaturated esters in high yields by reductive coupling of acrylates and allylic 
carbonates.88,89 Initial studies showed that regioselectivity was poor unless one terminus 
was sterically disfavoured, for example allylic carbonyl 194 gave 195 and 196 as a 56:44 
mixture, whereas, hydroallylation using 197 resulted in a 95:5 mixture of the two 
regioisomers (Scheme 61). 
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Scheme 61 Rhodium-catalysed hydroallylation 
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To develop this regioselective process further, Matsuda et al. introduced triorganosilyl 
groups to either end of the allylic termini of the allylic carbonate (Scheme 62).89 
Regioselectivities and yields were uniformly excellent using silylated allylic carbonates. 
Acidic protodesilylation proceeded in moderate yields. 
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MeO2CO
Me
SiMe2Ph+
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Me
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Scheme 62 Hydroallylation using silylated allylic carbonates 
 
1.8 Reductive Claisen Rearrangements 
 
The reductive Claisen rearrangement was reported  by Morken and Miller.90 Substituted 
allyl acrylates underwent rhodium-catalysed hydrosilylation and subsequent Ireland-
Claisen rearrangement to give γ,δ-unsaturated carboxylic acids in good yields and 
diastereoselectivities (Scheme 63). The reductive Claisen rearrangement of chiral substrate 
205 proceeded with little drop in enantiopurity. Product 206 was used as a key intermediate 
in the total synthesis of inostamycin (cf. 1.2.1.3).27
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Scheme 63 Rhodium-catalysed reductive Claisen reaction 
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Chapter 2 - Initial Studies into the Reductive Dieckmann 
Condensation 
 
2.1 Dieckmann Condensation 
 
As discussed in chapter 1, catalytic tandem reductive processes have been of great interest 
over the last two decades. Of particular interest is the use of Michael acceptors as latent 
enolates enabling reductive aldol, Mannich and Michael reactions to take place. However, 
to our knowledge there have been no examples of a reductive Dieckmann (or Claisen) 
condensation in which enolate 208, formed after hydrometallation, attacks the ester, 
eliminating an alkoxylate group to give a 1,3-dicarbonyl product 209 (Scheme 64). 
 
O
X
207
[M]-H O
X
208
[M]
OR
O
OR
O
O
X
O
209
- [M]-OR
 
Scheme 64 Proposed reductive Dieckmann condensation 
 
The Dieckmann condensation, an intramolecular variant of the Claisen condensation, is a 
convenient route into the formation of β-keto esters by treatment of a diester with strong 
base, typically sodium alkoxide (Scheme 65).1
 
CO2Et
CO2Et
O
CO2Et
i) NaOEt
ii) H3O+
210 211  
Scheme 65 Dieckmann condensation 
 
Although there are no examples of reductive Dieckmann condensations, comparable 
Michael Dieckmann condensations have been reported. For example, a key step in the 
synthesis of natural product (+/-)-napyradiomycin A1 214 is the Michael Dieckmann 
condensation of 212 with isobenzofuranone 213 (Scheme 66).2
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Scheme 66 Michael Dieckmann condensation as a key step towards the synthesis of (+/-)-napyradiomycin 
 
More recently, Frost et al. have reported the tandem rhodium-catalysed Michael 
Dieckmann condensation as a route to β-keto esters containing an all-carbon quaternary 
centre at the α-carbon.3,4 In their initial study, five- and six-membered β-keto esters were 
formed by the rhodium-catalysed conjugate addition of arylzinc chlorides to α-substituted 
acrylic esters 215a and 215b (Scheme 67). The reaction pathway is unclear with a number 
of possible routes proposed (Scheme 68). 
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Scheme 67 Rhodium-catalysed Michael Dieckmann condensation 
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Scheme 68 Plausible reaction pathways for Frost's Michael Dieckmann reaction 
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To develop this elegant methodology further, Frost et al. introduced a heteroatom into the 
carbon backbone of the α-substituted acrylic ester, enabling the synthesis of 3,3’-
disubstituted 4-oxopyrrolidines containing an all carbon quaternary centre.4 The rhodium-
catalysed addition of aryl boronic acids to acrylate 218, derived from sarcosine ethyl ester, 
was carried out. The desired Michael Dieckmann product 219 was found to be the major 
product of this process (Scheme 69). An addition/elimination reaction also occurs under 
these conditions giving acrylate 220, which can also undergo a Michael addition by a 
second equivalent of aryl boronic acid to give 221 (Scheme 69). 
 
tBuO
O
N
Me
OEt
O
PhB(OH)2 (3 equiv)
[Rh(C2H4)2Cl]2 (5 mol%)
rac-BINAP (5.5 mol%)
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218 219a : 60% 220 : 29% 221 11%  
Scheme 69 Rhodium-catalysed synthesis of 3,3’-disubstituted 4-oxopyrrolidines 
 
After initial studies into the rhodium-catalysed Michael Dieckmann condensation attention 
was then turned to asymmetric induction at the all-carbon quaternary centre by the 
introduction of a chiral ligand. After screening a range of chiral bisphosphines (S)-
DIFLUORPHOS 181 was found to be the most effective ligand giving 3,3’-disubstituted 4-
oxopyrrolidine 219b in a 69% yield and an excellent 96% ee (Scheme 70). The absolute 
stereochemistry of 223a was found to be R by X-ray crystallography. 
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Scheme 70 Asymmetric rhodium-catalysed Michael Dieckmann condensation 
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2.2 Molybdenum-Catalysed Conjugate Reduction 
 
Amongst the vast array of conjugate reduction literature is Keinan’s 1987 report on the 
molybdenum-catalysed conjugate reduction of Michael acceptors,5 a paper which has 
received little attention since publication. In this report, a number of Michael acceptors 
were reduced by molybdenum hexacarbonyl using phenylsilane as the terminal reductant 
(Scheme 71). By 1H NMR and isotope labelling studies, Keinan showed the process 
proceeded via a silyl enol ether which was protonated on addition of water at the end of the 
reaction. Excellent conversions were observed for the reduction of α,β-unsaturated ketones, 
esters, amides, nitriles and carboxylic acids (75-100% conversion determined by GC and 
1H NMR analysis). 
 
X
Ph
Mo(CO)6 (5 mol%)
PhSiH3 (1.5 equiv)
THF, reflux, 1.5-24 h
O
Me Ph
O
iPrO Ph
O
H3CHN Ph
O
HO Ph
NC
Ph
225a : 100% conv. 225b : 90% conv. 225c : 80% conv.
225d : 100% conv. 225e : 90% conv.
224a : X = -COMe
224b : X = -CO2iPr
224c : X = -CONHMe
224d : X = -CO2H
224e : -CN  
Scheme 71 Keinan's molybdenum-catalysed conjugate reduction 
 
It is the availability and low cost of Mo(CO)6 which makes it an attractive catalyst for 
organic transformations. Mo(CO)6 has many applications within organic chemistry. 
Mo(CO)6 can be converted into a range of molybdenum complexes by replacement of its 
carbonyl ligands by both π- and σ-donor ligands, but it can also be used as a catalyst in its 
own right.6 Beyond its use as a safe, convenient source of carbon monoxide,7-24 Mo(CO)6 
has been used in asymmetric allylic alkylations,25 alkyne metathesis,26,27 Pauson-Khand 
reactions,28,29 allenic Pauson-Khand reactions,30-32 [2+2] cyclisation,33 N-O bond 
reduction,34-40 cycloisomerisations41-44 and conjugate reduction.5
 
The catalytic activity of molybdenum depends on the ease in which coordinatively 
saturated Mo(CO)6 is converted to coordinatively unsaturated Mo(CO)6-n. Typically this is 
achieved thermally45 or photochemically.46-51 On investigating the thermal displacement of 
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carbonyl ligands from Mo(CO)6, Keinan showed that, although rapid activation occurs in 
diglyme between 90-100 oC, efficient activation of Mo(CO)6 can be achieved in THF at 
reflux.5 It was also noted that catalytic activity significantly depended on the physical 
removal of carbon monoxide from the reaction mixture; reactivity was retarded when the 
reaction was carried out in a sealed vessel. 
 
2.2.1 α-Substituted Acrylic Esters 
 
Of interest to the Frost group is the functionalisation of α-substituted acrylic esters and α-
substituted acrylic amides through rhodium-catalysed conjugate additions. Frost has shown 
that these challenging substrates can be used in the preparation of 2-alkylsuccinates, both α- 
and β-amino acid derivatives, 2-benzyl pyrrolizidinones, β-keto esters, α,α’-dibenzyl esters 
and in peptide modifications (Scheme 72).3, 52-60
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Scheme 72 Array of products synthesised from α-substituted acrylate esters by the Frost et al. 
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2.2.2 Conjugate Reduction of α-Substituted Acrylic Esters 
 
The use of α-substituted Michael acceptors in catalytic tandem reductive processes is a 
potential route to enantiomerically enriched all-carbon quaternary centres (Scheme 73). 
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Scheme 73 The use of α-substituted acrylic esters in tandem reductive processes 
 
To investigate the reduction of α-substituted acrylic ester, readily available dimethyl 
itaconate (DMI) 229 was used as a model substrate. Reduction of DMI was carried out 
using Keinan’s molybdenum-catalysed conjugate reduction reagents under microwave 
irradiation. It was found that after 10 minutes at 100 oC, complete conversion to dimethyl 
2-methylsuccinate 230 was observed, with a 60% conversion being observed after a period 
of 5 minutes (Table 1, entry 1). With this result in hand, an additive screen was performed 
in an attempt to improve the activity of the reductive system. In this regard, 5 mol% of 
additive was added to the reaction mixture which was heated to 100 oC for 5 minutes (Table 
1).  
 
A range of additives was screened and the reaction was either retarded or completely shut 
down by the addition of both Lewis acids and Lewis bases (Table 1, entries 2-10). 
However, great success was observed on the addition of N-methylmorpholine N-oxide 
(Table 1, entry 11). As discussed above (cf. 2.2), it is the removal of the carbonyl ligands 
from Mo(CO)6 and subsequent removal of carbon monoxide from the atmosphere which is 
key to the activation of the molybdenum catalyst. It is therefore unsurprising that the 
oxidative removal of the carbonyl ligands from Mo(CO)6 by N-methylmorpholine N-oxide 
(NMO) greatly increases the rate of reaction for conjugate reduction of DMI.  
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Table 1 Additive screen for the molybdenum-catalysed reduction of DMI 
O
MeO
OMe
O
Mo(CO)6 (5 mol%)
"additive" (5 mol%)
PhSiH3 (1.5 equiv)
O
MeO
Me
OMe
O
229 230
THF, MW, 100 oC, 5 min
then H2O
 
entry additive conversion, %b
1 no additive 60 
2 DMAP 0 
3 CyNH2 0 
4 triethylamine 18 
5 L-Proline 17 
6 binaphthyl-2,2’-diyl hydrogen phosphate 17 
7 BINOL 55 
8 boric acid 33 
9 BINAP 0 
10 DMSO 20 
11 NMO 100c
a Reaction conditions: DMI (1 equiv), Mo(CO)6 (5 mol%), additive (5 mol%), PhSiH3 (1.5 equiv), THF 
(1 mL); reaction mixtures were heated using microwave irradiation, 100 oC, 5 min (100 W).  
b  Conversions determined by 1H NMR. c 9 mol% of additive was used. 
 
2.2.3 Optimisation 
 
Complete conversion to 230 was still observed on lowering the reaction temperature to 80 
oC, however, reactivity decreased at temperatures below that point (Table 2). When the 
reduction of DMI was carried out at 80 oC over 5 minutes with one equivalent of NMO to 
Mo(CO)6 a drop in conversion from >99% to 56% was observed (entry 4, Table 2). Lower 
catalyst loading also resulted in lower yields (a yield of 22% was observed with a catalyst 
loading of 2 mol%, no product was observed at 1 mol%). Poor reactivity was observed 
when PhSiH3 was replaced with less reactive silanes. Ph2SiH2 gave a 3% conversion by 1H 
NMR whilst Cl3SiH, Me(EtO)2SiH, PMHS and Et3SiH did not react at all. It was also 
found that the reactivity was unaffected when the reaction was heated in an oil bath. 
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Table 2 Effect of temperature and reaction time on the reduction of DMI 
O
MeO
OMe
O
Mo(CO)6 (5 mol%)
NMO (9 mol%)
PhSiH3 (1.5 equiv)
O
MeO
Me
OMe
O
229 230
THF, MW, temperature,
5 min, thenH2O
 
entry temperature, oC time, min conversion, %b
1 100 5 100 
2 80 10 100 
3 80 5 >99 (95% yield) 
4 80 5 56c
5 70 5 69 
6 60 5 26 
7 40 5 20 
a Reaction conditions: DMI (1 equiv), Mo(CO)6 (5 mol%), NMO (9 mol%), PhSiH3 (1.5 equiv), THF 
(1 mL); reaction mixtures were heated using microwave irradiation, 5 min (100 W). b  Conversions 
determined by 1H NMR. 
 
2.2.4 Oxidative Removal of Ligands from Metal Carbonyls 
 
It was Hieber and Lipp who first reported the use of pyridine N-oxides to oxidatively 
remove carbonyl ligands from Fe(CO)5.61 In 1970 Alper and Edward illustrated the 
generality of this process by the deoxygenation of aliphatic, aromatic and heterocyclic 
amine N-oxides with Fe(CO)5; this method of oxidative removal of carbonyl ligands was 
even carried out with brucine N-oxide (BNO) hydrate 231 (Figure 1).62 Alper and Edward 
were the first to propose a mechanism for the transformation, a mechanism which is still 
widely accepted. Nucleophilic attack by the oxygen of the amine N-oxide on the carbonyl 
carbon occurs to form 232 which then eliminates the deoxygenated amine and carbon 
dioxide (Scheme 74). 
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231 : brucine N-oxide
N
O
N+
H
H
MeO
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Figure 1 Brucine N-oxide 
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O
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R
NR3 + CO2 + Fe(CO)4
232  
Scheme 74 Alper and Edward’s mechanism for the decarboxylation of Fe(CO)5 with amine N- oxides 
 
With the use of amine N-oxides as oxidative decarboxylating reagents established,63,64 Shi 
et al. carried out the first kinetic and mechanistic study into the reaction of trimethylamine 
N-oxide (TMANO) with the group 6 hexacarbonyls.65 Shi et al. showed that carbon-oxygen 
bond making and metal-carbon bond breaking contributed to the energies of the rate 
determining step. After decarboxylation by TMANO, (CO)5MPPh3 (M = Cr, Mo, W) was 
formed in the presence of PPh3 and (CO)5MNMe3 in the absence of phosphine (Scheme 
75). 
 
Me3NO + M(CO)6
(OC)5M C O
O NMe3
"(CO)5M" + Me3N
CO2 PPh3
(CO)5MPPh3
(CO)5MNMe3
234
233
M = Cr, Mo, W
 
Scheme 75 Oxidative decarboxylation of M(CO)6 (M = Cr, Mo, W) 
 
The use of amine N-oxides in transition metal catalysed organic transformations has been 
dominated by the Pauson-Khand reaction (PKR) following the discovery of the accelerating 
effects amine N-oxides have on this reaction. Amine N-oxides allow PKRs to be carried out 
at room temperature in high to excellent yields.66,67 More recent developments have seen 
the introduction of recyclable amine N-oxides bound to a solid phase68 and also the use of 
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chiral amine N-oxides in asymmetric PKRs by desymmetrisation of cobalt-alkyne 
complexes.69-75  
 
2.3 Molybdenum-Catalysed Reductive Dieckmann Condensation 
 
Following work by Frost et al. on the Michael Dieckmann condensation forming 3,3’-
disubstituted 4-oxopyrrolidines (cf. 2.1), we set out to develop a reductive Dieckmann 
condensation using molybdenum catalysis. Scheme 76 shows the envisaged reductive 
Dieckmann condensation, hydrosilylation of 234 would give silyl ketene acetal 235 which 
would undergo a 5-(enolexo)exo-trig cyclisation, this is formally favoured by Baldwin’s 
rules.76 Siloxane elimination gives 3,3’-disubstituted 4-oxopyrrolidine 237, a useful 
intermediate in the synthesis of fluoroquinolone antibacterials and their analogues. 
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Scheme 76 Envisaged molybdenum-catalysed reductive Dieckmann condensation 
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2.3.1 Fluoroquinolones 
 
Fluoroquinolones are a potent class of antibacterial agents with a broad spectrum of activity 
making them a valuable target in synthesis.77 Following the discovery of Nalidixic acid 238 
(a by-product from the synthesis of chloroquinine), structure-activity relationship studies 
soon showed that quinolones fluorinated at the C-6 position with a nitrogen containing 
heterocycle at the C-7 position showed fewer toxic effects, improved pharmacokinetic 
properties and extensive and potent activity against Gram-positive and Gram-negative 
bacteria (Figure 2). 
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240 : Moxif loxacin
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Figure 2 Fluoroquinolone antibacterials 
 
In 2004, Choi et al. synthesised fluoroquinolones 247a and 247b containing a chiral 
oxiimino pyrrolidine at the C-7 position. These new fluoroquinolones showed excellent in 
vitro antibacterial activities and pharmacokinetic profiles.78 N-Carboxybenzyl protected 
3,3’-disubstituted 4-oxopyrrolidine 243 was prepared by the Dieckmann condensation of 
glycine derived 241, followed by alkylation by methyl iodine.79 Optically-enriched 
products were obtained by resolution: N-tosyl protected L-proline was attached to the 
primary amine of 244 and diastereomers 246a and 246b were separated by column 
chromatography. This was followed by the base-catalysed removal of the amino acid 
(Scheme 77).  
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Scheme 77 Choi's synthesis of fluoroquinolone antibacterials 247a and 247b 
 
Kim et al. synthesised analogues of the pyrrolopiperidine side group of Moxifloxacin 
240.80 Again, access to optically-enriched materials was achieved by the separation of 
diastereomers 252a and 252b by column chromatography and subsequent removal of the 
optically active oxazolidinone 251 (Scheme 78).  
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Scheme 78 Synthesis of 3a-methylpyrrolo[3,4-c]piperidine 
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Although effective, resolution of products obtained from racemic 3,3’-disubstituted 4-
oxopyrrolidines 243 and 249 does result in poor atom and step economy. We envisage that, 
through an asymmetric reductive Dieckmann condensation, optically active 3,3’-
disubstituted 4-oxopyrrolidines could be obtained efficiently from α-substituted acrylic 
esters. 
 
2.3.2 Racemic Molybdenum-Catalysed Reductive Dieckmann 
Condensation 
 
To study the molybdenum-catalysed reductive Dieckmann condensation, a range of α-
substituted acrylate esters was synthesised bearing different nitrogen functionalities. Using 
a synthetic route developed by Greaney et al.,81 substrates were formed by the alkylation of 
the corresponding N-protected glycine ethyl or methyl ester with tert-butyl 2-
(bromomethyl)acrylate; 218 was formed from the alkylation of sarcosine ethyl ester 
(Scheme 79).4,81
 
O
tBuO Br
N
H
PG OR
O
+
NaH
THF, 0 o-r.t., 24 h
O
tBuO N
PG
OR
O
254a PG = Bn, R = Et
254b PG = Boc, R = Et
254c PG = Allyl, R = Me
254d PG = Me, R = Et
255 222 64% PG = Bn, R = Et
256 80% PG = Boc, R = Et
257 53% PG = Allyl, R = Me
218 80% PG = Me, R = Et  
Scheme 79 Substrate synthesis 
 
Extended reaction times were required to allow for cyclisation to the desired product (Table 
3, entries 1-3). Even with shorter reaction times, acrylate 222 was completely consumed, 
the corresponding uncyclised, conjugate reduction product was the only other product 
observed with reaction times of four and eight hours (Table 3, entries 1 and 2). Benzyl 
substitution on the nitrogen atom gave the most favourable yield with 3,3’-disubstituted 4-
oxopyrrolidine 258 being isolated in an 88% yield (Table 3, entry 3). A lower yield was 
observed with the electron-withdrawing Boc substitution (entry 3) while a number of side 
products were observed in the reductive Dieckmann condensation of allyl substituted 259 
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(entry 5). A low yield was also observed for the formation of methyl substituted 260 (entry 
6). 
 
Table 3 Molybdenum-catalysed reductive Dieckmann Condensation 
O
tBuO N
PG
OR
O
PhSiH3 (1.5 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
THF, 80 oC, 16 h N
PG
O
OtBu
O
 
entry protecting group R time, h product yield, %b
1 Benzyl Et 4 258 57 
2 Benzyl Et 8 258 74 
3 Benzyl Et 16 258 88 
4 Boc Et 16 249 61 
5 Allyl Me 16 259 51 
6 Methyl Et 16 260 67 
a Reaction conditions : Substrate (1 equiv), PhSiH3 (1.5 equiv), Mo(CO)6 (5 mol%), NMO (9 mol%), 
THF, reflux, 16 h. b Isolated yields. 
 
2.3.3 Asymmetric Reductive Dieckmann Condensation 
 
Having established precedent for the reductive Dieckmann condensation, attention was 
focused on asymmetric induction at the newly formed quaternary centre. A number of 
pathways were envisaged to form enantiomerically enriched products (Scheme 80). Firstly, 
ligation of the transition metal catalyst with a chiral ligand (pathway a), secondly, the 
formation of a chiral silyl ketene acetal (pathway b), and thirdly, the use of chiral 
auxiliaries either on the terminal ester (pathway c) or as a chiral amine protecting group 
(pathway d) were all envisaged. 
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Scheme 80 Possible pathways to an asymmetric reductive Dieckmann condensation 
 
2.3.3.1 Ligation of Molybdenum 
 
A large amount of research has been focused on the molybdenum-catalysed asymmetric 
allylic alkylation reaction.25 High enantioselectivities were achieved by the use of nitrogen 
donor ligands such as pyridylamides 261, bis(dihydrooxazoles) 262 and bipyridines 263 
(Figure 3). Unfortunately, there have been no reports of a molybdenum-catalysed 
asymmetric conjugate reduction. It was envisaged that a chiral molybdenum-hydride 
species could be accessed on addition of phenylsilane to a molybdenum complex 
containing chiral N-donor ligands. 
 
NH HN
O O
N N
NH HN
O O
O
N N
O
R R
N N
261 262 263  
Figure 3 Common ligands for molybdenum-catalysed asymmetric allylic alkylations 
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Ligands 264 and 265 (Scheme 81), 1.5 equivalents to molybdenum, were added to a 
solution of Mo(CO)6 and NMO in THF and stirred for an hour at 80 oC, in both instances a 
deep red solution was observed. After addition of all other reagents, and a further 16 hours 
heating, only starting material was observed. Following on from these results, chiral diene 
266 was used (1.5 equivalents to molybdenum) giving the desired product in 88% isolated 
yield as the racemate (Scheme 81). This suggests that either the ligand is not interacting 
with the metal centre or that it is a silicon, not a molybdenum, enolate which attacks the 
terminal ester. In light of these results no further attempts were made to induce chirality by 
ligation of molybdenum. 
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Scheme 81 Asymmetric molybdenum-catalysed reductive Dieckmann condensation using chiral ligands 
 
2.3.3.2 Ligation of Silicon 
 
Extensive research has been carried out into the use of chiral Lewis acids in organosilcon 
chemistry which enables the formation of chiral, hypervalent silicon species (the chemistry 
of hypervalent silicon will be discussed in Chapter 4).82,83 In one example from Nakajima et 
al., lithium binaphtholate 270 enabled an asymmetric Mukaiyama aldol reaction forming 
syn-269 in 97% ee and anti-269 in 84% ee (Scheme 82).84
 
 54
Chapter 2 
O
Cy H
(MeO)3SiO
+
(R)-270 (10 mol%)
H2O (1.5 equiv)
THF, -23 oC
94% (58:42 dr)
O
Cy
HO
O
Cy
HO
267 268 syn-269 : 97% ee anti-269 : 84% ee
OLi
OLi
Br
Br
(R)-270  
Scheme 82 Lithium binaphthol-catalysed asymmetric Mukaiyama aldol reaction 
 
Assuming that the molybdenum reductive Dieckmann condensation proceeds via a silyl 
ketene acetal, it was proposed that the introduction of a chiral Lewis base would result in a 
chiral silyl ketene acetal and in turn an enantiomerically enriched product. 50 mol% of 
[Li2{(R)-binol}]85 271 was added to the reaction mixture which was refluxed for 16 hours. 
Crude 1H NMR and TLC analysis showed the formation of a multitude of compounds from 
which no products were isolated. 
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Scheme 83 Lithium binaphthol-directed reductive Dieckmann condensation 
 
2.3.3.3 Chiral Auxiliaries 
 
Although criticised for poor step economy and cost of stoichiometric amounts of auxiliary, 
the introduction of chirality by the use of chiral auxiliaries still remains a powerful tool in 
asymmetric organic synthesis.86 An enantioselective version of this reductive Dieckmann 
condensation could be envisioned by using a chiral auxiliary either on the terminal ester 
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moiety or on the nitrogen atom (Scheme 84). Attachment of the chiral auxiliary to the 
terminal ester offers a particularly attractive approach as the directing group would be 
acting as a traceless chiral auxiliary and could be recovered from the reaction mixture, 
reducing process cost. 
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Scheme 84 Chiral auxiliary directed asymmetric reduction Dieckmann condensation 
 
To investigate the effect of a chiral nitrogen substitutent, α-substituted acrylic ester 275 was 
synthesised using inexpensive, readily available (R)-α-methylbenzylamine. Alkylation of 
(R)-α-methylbenzylamine 272 by ethyl bromoacetate 273 proceeded smoothly to give 274 
in 87% yield, which was alkylated by 255 to give 275 in 46% yield (Scheme 85). 
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Scheme 85 Synthesis of 275 
 
275 was exposed to the molybdenum-catalysed reductive conditions described above (cf. 
2.3.2) giving 3,3’-disubstituted 4-oxopyrrolidine 276 in 92% isolated yield. 1H NMR 
analysis of 276 showed a 1:1 ratio of diastereomers, suggesting that the α-
methylbenzylamino group is too removed from the reaction centre to induce any chirality 
(Scheme 86). 
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Scheme 86 Reductive Dieckmann condensation of chiral acrylic ester 275 
 
In a related example from Chemla et al., a chiral α-methylbenzylamino group was used to 
deliver high levels of diastereoselectivity for the synthesis of 3,4-disubstituted β-prolines 
via either a carbometalation or domino Michael addition/carbometalation reaction (Scheme 
87).87 The high levels of control are a consequence of zinc(II)-Ar interactions as well as 
zinc(II) interactions with the carbomethoxy and nitrogen mioeties. It is the steric interaction 
between the methyl and allyl moieties in 281 which makes it less favourable than 280 
(Figure 4). 
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Scheme 87 Diasterocontrolled synthesis of enantioenriched 3,4-disubstituted β-prolines 
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Figure 4 Origin of the chirality transfer in the carbocyclisation reaction from zinc enolates 
 
In light of the disappointing asymmetric results we next turned to the use of a traceless 
chiral auxiliary as the terminal ester moiety. 
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Nagao et al. used traceless chiral auxiliaries in a Dieckmann condensation giving the 
annulation product in excellent enantiomeric excess.88 Diamide 282 was cyclised under 
basic conditions and, following methanolysis, gave methyl ester 283 in 69% overall yield 
and 96% ee (Scheme 88). 
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Scheme 88 Asymmetric Dieckmann condensation directed by 4(S)-isopropyl-1,3-thiazolidine-2-thione 
 
Later, Trova and Wang, whilst attempting the asymmetric double alkylation of 284a and 
284b, observed Dieckmann products 285a and 285b respectively.89 Moderate yields (55% 
for both 285a and 285b) were observed and the two diastereomers of 285a were isolated in 
a 1:1 ratio (Scheme 89). 
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Scheme 89 Dieckmann condensation directed by oxazolidinones 
 
Sieburth and Chen found that a tandem alkylative Dieckmann reaction of organosilane 286 
could be achieved using LDA, giving alkylative Dieckmann product 287 as the syn-
product. It was found that on switching to NaHMDS, like Trova and Wang, only 
Dieckmann condensation product 288 was observed (Scheme 90).90
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Scheme 90 Alkylative Dieckmann Condensation 
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Due to its relatively low cost and availability, initial studies into the effect of a chiral 
terminal ester moiety focused on (+)-menthol ester 292. N-Boc glycine menthol ester 290 
was synthesised as described by Franchini.91 Benzylation of 290 and removal of the Boc 
protecting group gave N-benzyl glycine menthol ester 291; this was alkylated by acrylic 
ester 255 to give substrate 292 (Scheme 91). 
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Scheme 91 Synthesis is (+)-menthol ester 292 
 
The reductive Dieckmann condensation of 292 using the conditions described above (cf. 
2.3.2) proceeded smoothly forming 258 in 79% isolated yield with a 60% recovery of (+)-
menthol 293 (Scheme 92). HPLC analysis of 258 showed a 44% ee for this transformation. 
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Scheme 92 Asymmetric reductive Dieckmann condensation of 292 
 
To investigate the effect of the chiral auxiliaries further, esters of (R)-pantolactone 298 and 
(S)-1-phenylethanol 299 were formed from the coupling with acid 295 and the required 
alcohol. Carboxylic acid 295 was accessed form the alkylation of N-benzyl glycine 294 by 
acrylate 255 (Scheme 93). 
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Scheme 93 Synthesis of chiral esters 296 and 297 
 
258 was formed from both 296 and 297 in comparable yields to that observed with the 
mentholate ester 292, however, poor enantioselectivity was observed: 9% and 2% ee 
respectively (Scheme 94). 
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Scheme 94 Reductive Dieckmann condensation of 296 and 297 
 
Using menthol ester 292, a silane screen was carried out to see what effect the bulk of the 
silyl ketene acetal has on the enantioselectivity of the reaction. Knowing that PMHS, 
(EtO)2MeSiH, Et3SiH and Cl3SiH do not reduce Michael acceptors under molybdenum 
catalysis (cf. 2.2.2),5 Ph2SiH2 and Ph3SiH were used. Like the other less reactive silanes, 
Ph3SiH gave no product, while Ph2SiH2 gave reductive Dieckmann product 258 in 85% 
isolated yield (Scheme 95). A decrease in enantioselectivity was observed, 20% ee, despite 
the increased bulk of the silane. It is likely that the decrease in enantioselectivity is a 
consequence of the increased Lewis acidity of the silicon centre formed after 
hydrosilylation of 292; this electronic effect is likely to increase the rate of cyclisation. 
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Scheme 95 Asymmetric molybdenum-catalysed reductive Dieckmann condensation with Ph2SiH2
 
2.3.4 Proposed Mechanism 
 
In the initial report of the molybdenum-catalysed conjugate reduction using phenylsilane, 
Keinan et al. showed that the reaction proceeds via a silyl enol ether with a hydride 
delivered from the silane to the β-carbon and a proton delivered to the α-carbon on 
hydrolysis (Scheme 96).5 Unfortunately, no further mechanistic evidence was gathered 
from this study and the exact role of any molybdenum species formed in this process 
remains unclear. 
 
Me
O
Ph
Mo(CO)6
PhSiH3
Me
O
Ph
H2(Ph)Si H H2O
Me
O
Ph
H
H
224a 300 : E:Z 1:3 225a  
Scheme 96 Keinan's mechanistic insight 
 
Another observation from Keinan is that Michael acceptors with fixed transoid 
conformation were not reduced under these conditions, suggesting that an η4-1-oxa-1,3-
diene molybdenum species are formed with the coordinatively unsaturated molybdenum 
acting as a Lewis acid activator of the Michael acceptor. The formation, isolation and 
catalytic activity of a number of molybdenum oxadiene complexes 303 were explored by 
Schmidt (Scheme 97).92,93  
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Scheme 97 Schmidt's synthesis of oxadiene molybdenum species 
 
The η2-coordination of a silicon-hydrogen bond to a metal centre has significant 
consequences for the activity of the Si-H bond in transition metal catalysed 
hydrosilylations.94 Activation of Si-H bonds by η2-coordination to molybdenum has been 
observed for primary, secondary and tertiary silanes, with Si-H bond elongation being 
observed.95-100 These σ-complexes are often formed by either thermally or photochemical 
decarboxyation of Mo(CO)6 to give [Mo(CO)5] which reacts with the silane (Scheme 98). 
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Scheme 98 Synthesis of η2-HSiR3 complexes of Mo(CO)6
 
With no evidence of a molybdenum-hydride species being formed form oxidative insertion 
into a Si-H bond we propose a mechanism in which the molybdenum is coordinated, and 
therefore activating, both the Michael acceptor and the silane (Scheme 99). Delivery of the 
hydride to the β-carbon of the Michael acceptor is followed by reductive elimination giving 
silyl ketene acetal 304 which undergoes an 5-(enolexo)exo-trig cyclisation to give 3,3’-
disubstituted 4-oxopyrrolidine 258. 
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Scheme 99 Catalytic cycle for the molybdenum-catalysed conjugate reduction of Michael acceptors 
 
2.4 Exploring Other Metal Catalysts 
 
Taking 44% ee as the highest achievable selectivity under molybdenum catalysis we looked 
to other transition metals to catalyse this transformation. The conjugate reduction literature 
is dominated by the late group transition metals ruthenium, cobalt, rhodium, iridium, 
nickel, palladium and copper as well as indium.101 Using menthol ester 292, we screened a 
range of catalysts which resulted in the isolation of a number of products. 
 
2.4.1 Indium- and Palladium-Catalysed Reductive Dieckmann 
Condensation 
 
Both indium- and palladium reductive conditions failed to give the desired reductive 
Dieckmann product. For indium-catalysis, reductive conditions described by Miura and 
Hosomi were adapted for this reductive process using In(acac)3 and In(OAc)3 as catalysts 
and PhSiH3 as the stoichiometric reductant.102 Only starting material was recovered after 
the reaction was stirred in THF at 80 oC for 24 h. 
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Complete consumption of 292 was observed using palladium, however, under these 
conditions from Keinan and Greenspoon,103 the only product observed was N-benzyl 
glycine menthol ester as a result of removal of the allyl unit from the amine linker (Scheme 
100).104
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Scheme 100 Palladium-catalysed allyl deprotection of 291 
 
2.4.2 Rhodium-Catalysed Reductive Dieckmann Condensation 
 
As with palladium and indium catalysis, reduction with rhodium did not yield the desired 
product. The rhodium-catalysed reduction was undertaken using adapted conditions from 
Morken et al.,105 using [Rh(cod)Cl]2 ligated by PPh3 with Me2PhSiH as the stoichiometric 
reductant. The reaction gave isomerised product 306 in 40% yield and conjugate reduction 
product 305 in a 9% yield (Scheme 101). 
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Scheme 101 Rhodium-catalysed reduction of 292 
 
It is proposed that hydrorhodiation of 292 gives organorhodium species 307 and β-hydride 
elimination results in the formation of enamine 306 (Scheme 102).106 Tautomerisation of 
307 to rhodium enolate 308, occurring at a slower rate than β-hydride elimination, is 
followed by σ-bond metathesis to give silyl ketene acetal 309 which is protonated on work 
up to give conjugate reduction product 305 (Scheme 103). 
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Scheme 102 Rhodium-catalysed isomeration of 292  
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Scheme 103 Rhodium-catalysed conjugate reduction of 292 
 
2.4.3 Cobalt- and Nickel-Catalysed Reductive Dieckmann Condensation 
 
Lam et al. have developed both cobalt- and nickel-catalysed reductive aldol and reductive 
Mannich reactions which use Et2Zn as a stoichiometric reductant.107-113 The required 
cobalt- and nickel-hydride species are formed by the transmetallation of an ethyl group 
onto the cobalt or nickel centre which undergoes β-hydride elimination to give the metal 
hydride species and ethene. 
 
Reduction of 292 under Lam’s cobalt-catalysed reductive conditions107 gave the desired 
reductive Dieckmann product 258 in a 44% isolated yield with a 51% recovery of 292. 
Analysis of the product showed an enantioselectivity of 29% ee (Scheme 104). 
 
Co(acac)2 (5 mol%)
Et2Zn (2 equiv)
N
Bn O
Xc
THF, r.t., 16 h N
Bn
CO2tBu
O
258 : 44% Yield
29% ee
O
tBuO
292
 
Scheme 104 Colbalt-catalysed reductive Dieckmann condensation 
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Complete consumption of 292 was observed with the nickel-catalysed reductive 
Dieckmann condensation using Lam’s conditions,109 higher reactivity, relative to the 
analogous cobalt reductive system, was also observed by Lam. The desired compound was 
isolated in a 67% yield with an 18% ee; however, the reaction was complicated by the 
formation of a second product, this was found to be the alkylative Dieckmann product 310, 
isolated in 29% yield (Scheme 105). This product was formed from the nickel-catalysed 
conjugate addition of an ethyl group followed by Dieckmann condensation, this observation 
is unsurprising as Lam et al. reported a competitive alkylative aldol cyclisation when 
forming both γ-lactams and γ-lactones.109
 
Ni(acac)2 (5mol%)
Et2Zn (2 equiv)
N
Bn
CO2tBu
O
N
Bn
CO2tBu
nPrO
258 : 67 % yield
18 % ee
THF, r.t., 16 h
N
Bn O
Xc
O
tBuO
292 310 : 29% yield
+
 
Scheme 105 Nickel-catalysed reductive and alkylative Dieckmann condensation 
 
With the complication of the nickel-catalysed reductive Dieckmann condensation by the 
competitive alkylative Dieckmann condensation and with little scope to improve the 
disappointing selectivities, cobalt and nickel catalysis were pursued no further. 
 
2.4.4 Copper-Catalysed Reductive Dieckmann Condensation 
 
Copper hydride species, CuH, stabilised by phosphine ligands, are excellent catalysts for 
conjugate reduction and the chemistry of these species has been covered in recent 
reviews.114,115 The use of copper as a catalyst for conjugate reductions grew exponentially 
from the first application of the hexamer [(Ph3P)CuH]6, Stryker’s reagent.116-119 Moving on 
from Stryker’s reagent, a number of copper salts have been used for the in situ generation 
of CuH, including CuCl (with NaOtBu as an additive), (Ph3P)CuF•H2O, Cu(OAc)2, CuCl2, 
CuOtBu and CuF2. Predominantly, silanes have been employed as stoichiometric 
reductants, commonly the inexpensive polymethylhydrosiloxane, PMHS. Switching from 
triphenylphosphine to chiral bisphosphines leads to the generation of chiral CuH species 
capable of highly stereoselective 1,2- and 1,4-reductions. This is a very attractive 
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methodology due to the vast array of commercially available atropisomeric bisphosphines 
and ferrocenyl bisphosphines ligands. 
 
The initial investigation was into the effect of a range of achiral bisphosphines on the 
reductive Dieckmann condensation of 292; Cu(OAc)2 was employed as the precatalyst. 
Higher isolated yields and enantioselectivities were observed on using PMHS as the 
stoichiometric reductant compared to 1,1,3,3-tetramethylhydrosilane, TMDS (Table 4, 
entries 1-4). Moderate yields were observed for all ligands with the exception of dppf 
(entry 2), dppm (entry 5) and dppb (entry 8). The highest enantioselectivity was observed 
with dppe, 50% ee (entry 6); changes in the bite angle of the bisphosphine resulted in lower 
selectivity, particularly Xantphos 311 (Figure 5) whose tricyclic structure results in a 
notably large bite angle (entry 10). Changing from dppe to the more electron rich and 
bulkier dcpe resulted in a depletion of enantioselectivity whilst an increase in yield from 
68% to 78% was observed (entry 9).  
 
 
O
PPh2 PPh2
311 : Xantphos  
Figure 5 Xantphos 
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Table 4 Ligand screen on achiral bisphosphine ligands 
tBuO
O
N
Xc
O
Cu(OAc)2 (5 mol%)
Ligand (5 mol%)
PMHS
THF, 50 oC, 16 h N
Bn
CO2tBu
O
Bn
292 258  
entry ligand yield (%)b ee (%)c
1 dppf 5d,e - 
2 dppf 43 36 
3 rac-BINAP 20d 41 
4 rac-BINAP 59 48 
5 dppm 21 44 
6 dppe 68 50 
7 dppp 73 46 
8 dppb 20 43 
9 dcpe 78 40 
10 Xantphos 62 30 
a Reaction conditions : 292 (0.2 mmol), PMHS (1.5 equiv), Cu(OAc)2 (5 mol%), Ligand (5 mol%), THF, 
50 oC, 16 h. b Isolated Yields. c Determined by HPLC (Chiracel OJ, 1% iPrOH : Hexane, 0.5 mL.min-1). d 
TMDS (1.5 equiv) used in place of PMHS. e Conversion determined by 1H NMR; product not isolated. 
 
2.4.4.1 Effect of Chiral Ligands on Enantioselectivity 
 
In light of the success of the copper-catalysed reductive Dieckmann condensation using 
achiral ligands, a range of chiral bisphosphines was screened for the reductive cyclisation 
of mentholate ester 292. 
 
An initial investigation into the match/mismatch effect between the two isomers of BINAP 
and the enantiomerically pure mentholate ester of 292 showed that, with esters of (+)-
menthol, (R)-BINAP gave the highest selectivity with a 79% ee being observed against a 
selectivity of 14% being observed with (S)-BINAP (enties 1 and 2, Table 5). Following on 
from this study, the R-enantiomer of a range of chiral bisphosphines was screened (Table 
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5). Increasing the bulk of the aryl substituents on BINAP phosphines was found to deplete 
the selectivity of the reactions (entries 1, 3 and 4); a similar trend is observed with (R)-iPr-
DuPhos 315 and (R)-Me-DuPhos 314 (entries 5 and 6). The use of ferrocene derived 
bisphosphines (R)-(S)- and (S)-(R)-Josiphos 316 gave 258 in excellent yields, however, 
poor enantioselectivities were observed in both cases (entries 7 and 8). Very poor 
selectivity was observed with (R)-PhanePhos 318 (entry 9) while moderate selectivity is 
observed with the BIPHEP derived (R)-SYNPHOS 317 (entry 10). 
 
Table 5 Effect of chiral ligands of the copper-catalysed reductive Dieckmann condensation 
tBuO
O
N
Bn O
Cu(OAc)2 (5 mol%)
L* (5mol%)
PMHS
THF, 50 oC, 16 h N
Bn
CO2tBu
O
Xc
292 258  
entry ligand yield (%)b ee (%)c
1 (R)-BINAP 27 79 
2 (S)-BINAP 62 14 
3 (R)-Tol-BINAP 45 75 
4 (R)-Xylyl-BINAP 79 35 
5 (R,R)-iPr-DuPhos 66 46 
6 (R,R)-Me-DuPhos 68 86 
7 (R)-(S)-Josiphos 86 45 
8 (S)-(R)-Josiphos 99 49 
9 (R)-PhanePhos  53 15 
10 (R)-SYNPHOS  52 65 
11 (R)-P-Phos 78 63 
12 (R)-Xylyl-P-Phos 58 91 
a Reaction conditions : 292 (0.2 mmol), PMHS (1.5 equiv), Cu(OAc)2 (5 mol%), Ligand (5 mol%), THF, 
50 oC, 16 h. b Isolated Yields. c Determined by HPLC (Chiracel OJ, 1% iPrOH : Hexane, 0.5 mL.min-1). 
 
With (R)-Me-DuPhos 314 appearing to be the ligand of choice, our attention turned to 
dipyridylphosphine ligand (R)-P-Phos 319 and its analogue (R)-Xylyl-P-Phos 320. 
Developed by Chan et al., the P-Phos series of ligands has been used in the copper-
catalysed asymmetric reduction of ketones with selectivities of up to 98% ee.120-124 A 
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moderate enantioselectivity of 63% ee was observed with (R)-P-Phos (Table 5, entry 11), 
while (R)-Xylyl-P-Phos gave 258 in an excellent 91% ee with a decrease in yield being 
observed (entry 12). Carrying out the reaction at ambient temperature over 3 hours resulted 
in an increased selectivity, 93% ee, and a slight decrease in yield (Scheme 106). 
 
tBuO
O
N
Xc
O
Cu(OAc)2 (5 mol%)
319 (5 mol%)
PMHS
THF, r.t., 3 h N
Bn
CO2tBu
O
Bn
292 258 : 47% yield
93% ee  
 
 
Scheme 106 Asymmetric copper-catalysed reductive Dieckmann condensation 
 
The asymmetric copper-catalysed reductive Dieckmann condensation of 222, with its 
terminal ethyl ester, was carried out using both (R,R)-Me-DuPhos 314 and (R,R)-iPr-
DuPhos 315 as chiral ligands. Unlike the reductive cyclisation of mentholate ester 292, 
(R,R)-iPr-DuPhos was found to give an enantiomeric excesses higher than that obtained 
with the use of (R,R)-Me-DuPhos: 20% ee and 15% ee, respectively (Scheme 107). These 
results clearly show the strong influence the (+)-menthol chiral auxiliary is having on this 
transformation, it is little wonder that enantiomeric excesses of up to 50% can be obtained 
with achiral bisphosphine ligands in conjunction with the chiral auxiliary. 
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tBuO
O
N
Bn
OEt
O
N
Bn
O CO2tBu
222 258 : 314 79% yield, 15% ee
315 26% yield, 20% ee
Cu(OAc)2 (5 mol%)
314 or 315 (5 mol%)
PMHS (1.5 equiv)
THF, 50 oC, 16 h
 
Scheme 107 Copper-catalysed asymmetric reductive Dieckmann condensation of 222 
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Figure 6 Chiral bisphosphines 
 
 
2.4.4.2 Catalytic Cycle 
 
Scheme 108 shows the proposed catalytic cycle for the copper-catalysed reductive 
Dieckmann condensation and is adapted from the catalytic cycles proposed for the copper-
catalysed reductive aldol reaction.114,115,125,126 In situ formation of CuH is followed by 
coordination of the copper centre to the Michael acceptor, forming π-complex II. The 
 71
Chapter 2 
copper enolate III is formed after delivery of hydride to the β-carbon atom. Lewis acid 
activation of the terminal ester and attack by the copper enolate onto the electrophilic centre 
occurs to give acetal IV. The acetal is then converted to the desired product 258 generating 
LCuOR V, an ideal precursor to LCuH which is rapidly reformed on reaction with 
PHMS.114
 
LCu(OAc)
LCuH
Cu(OAc)2 + Ligand
PMHS O
tBuO N
Bn
OR
O
tBuO2C N
Bn
OR
O
LCu
H
NtBuO
O
CuL
Bn
O
RON
Bn
CO2tBuO
RO
CuL
N
Bn
CO2tBuO
PMHS
258
LCuOR
I
II
III
IV
V
 
Scheme 108 Catalytic cycle for the copper-catalysed reductive Dieckmann condensation 
 
2.4.4.3 Prediction of Absolute Stereochemistry 
 
Unfortunately, attempts to determine the absolute stereochemistry of 258 by X-ray 
crystallography failed, as attempts to structurally modify 258 to give a crystalline derivative 
resulted in a multitude of products.  
 
In the carbon-carbon bond forming step, attack of the enolate on re-face of the terminal 
ester and elimination of CuOR results in the formation of (R)-258, while attack on the si-
face of the terminal ester results in the formation of (S)-258 (Scheme 109). 
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N
Bn
O
CO2tBu
Me
N
Bn
O
CO2tBu
Me
xx
xx
(R)-258
(S)-258
re-face attack
si-face attack
O M
O
Xc
OtBu
Me
N
Bn
O M
O
OtBu
Xc
Me
N
Bn
 
Scheme 109 Enantioselectivity in the formation of 258 
 
In analogous, unpublished work, Frost et al. formed 3,3’-disubstituted 4-oxopyrrolindine 
(R)-322 by the rhodium-catalysed Michael Dieckmann condensation of 292 (Scheme 110). 
This suggests that for the rhodium-catalysed Michael Dieckmann reaction, attack of the si-
face of the mentholate ester is blocked by the isopropyl group of (+)-menthol. 
 
O
tBuO N
Bn
O
O N
Bn
O
CO2tBu
OMe
MeO
B(OH)2
[Rh(cod)Cl]2 (2.5mol%)
KOH (1 equiv)
THF, 80 oC, 20 h
+
292 321 (R)-322 : 42% yield, 59% ee  
Scheme 110 Rhodium-catalysed Michael Dieckmann condensation of mentholate ester 322 
 
2.5 Conclusion 
 
A preliminary study has been carried out into the reductive Dieckmann condensation 
focusing on expeditious synthesis of enantiomerically enriched 3,3’-disubstituted 4-
oxopyrrolidines containing an all-carbon quaternary centre. 
 
Initial studies involved molybdenum-catalysis in which activation of the Mo(CO)6 
precatalyst occurred by the oxidative removal of carbonyl ligands by NMO. An 
enantiomeric excess of 44% was achieved when using (+)-menthol as a traceless auxiliary 
in this process. 
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Cu(OAc)2 was identified as a suitable precatalyst for the same transformation. 
Enantiomeric excesses of up to 50% were observed with achiral bisphosphines, while 
enantiomeric excesses of up to 93% were recorded when (R)-Xylyl-P-Phos was used as a 
chiral bisphosphine ligand in conjunction with (+)-menthol as a chiral auxiliary. 
 
As stated, this is a preliminary study, due to time constrains a full study into the reductive 
Dieckmann condensation was not carried out. Substrate scope is broad and a wide variety 
of chiral auxiliaries are available. 
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Chapter 3 - Two-Carbon Homologation of Aldehydes by 
Tandem Molybdenum-Catalysed Hydrosilylations 
 
3.1 Meldrum’s Acid and its Derivatives 
 
Meldrum’s acid 325 (MA) and its derivatives are important reagents in organic chemistry 
and have been used in the synthesis of a number of natural products and their analogues.1 
The range of chemistry carried out using MA has been covered in a number of reviews,2-5 
including one devoted to the synthetic applications of the pyrolysis of MA derivatives.6 The 
unique reactivity of MA and its derivates comes as a consequence of MA’s remarkable 
acidity (pKa 7.3 in DMSO at 25 oC) compared to the related dimedone 326 and 
dimethylmalonate 327 (Figure 7),7 a physical property owing to the fixed E-conformation 
of the two ester functionatities.8-13
 
O O
O O O O
MeO
O
OMe
O
325
Meldrum's acid
pKa : 7.3 (DMSO)
326
dimedone
pKa : 11.2 (DMSO)
327
dimethyl malonate
pKa : 15.9 (DMSO)  
Figure 7 Comparable equilibrium acidities in DMSO solutions of MA, dimedone and dimethyl malonate 
 
The synthesis of 1,3-dicarbonyl compounds from acyl malonates is one of the most 
important transformations carried out by MA derivatives. Nucleophilic attack at the one of 
the ester groups, often by an alcohol or amine, is followed by loss of acetone and carbon 
dioxide giving the 1,3-dicarbonyl compound which then can be carried through to a vast 
array of biologically active natural products and their analogues.1 Beyond 1,3-dicarbonyl 
compounds, biologically active furanones, pyranones, tetramic acids and their analogues, 
terpeniods and pyridine alkaloids can be accessed from MA (Scheme 111). 
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Scheme 111 Examples of natural products synthesised from MA 
 
3.1.1 Alkylidene Meldrum’s Acid Derivatives as Michael Acceptors 
 
Alkylidene MA derivatives, synthesised by the Knoevenagel condensation between 
aldehydes and MA, are of particular interest. Recently, Kaumanns and Mays demonstrated 
the high electophilicity of benzylidene MA derivatives by analysing the reaction kinetics of 
these derivatives with acceptor-substituted carbanions.14 From this study, benzylidene MA 
328a was assigned an electrophilicity parameter comparable to that for carbocation 329 
(Figure 8). The high electrophilicity of these substrates has been attributed to, like MA’s 
high acidity, to the fixed E-conformation of the two ester groups. 
 
O
O
O
OMeO
N N
328
E = -10.28
329
E = -10.04  
Figure 8 Electrophilicity parameters of 328 and 329 
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3.1.2 Synthesis of Alkylidene Meldrum’s Acid Derivatives 
 
The synthesis of alkylidene MA derivatives 328 is achieved by the Knoevenagel 
condensation of MA and aldehydes. The condensation reaction can be complicated by the 
Michael addition of another molecule of MA to the newly formed alkylidene MA to give 
the bis-adduct 330 (Scheme 112).  
O
O
O
O
R
CHO
+
O
O
O
O
R
O
O
O
O
R
39 325 328 330
Knoevenagel
Condensation
O
O
O
O
O
OO
O
 
Scheme 112 Knoevenagel condensation of benzyaldehydes and Meldrum's acid 
 
A number of conditions for this Knoevenagel condensation have been reported with a view 
to increasing the substrate scope of this reaction. One method of avoiding bis-adduct 
formation is the addition of a nucleophile, such as a methoxide,15 an amines16 or a thiols,17 
to alkylidene MA derivatives; the newly formed adduct is then transformed into the desired 
alkylidene at the end of the reaction (Scheme 113). Although effective, in light of step and 
atom economy, this is an unattractive process. 
 
O
O
O
O
331
Na RCHO
MeOH
r.t., 10 min
O
O
O
O
332
Na
R
OMe
HCl(aq)
O
O
O
O
333 : R = Me, 85%
334 : R = Et, 89%
335 : R = nPr, 95%
R
 
Scheme 113 Synthesis of alkylidene MA’s in methanol 
 
Other methods for the synthesis of alkylidene MA’s include the use of ionic liquids,18,19 
microwave irradiation,20 amines supported on silica gel,21 surfactants22 and simply heating 
the two components in water.23 Fillion et al. reported a general synthesis of alkylidene 
MA’s using pyrrolidinium acetate as a catalyst (10 mol%) in benzene.24 By this method, 
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Fillion successfully synthesised 336 from benzaldehyde in 85% yield, a significant result as 
under all other conditions 336 undergoes Michael addition of MA (Scheme 114). 
 
O
O
O
O
CHO
+
O
O
O
O
9 325
O
O
OO
O
OO
O
A : TBAB (10mol%)
H2O, r.t., 2 h
B : H2O, 75 oC, 2 h
C : pyrrolidinium
acetate (10mol%)
PhH, r.t., 24 h
336 337
A 13 : 87
B 7 : 93
C 97 : 3  
Scheme 114 Synthesis of alkylidene MA derivative 336 
 
3.1.3 Michael Addition to Alkylidene Meldrum’s Acid Derivatives  
 
Michael addition to alkylidene MA derivatives has been a key step in a number of 
multicomponent reactions; MA is reacted with an aldehyde and the desired nucleophile, 
typically a vinyl ether, enolate or indole.5 Copper-catalysed additions of Grignard reagents 
proceeded smoothly,25-27 however, more recently, research has focused on the addition of 
terminal alkynes, dialkylzinc reagents and vinylstannanes to alkylidene MA derivatives. 
 
Alkylation of alkylidene MA derivatives by asymmetric copper-catalysed conjugate 
addition of diethylzinc was reported by Carreira et al. using BINOL-derived chiral 
phosphoramidite 341.28 High yields and enantioselectivities were observed with both 
aliphatic and aromatic substitutents on the alkylidene MA; aliphatic substitutents were 
found to be the most favourable (Scheme 115). 
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Scheme 115 Asymmetric copper-catalysed alkylation of alkylidene MAs 
 
Fillion et al. also used copper ligated with BINOL derived chiral phosphoramidites for the 
asymmetric alkylation of β,β’-disubstituted alkylidene MA derivatives with dialkylzinc 
reagents; excellent yields and enantioselectivities of up to 95% were observed (Scheme 
116).29 Wilsily and Fillion later reported the expedient preparation of succinimides, 
succinate esters and acids, γ-butyrolactones and β-amino acid derivatives using this 
methodology (Scheme 117).30 This process was extended to the 1,6-conjugate addition of 
dialkylzinc reagents to α,β,γ,δ-unsaturated MAs 350 which saw a drop in yields and 
enantioselectivities (Scheme 118).31  
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O O
OAr
O
O
R Me
342 343 : upto 99% yield and 95% ee
R2Zn (2 equiv)
Cu(OTf)2 (5 mol%)
344 (10mol%)
DME, -40 oC to r.t., 24 h
344
 
Scheme 116 Copper-catalysed conjugate addition of dialkylzinc reagents giving all-carbon quaternary centres 
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Scheme 117 Addition of dialkylzinc reagents to 2-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)aryl acetates 
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Scheme 118 1,6-conjugate addition of dialkylzinc reagents 
 
Fillion et al. synthesised more complex γ-butyrolactones via a sequential Rh(I)/Pd-
catalysed 1,4-addition/intramolecular allylation.32 This process was initiated by the Michael 
addition of vinylstannanes to alkylidene MA 336. This was followed by the palladium-
catalysed allylic O-alkylation and ring opening by ethanol to give the desired γ-
butyrolactone (Scheme 119). 
 
O
OPh
O
O
336
Bu3Sn OCO2Et
352 (1 equiv)
[RhCl(cod)]2 (3mol%Rh)
8h, rt, THF
O
OPh
O
O
353
SnBu3
OCO2Et
O
O
Ph
EtO2C
Pd(PPh3)4 (5 mol%)
TBAB (1.5 equiv)
THF:EtOH (10:1)
40 oC, 18 h
354  
Scheme 119 Sequential Rh(I)/Pd-catalysed 1,4-addition/intramolecular allylation 
 
Alkynylation of alkylidene MA derivatives was first achieved using trimethylsilylethynyl 
magnesium bromide33 and later lithium phenylalkynylide.34-36 However, Carreira et al. have 
developed a powerful technique which enables the direct use of terminal alkynes without 
the need for a separate metallation step.37-41 Copper- and zinc-catalysed conjugate addition 
of terminal alkynes to alkylidene MA derivatives have been reported giving adducts in high 
yields (Scheme 120). Copper-catalysed additions of terminal alkynes are carried out in 
aqueous media.  
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60 oC
85-90% yield 55-98% yield
 
Scheme 120 Zinc- and copper-catalysed alkynylation of alkylidene MAs 
 
Asymmetric alkynylation of alkylidene MA derivatives was not achieved under zinc 
catalysis, however, excellent enantioselectivities were achieved with copper catalysis. 
Carreira et al. developed the novel chiral P,N-ligand 356 (PINAP) from QUINAP for this 
transformation; excellent enantioselectivities were achieved for the addition of aromatic 
alkynes to alkylidene MA derivatives (Scheme 121).38,40
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N
N
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356 : PINAP  
Scheme 121 Asymmetric alkynylation of alkylidene MAs 
 
3.1.4 Meldrum’s Acids as Acylating Agents 
 
Fillion et al. have pioneered the use of 5-mono- and 5,5’-dialkyl-MAs as acylating agents 
in the catalytic intramolecular Friedel-Crafts reaction. Initial studies showed scandium 
triflate to be a suitable Lewis acid catalyst for the synthesis of polysubstituted 1-indanones, 
while trimethylsilyl triflate and triflic acid were also able to catalyse the transformation.42,43 
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Substitution at the α- and/or β-carbons of the substrates were found to be essential for 
maintaining good yields (Scheme 122). Fillion and Fishlock used this methodology in the 
synthesis of (±)-taiwaniaquinol B 362.44 The formation of the tricyclic core via a domino 
trimethylsilyl triflate catalysed Friedel-Crafts acylation/carbonyl α-tert-alkylation reaction 
was the key step in the synthesis (Scheme 123).  
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R'' R' O
O
R''' R'''
O
R
R'''
R'Sc(OTf)3 (12mol%)
CH3NO2, reflux
13-83%
357 358  
Scheme 122 Intramolecular Sc(OTf)3-catalysed Friedel-Crafts acylation 
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Scheme 123 Fillion's synthesis of taiwaniaquinol B 
 
Fillion and Dumas synthesised fused 4,5-disubstituted indole ring systems by an 
intramolecular Friedel-Crafts acylation of N-nosyl-4-substituted indoles.45 Selective 
acylation at the 5 position was observed giving the desired tricyclic products under Lewis 
acid catalysis by boron trifluoride etherate. Both 5-mono and 5,5’-dialkyl MAs cyclised in 
high yields with pentacyclic 366 being accessed in 84% yield from spiro MA derivative 
365 (Scheme 124). 
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DCE, 80 oC, 35 min
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H
H
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Scheme 124 Synthesis of fused 4,5-disubstituted indole ring systems 
 
3.2 Synthesis of Alkylidene Meldrum’s Acid Derivatives 
 
Due to their synthetic utility, a range of alkylidene MA derivatives was synthesised using 
the convenient procedure proposed by Bigi et al..23 This uncatalysed procedure was carried 
out in water, giving the desired product as a precipitate on cooling of the reaction mixture. 
All products are easily purified by recrystallisation from hot ethanol giving highly coloured 
crystalline solids. 
 
Good yields were observed for a range of aldehydes with both electron-donating and 
electron-withdrawing substituents being tolerated (Table 6). This can be rationalised by 
considering the transformation as a two step process. Electron-deficient aldehydes favour 
the initial nucleophilic attack of MA, while electron-rich substituents facilitate the loss of 
water giving the conjugation stabilised olefin.  
 
Pleasingly, a range of heteroatoms was tolerated under the reaction conditions (Table 6, 
entries 1-3). A lower yield was observed with sterically bulky 2,3,4-
trimethoxybenzaldehyde (entry 9). A disappointing 48% yield was observed for the 
formation of 328k (entry 11). 
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Table 6 Synthesis of alkylidene MA's 
O
O
O
O
R
CHO +
O
O
O
O
39 325 328a-k
H2O
75 oC, 2 h
R
 
entry R product yield, %b
1 4-(OMe)C6H4 328a 72 
2 4-(SMe)C6H4 328b 75 
3 4-(NMe2)C6H4 328c 92 
4 3,4-(OCH2O)C6H3 328d 82 
5 2,3-(OCH2O)C6H3 328e 73 
6 C6H5CHCH 328f 87 
7 3,4-(OMe)2C6H3 328g 81 
8 2,5-(OMe)2C6H3 328h 73 
9 2,3,4-(OMe)3C6H2 328i 69 
10 4-(NO2)C6H4 328j 83 
11 4-(OBn)C6H4 328k 48 
a Reaction conditions : aldehyde (1 equiv.), Meldrum’s acid (1.1 equiv.), H2O, 75 oC, 2 h. b Isolated yields 
after recrystallisation. 
 
3.3 Reduction of Meldrum’s Acid Arylidenes 
 
Alkylidene MA 328a was exposed to the molybdenum-catalysed reductive conditions 
developed for the reduction of dimethyl itaconate (cf. 2.2.2). The reaction mixture was 
heated to 80 oC for 10 minutes by microwave irradiation. After hydrolysis of the reaction 
mixture, a 29% conversion (determined by 1H NMR) to 5-monoalkyl MA 367a was 
observed (Scheme 125). 
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Mo(CO)6 (5 mol%)
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PhSiH3
THF,MW, 80 oC, 10mins
then H2O MeO O
O
O
O
367a : 29% conv.  
Scheme 125 Molybdenum-catalysed conjugate reduction of 328a 
 
To investigate this process further the reaction was repeated with an extended reaction time 
of 16 hours (the reaction being carried in an oil bath). After hydrolysis of the reaction 
mixture, crude 1H NMR analysis did not show the gem-dimethyl peaks of 328a (1.76 ppm) 
or 367a (1.72 and 1.48 ppm), suggesting complete consumption of 328a and no formation 
of 367a. The major peaks present in the crude 1H NMR, along with the two aromatic 
doublets and the singlet present for the methoxy group, were a 1H triplet at 9.81 ppm (J = 
1.5 Hz), a 2H triplet at 2.91 ppm (J = 7.2 Hz) and a 2H multiplet at 2.78-2.72 ppm 
suggesting the formation of an aldehyde. Purification by flash column chromatography 
revealed β-aryl aldehyde 368a as the sole product of the reaction in an 85% yield (Scheme 
126). Interestingly, no over-reduction of aldehyde 368a to 3-(4-methoxyphenyl)propan-1-ol 
was observed. Keinan had previously reported that aldehyde reduction occurs under his 
molybdenum-catalysed reductive conditions,46 suggesting that the aldehyde functionality is 
protected against reduction until hydrolysis. 
 
MeO O
O
O
O
328a
Mo(CO)6 (5 mol%)
NMO (9 mol%)
PhSiH3
THF, 16 h, 80 oC
then H2O
MeO
O
368a : 85% yield
H
MeO O
O
O
O
367a : 0%
 
Scheme 126 Molybdenum-catalysed synthesis of aldehyde 368a 
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This is a completely novel transformation, previous reports of the reduction of benzylidene 
MAs resulted in high yields of 5-monoalkyl MA derivatives. Reductants for this process 
include sodium hydrogen telluride,47 borane•dimethylamine complex,48 triethylammonium 
formate,49 NaBH450, 51 and NaBH3CN.42
 
This novel transformation can be described as the two-step, two-carbon homologation of 
aldehydes. 
 
3.3.1 Synthesis of β-Substituted Propionaldehydes 
 
Beyond dihydrocinnamaldehyde, there are few commercially available β-substituted 
propionaldehydes. Other reported routes to β-substituted propionaldehydes often involve 
the reduction of dihydrocinnamates using DIBAL-H or the oxidation of 3-substituted 
propan-1-ols by a Swern oxidation or by PCC.52 Reduction of carboxylic acid derivatives to 
aldehydes using DIBAL-H can be capricious with some substrates lacking reactivity and 
the over-reduction to the corresponding alcohol being a common drawback. In addition, 
DIBAL-H ignites upon prolonged exposure to air and reacts violently with water. The 
oxidising agents mentioned above involve the use of toxic and environmentally damaging 
reagents.  
 
An alternative route to β-substituted propionaldehydes is the hydroformylation of styrene 
and its derivatives. Although the oxo process is highly developed, the hydroformylation of 
styrene often favours the formation of α-phenylpropanal.53 A recent paper from Zhang et al. 
has reported the highest linear-selectivity for the hydroformylation of styrene with a 
linear:branched ratio of up to 22:1.54
 
A comparable protocol involving the two-carbon homologation of aldehydes was reported 
by Lee and Jones in which 1-naphthaldehyde is converted to 3-(1-naphthyl)propanal 373 in 
three steps.55 Weinreb amide 371 was formed from 1-naphthaldehyde and N-methoxy-N-
methyl-2-(triphenylphosphoranylidine)acetamide 370.56 Alkene hydrogenation and 
reduction of the Weinreb amide with LiAlH4 gave the desired aldehyde 373 (Scheme 127). 
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Scheme 127 Three-step, two-carbon homologation of 1-naphthaldehyde 
 
Ylide chemistry was also employed by Wallsgrove et al. in the multi-step synthesis of 3-(4-
methylphenyl)propanal 379: the β-substituted propionaldehyde was accessed from 4-
methylbenzaldehyde 374 in a 56% overall yield (Scheme 128).57a This synthetic route was 
later used by Faber et al. for the synthesis of 3-(4-halophenyl)propanals.57b
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+
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Scheme 128 Four-step, two-carbon homologation of 4-methylbenzaldehyde 
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3.3.2 Optimisation 
 
It has already been established that molybdenum-catalysed conjugate reductions require 
heating in THF for good reaction efficiency, for that reason, no temperature or solvent 
screen was carried out for this novel transformation (cf. 2.2). 
 
A decrease in aldehyde formation was observed with shorter reaction times (Table 7). In all 
cases complete consumption of alkylidene MA 328a was observed with 5-monoalkyl MA 
367a being the only other product observed. 
 
Table 7 Time dependence of the molybdenum-catalysed synthesis of aldehydes 
MeO O
O
O
O
328a
Mo(CO)6 (5 mol%)
NMO (9mol%)
PhSiH3
THF, 80 oC
then H2O MeO
O
368a
H
 
entry time, h yield, %b
1 2 48 
2 4 65 
3 8 77 
4 16 85 
a Reaction conditions : 328a (1.0 equiv.), phenylsilane (3.0 equiv.), Mo(CO)6 (5 mol%), N-methylmorpholine 
N-oxide (9 mol%), THF, 80 oC. b Isolated yields. 
 
 
The use of less reactive silanes (Ph2SiH2, Et3SiH and PMHS) gave no reduction, while 
reducing the equivalents of phenylsilane from three to two equivalents led to a lower yield 
of 49%. A lower yield of 43% and more complex reaction mixture was observed when the 
additive NMO was removed from the reaction mixture. 
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3.3.3 Exploring the Scope of the Reaction 
 
Having established the basis for a useful new functional group transformation, different 
alkylidene MA derivatives were exposed to the reaction conditions (Table 8). 
 
Table 8 Synthesis of 3-substituted propionaldehydes 
O
O
O
O
R
328a-k
PhSiH3 (3 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
H
O
R
368a-k
THF, 80 oC, 16 h
then H2O
 
entry R product yield, %b
1 4-(OMe)C6H4 368a 85 
2 4-(SMe)C6H4 368b 66 
3 4-(NMe2)C6H4 368c 81 
4 3,4-(OCH2O)C6H3 368d 65 
5 2,3-(OCH2O)C6H3 368e 78 
6 C6H5CHCH 368f 39 
7 3,4-(OMe)2C6H3 368g 59 
8 2,5-(OMe)2C6H3 368h 76 
9 2,3,4-(OMe)3C6H2 368i 48 
10 4-(NO2)C6H4 368j 37 
11 4-(OBn)C6H4 368k 45 
a Reaction conditions : 328 (1.0 equiv.), phenylsilane (3.0 equiv.), Mo(CO)6 (5 mol%), N-methylmorpholine 
N-oxide (9 mol%), THF, 80 oC, 16 h. b Isolated yields. 
 
Pleasingly, a number of heteroatoms were tolerated in this process giving the desired 
aldehydes in high yields (Table 8, entries 1-3). Isolated yields were consistently good for a 
range of substrates containing electron-donating aryl substituents, with the exception of the 
sterically hindered 368i (entry 9). A poor yield was observed for the synthesis of electron-
poor 368j, this observation can be rationalised by the inductive deactivation of the 
alkylidene MA derivative to the initial conjugate reduction by the electron-withdrawing 
para-nitro group (entry 10). An unexpectedly low yield of 45% was observed for the 
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formation of 368k (entry 11). A poor yield of 39% and incomplete consumption of starting 
material was observed with α,β,γ,δ-unsaturated 328f, however, no hydride addition to the δ-
carbon was observed (entry 6).  
 
3.3.4 Reduction of 5-Monoalkyl and 5,5’-Dialkyl Meldrum’s Acid 
Derivatives 
 
To investigate the scope of the reaction further, alkylated MA derivates 367j, 367a and 380 
were exposed to the reductive conditions. Nitrophenyl substituted aldehyde 368j, which 
had previously been isolated in a poor 37% yield, was accessed in 91% yield from 367j 
(Table 9, entry 1). This suggests that the reduction of 328j is limited by the slow conjugate 
reduction of its deactivated alkene. Monoalkylated 367a was reduced in good yield (Table 
9, entry 2), however, 1H NMR analysis showed that 380 was unaffected by the reductive 
conditions (Table 9, entry 3). 
 
Table 9 Reduction of alkylated MAs 
O
O
O
O
R
R'
H
O
R
R'
PhSiH3 (3 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
THF, 80 oC, 16 h
then H2O  
entry substrate R R’ product yield, %b
1 367j NO2 H 368j 91 
2 367a OMe H 368a 72 
3 380 OMe Me 381 0 
a Reaction conditions : Substrate (1.0 equiv.), phenylsilane (3.0 equiv.), Mo(CO)6 (5 mol%), N-
methylmorpholine N-oxide (9 mol%), THF, 80 oC, 16 h. b Isolated yields. 
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3.3.5 Exploring Other Electrophiles 
 
Following the successful quenching of the reaction mixture with water, a number of 
different electrophiles were used to quench the reaction mixture using alkylidene MA 328a 
as the substrate. Bromination was attempted using both bromine and N-bromosuccinamide, 
however, after aqueous work-up propionaldehyde 368a was the only observed product with 
no bromine incorporation. The same result was observed when methyl iodide was added to 
the reaction mixture after 16 hours. 
 
3.3.6 Mechanistic Studies 
 
The formation of 5-monoalkyl MA when reaction times are shortened shows the synthesis 
of β-substituted propionaldehydes from alkylidene MA derivatives is initiated by a 
molybdenum-catalysed conjugate reduction. It was postulated that the newly formed 
enolate is the key intermediate for the transformation, which is supported by the study into 
5-mono and 5,5-dialkyl MAs. It is, therefore, due to the fixed keto form of 5,5’-dialkyl MA 
380 that no aldehyde formation is observed, while easily enolisable 5-monoalkyl MA 
derivatives readily form the desired product.  
 
3.3.6.1 Deuterium Labelling Studies 
 
To investigate this novel transformation further, deuterium labelling studies were carried 
out. Firstly, 328a was reduced using trideuteriophenylsilane58 as the terminal reductant. On 
hydrolysis of the reaction mixture and isolation of the product, NMR analysis showed that 
there was no aldehyde peak present in the 1H NMR spectra at 9.81 ppm (Figure 10). 
However, in the 2D NMR spectra there was a singlet present at 9.75 ppm (Figure 9). 13C 
NMR analysis showed a triplet at 201.9 ppm (J = 26 Hz) and IR bands were observed at 
2081 cm-1 (C-D) and 1712 cm-1 (C=O), suggesting the formation of a deuteroaldehyde. A 
change in the 1H NMR for the ethyl bridge was also observed (Figure 10 and Figure 11). A 
1H multiple was observed at 2.92-2.86 ppm and at 2.74 ppm a 2H doublet (J = 7.9 Hz) 
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were observed. 2H NMR analysis of the product also showed a singlet at 2.81 ppm 
suggesting deuteration at the β-carbon indicative of the conjugate reduction of 328a (Figure 
9).46 This analysis suggests the formation of the deuterio-aldehyde 382a (Scheme 129); this 
was confirmed by 1H-, 2D- and 13C NMR, mass spectrometry and IR analysis. 
 
MeO O
O
O
O
328a
MeO
O
382a
D
H D
PhSiD3 (3 equiv)
Mo(CO)6 (5 mol%)
NMO (9mol%)
THF, 80 oC, 16 h
then H2O
79%  
Scheme 129 Reduction of 328a using trideuterophenylsilane 
 
Figure 9 2D NMR 1,3-dideutero-3-(4-methoxyphenyl)propanal 382a 
 
Figure 10 1H NMR of 1,3-dideutero-3-(4-methoxyphenyl)propanal 382a 
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Figure 11 1H NMR of 3-(4-methoxyphenyl)propanal 368a 
 
Following the deuterium labelling using trideuteriophenylsilane, the reduction of 328a with 
phenylsilane and hydrolysis with deuterium oxide was carried out. The isolated product 
showed a 1H singlet at 9.81 ppm in the 1H NMR (Figure 13), this is a change from the 1H 
triplet observed for 368a at 9.81 ppm (Figure 14), this suggests a α,α’-dideuterated product. 
The 2D NMR showed only a singlet at 2.64 ppm (Figure 12), confirming deuteration at the 
α-carbon. The 1H NMR did not show cleanly either mono- or di-deuteration at the α-
carbon, a singlet was observed at 2.90 ppm and a multiplet was observed at 2.74-2.71 ppm, 
these peaks integrated in a ratio of ~5:1 (Figure 13). Mass spectrometry showed the 
presence of dideuterated 383a, monodeuterated 384a and 368a in a 73:20:7 ratio, which 
concurs with the integration values (Scheme 130). 
 
MeO O
O
O
O
328a
MeO
O
383a
H
D D
MeO
O
384a
H
D H
MeO
O
368a
H
H H
PhSiH3 (3 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
THF, 80 oC, 16 h
then D2O
383a:384a:368a : 73:20:7
75%
 
Scheme 130 Reduction quenched by deuterium oxide 
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Figure 12 2D NMR of α,α'-dideutero-3-(4-methoxyphenyl)propanal 383a 
 
Figure 13 1H NMR of α,α'-dideutero-3-(4-methoxylphenyl)propanal 383a 
 
Figure 14 1NMR of 3-(4-methoxyphenyl)propanal 368a 
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3.3.7 Proposed Mechanism 
 
In light of the mechanistic studies, we propose a mechanism in which hydride is delivered 
to the β-carbon of 328a by a molybdenum-catalysed hydrosilylation giving dioxinone 386 
(Scheme 131). On heating, rapid cycloreversion occurs, eliminating acetone to reveal 
ketene 387. It is proposed that the newly formed ketene undergoes hydrosilylation by a 
second equivalent to phenylsilane to afford enol silane 388. This intermediate remains in 
solution, protecting the aldehyde functionality from further reduction, until hydrolysis at 
the end of reaction. As shown by the deuterium labelling studies, hydrolysis delivers two 
protons to the α-carbon. The elimination of carbon dioxide on hydrolysis was confirmed by 
limewater test. 
 
MeO
CHO
O O
OO
MeO O
O
O
O
O
MeO
C
O
OSiR3
O
MeO
OSiR3
O
H OSiR3
O
H
MeO
H H
cycloreversion
ketene
hydrosilylation
enol silane protonation
decarboxylation-protonation
H2O
CO2
MeO O
O
OSiR3
O
328a 386
387
388368a
PhSiH3
Mo(CO)6
NMO
H
H
PhSiH3
Mo(CO)6
NMO
HH
two-carbon
homologation
 
Scheme 131 Proposed mechanism for the two-carbon homologation of aldehydes 
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Attempts to observe reaction intermediates by NMR were unsuccessful; however, 
disappearance of the isopropylene group of MA and appearance of acetone in the reaction 
mixture was observed when the reaction was carried out in deuterated THF, in a sealed 
NMR tube. Along with the positive limewater test, this clearly suggests that acetone is 
eliminated prior to protonation, while carbon dioxide is eliminated on protonation. 
 
A number of important transformations undertaken by Meldrum’s acid derivatives can also 
be attributed to the cyclic malonate’s ability to undergo cycloreversion giving α-oxoketenes 
after elimination of acetone. The synthesis of ketenes from MA derivatives using flash 
vacuum pyrolysis is well established,6 however, it was not until 1997 that an efficient, mild 
method of generating α-oxoketenes was reported by Sato et al.59 IR and 1H NMR 
spectroscopy provided direct evidence of ketene formation from enolised MA derivatives in 
the synthesis of linear malonates (Scheme 132). 
 
O O
PO O
R
O
O
C
PO
R
O
cycloreversion
390α-oxoketene
r.t. - 50 oC tBuOH
O
PO
R
OtBu
O
389 391
P : Meor TBDPS  
Scheme 132 Generation of α-oxoketenes from enolised MA derivatives 
 
As well as the synthesis of linear malonates, intermediate α-oxoketenes have been used in 
cyclocondensations with imines in the synthesis of both bicyclic sulfur-containing 2-
pyridones and multi-ring fused 2-pyridones (Scheme 133).60-63 Almqvist et al. showed that, 
under acid conditions 2-pyridones could be synthesised in excellent yields. 
 
O
O
OH
R
O
O
R
O
C
O
N
S
R'
CO2Me
N
S
CO2Me
R'
O
RHCl(g)
dioxane
392 393 394  
Scheme 133 Almqvist's synthesis of bicyclic sulphur-containing 2-pyridones 
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An alternative mechanism, in keeping with the deuterium-labelling studies, can be 
envisaged in which α-oxoketene 387 is not formed. Hydrosilylation of the ester moiety of 
dioxinone 386 could occur to give disilylated 395, which then undergoes cycloreversion to 
give intermediate 388 (Scheme 134).  
 
MeO
CHO
O O
OO
MeO O
O
O
O
MeO
OSiR3
O
H OSiR3
O
H
MeO
H H
enol silane protonation
decarboxylation-protonation
H2O
CO2
MeO O
O
OSiR3
O
328a 386
388368
PhSiH3
Mo(CO)6
NMO
H
HH
two-carbon
homologation
ester
hydrosilylation
PhSiH3
Mo(CO)6
NMO
O
cycloreversion
MeO O
O
OSiR3
395
H
H
R3SiO
 
Scheme 134 Alternative mechanism for two-carbon homologation of aldehydes 
 
3.4 Conclusion 
 
We have reported a expeditious two-carbon homologation of aldehydes, catalysed by the 
cheap, stable Mo(CO)6. Moderate to good isolated yields have been observed for a range of 
alkylidene MA derivatives with the highest yields being observed with electron-rich 
olefins. It is proposed that this novel transformation is initiated by the hydrosilylation of the 
α,β-unsaturated ester, followed by cycloreversion which reveals an α-oxoketene which is, 
in turn, hydrosilylated. On termination of the reaction, decarboxylative protonation 
furnishes the desired 3-substituted propionaldehyde. 
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The proposed mechanism is supported by deuterium labelling studies in which deuterium 
has been used as both an electrophile, in the form of deuterium oxide, and as a nucleophile, 
in the form of trideuteriophenylsilane. 
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Chapter 4 - Amine Promoted Reduction of Malonic Esters 
to β-Substituted Propionaldehydes and γ-Substituted 
Propylamines 
 
4.1 Lewis Base Catalysis 
 
In a recent, comprehensive review, Denmark and Beutner define Lewis base catalysis as: 
 
“…the process by which an electron-pair donor increases the rate of a given chemical 
reaction by interacting with an acceptor atom in one of the reagents or substrates. The 
binding event may enhance either the electrophilic or nucleophilic character of the bound 
species. Furthermore, the Lewis base should not be consumed or altered during the course 
of the reaction – a hallmark of any catalytic process.”1
 
One key application of Lewis base catalysis is the activation of silicon reagents enabling 
efficient ligand transfer to acceptor electrophiles. 
 
4.1.1 Hypervalent Silicon 
 
In 1809 Gay-Lussac discovered SiF4.2NH3, the first reported hypervalent silicon reagent.2 
However, it was not until the late 20th century and into the 21st century that the synthetic 
utility of hypervalent silicon reagents was fully explored. A vast range of stereoselective 
transformations have been reported with particular attention being paid to Lewis base 
catalysis, where, through coordination of optically active organic compounds to tetrahedral 
silicon reagents, highly selective transformations have been achieved.1, 3-5  
 
Unlike carbon, in the presence of Lewis bases, silicon can form five-, six- and even seven-
coordinated silicon species.6-8 Two explanations have been proposed for the formation of 
hypervalent silicon species; firstly, it is due to the participation of silicon’s 3d orbitals,3,5 
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and secondly, it is due to “hypervalent bonding” and the formation of 3-centre-4-electron 
molecular bonds.9
 
If hypervalency is a consequence of 3d orbital participation then the five-coordinate species 
would be sp3d hybridised with trigonal-bipyramidal geometry whilst the six-coordinate 
species would be sp3d2 hybridised with octahedron geometry (Scheme 135). As the s-
character of the silicon centre decreases, the Lewis acidity increases and the Si-R bond is 
elongated leading to efficient hydride or carbon nucleophile transfer to a donor molecule. 
 
L
Si
L L
L R Si L
L
L
L
Si
L
R L
L
L
L
L L
sp3 sp3d s 3d2silicon orbital
hybridisation
R = H or C(spn) (n = 1-3)
L = negatively charged or neutral siliphilic ligand
p
increase in Lewis acidity
decrease in s-character  
Scheme 135 Participation of 3d-orbitals in hypervalent silicon species  
 
It was Denmark et al. who proposed that it is the participation of “hypervalent bonding” 
and the formation of one (pentavalent) or two (hexavalent) 3-centre-4-electron bonds which 
enables the formation of hypervalent silicon species, ruling out the participation of the 3d 
orbitals.9 The 3-centre-4-electron molecular bonds are formed from a silicon p-orbital and 
two orbitals from two electronegative ligands, the remaining silicon p-orbitals and s-orbital 
hybridise and form more conventional covalent bonding. In the case of the hypervalent 
bonds, the majority of the electron density is placed on the ligands due to the HOMO being 
a non-bonding interaction. The silicon centre, therefore, increases in s-character and Lewis 
acidity as the number of hypervalent bonds increases (Scheme 136). 
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Scheme 136 Formation of "hypervalent bonds" in hypervalent silicon species 
 
Three different reaction modes are possible with hypervalent silicon reagents. Firstly, it can 
act as a Lewis acid, activating a substrate to attack from an external nucleophile (Scheme 
137, pathway a). Secondly, the nucleophilic ligand of the silicon reagent is transferred to 
the substrate with no substrate-silicon interaction (Scheme 137, pathway b). The final 
reaction pathway involves substrate activation by the Lewis acidic silicon reagent with 
nucleophilic ligand transfer occurring at the same time (Scheme 137, pathway c).  
 
L3Si R
"activation"
Lewis base (LB)
L3Si Rδ-
LB
L3Si R
LB
O
R'
R''
Nuc-
OH
R'R'' Nuc
O
R' R''
O
R' R''
O
R' R''
L3Si Rδ-
LB
O
R'
R''
OH
R'R'' R
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Scheme 137 Reaction modes involving hypervalent silicon species 
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4.1.2 Lewis Base Promoted Reduction of Ketones by Silanes 
 
Corriu et al. first recognised the tendency of hypervalent silanes to release hydrides on 
addition of a Lewis base when he demonstrated the reduction of acetophenone to phenyl 
ethanol 396 using triethoxysilane and CsF (Scheme 138).10-12 The addition of CsF was 
found to be essential as ketones are chemically inert to trialkoxysilanes.  
 
 
 
O
0 oC, 0.5 h
OH
112 396 : 80%
(EtO)3SiH (1 equiv)
CsF (1 equiv)
Scheme 138 Fluoride promoted reduction of acetophenone 
 
Activation of silanes by alkoxy ligands enabled the development of asymmetric Lewis base 
catalysed reductions.13a The first example of catalytic asymmetric reduction of ketones by 
trialkoxysilanes was promoted by the dilithium salts of chiral diols or amino alcohols 
(Scheme 139).13b
 
O OH
112 (R)-396 : 89% yield
52% ee
(MeO)3SiH (1.5 equiv)
(S)-397 (0.4 mol%)
THF, r.t.
N
Li
OLi
(S)-397  
Scheme 139 The first asymmetric reduction of ketones using trialkoxysilanes 
 
Since the example above (Scheme 139), the development of asymmetric organocatalysis 
has exploded within organic chemistry. Recent examples of asymmetric ketone reductions 
give the desired products in excellent yields and enantioselectivities (Scheme 140).14 
Trichlorosilane is often employed in these transformations as a cheap stoichiometric 
reductant. 
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O
RAr
HSiCl3
400 (10mol%)
CHCl3, r.t., 6 h
OH
RAr
NHO2C
CHO
398 399 : up to 97% ee
400  
Scheme 140 Lewis base promoted ketone reduction 
 
4.1.3 Lewis Base Promoted Conjugate Reduction by Silanes 
 
Nakajima et al. reported the first example of a Lewis base catalysed conjugate reduction 
and a reductive aldol reaction.15 Hexamethylphosphoramide (HMPA) and aryl phosphine 
oxides, including (S)-BINAPO 405, enabled highly selective asymmetric transformations 
(Scheme 141). The one-pot reductive aldol reaction is particularly pleasing as benzaldehyde 
reduction was scarcely observed under the reaction conditions described. The observed 
stereoselectivities are competitive with many asymmetric transition metal catalysed 
reductive aldol reactions (cf. 1.2). 
 
O
Ph Ph
Me
Cl3SiH (2 equiv)
(S)-405 (10 mol%)
DCM, 0 oC, 20 h
O
Ph Ph
Me
401 402 : 97% yield
97% ee
Me
O
Me
Me Me
Cl3SiH (2 equiv)
PhCHO (1.2 equiv)
(S)-405 (10 mol%)
DCM, -78 oC, 21 h
O
Me Ph
OH
Me Me
Me
403 404 : 67% yield
syn/anti : 69/1
96% ee (syn)
P
P
O
O
Ph
Ph
Ph
Ph
405 : (S)-BINAPO  
Scheme 141 (S)-BINAPO catalysed asymmetric conjugate reduction and reductive aldol 
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4.2 Reduction of 5-Monoalkyl Meldrum’s Acid Derivatives 
 
During previous work into the molybdenum-catalysed two-carbon homologation of 
aldehydes (cf. Chapter 3), it was shown that β-substituted propionaldehdyes 368 could be 
formed by the reduction of both alkylidene MA derivatives 328 and 5-monoalkyl MA 
derivatives 367 (Scheme 142). In the latter example the reaction was initiated by 
enolisation, not a molybdenum-catalysed conjugate reduction. 
 
O
O
O
O
367a
H
O
368a : 72%
MeO MeO
PhSiH3 (3 equiv)
Mo(CO)6 (5mol%)
NMO (9 mol%)
THF, 80 oC, 16 h
thenH2O
O
O
O
O
328a
H
O
368a : 85%
MeO MeO
PhSiH3 (3 equiv)
Mo(CO)6 (5mol%)
NMO (9 mol%)
THF, 80 oC, 16 h
thenH2O
 
Scheme 142 Molybdenum-catalysed synthesis of β-substituted propionaldehydes 
 
It was proposed that the reaction proceeded via α-oxoketene 387, formed from the 
cycloreversion of 386 (Scheme 143). This ketene was hydrosilylated to give 388 which, 
after decarboxylative protonation, gave of the desired aldehyde. 
 
O
OR
O
O
O
OR
O
OSiR3
Mo(CO)6 (5mol%)
NMO (9 mol%)
PhSiH3 (3 equiv)
THF, 80 oC, 16 h
- acetone C
OR
OSiR3
O
cycloreversion
HR
O
OR
OSiR3
OSiR3H
hydrosilylation
328 368
H2O
-CO2
386 387 388  
Scheme 143 Proposed mechanism for the molybdenum-catalysed synthesis of β-substituted propionaldehydes 
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In light of this work, it was postulated that a metal-free variant of this transformation could 
be carried out using a hypervalent silicon reagent to reduce the cyclic malonate to the 
desired β-substituted propionaldehyde. In an initial investigation into this Lewis base 
promoted transformation, 5-monoalkyl MA derivative 367a was stirred, with phenylsilane 
and triethylamine, in THF at 80 oC for 16 hours. 1H NMR analysis of the reaction mixture 
showed complete conversion of 367a to 3-(4-methoxyphenyl)propanal 368a. In the absence 
of triethylamine no reaction was observed. Pleasingly, complete consumption of 367a was 
achieved after two hours at ambient temperature giving 368a in an 84% isolated yield 
(Scheme 144).  
 
O
OO
O O
H
PhSiH3 (3 equiv)
Et3N (2 equiv)
THF, r.t., 2 h
then H2OMeO MeO
367a 368a : 84%  
Scheme 144 Triethylamine promoted reduction of 367a 
 
4.2.1 Optimisation 
 
4.2.1.1 Lewis Base Screen 
 
A number of different Lewis bases were screened for this reaction (Table 10). 50 mol% of 
Lewis base was used in the additive screen, however, it was found that no turnover of 
catalyst was observed (all conversions were below 50%). Reactivity was observed with all 
amine bases, excellent conversions were observed for triethylamine and N,N-
dimethylaminopyridine, DMAP (Table 10, entries 1 and 2). Due to increased steric bulk, 
lower conversions were observed for Hunig’s base and diazabicycloundec-7-ene, DBU 
(entries 4 and 5). A good conversion was observed using N-methylmorpholine N-oxide 
(entry 3); activation of silanes using amine-N-oxides has been documented in a number of 
recent reviews.4 No reactivity was observed on using dicyclohexylurea (DCU), 
triphenylphosphine, dimethylsulfoxide (DMSO) or dimethylformamide (DMF) as Lewis 
bases (entries 6-9). Importantly, no reactivity was observed when using potassium 
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carbonate, illustrating that the role of the base is not only the deprotonation of the substrate 
but also the activation of the silane (entry 10). 
 
Due to cost and ease of handling, triethylamine was chosen as the preferred Lewis base 
promoter for this transformation. 
 
Table 10 Lewis base screen 
O
OO
O O
H
MeO MeO
367a 368
PhSiH3 (3 equiv)
Lewis base (0.5 equiv)
THF, r.t., 2 h
then H2O
 
entry Lewis base conversion, %b
1 Et3N 49 
2 DMAP 49 
3 NMO 45 
4 DIPEA 40 
5 DBU 30 
6 DCU 0 
7 PPh3 0 
8 DMSO 0 
9 DMF 0 
10 K2CO3 0 
a Reaction conditions: 367a (1 equiv), phenylsilane (3 equiv), Lewis base (0.5 equiv), THF, r.t., 2 h. 
b Conversion determined by 1H NMR. 
 
4.2.1.2 Silane Screen 
 
As with the molybdenum-catalysed synthesis of β-substituted aldehydes, less reactive 
silanes did not result in successful product synthesis. Diphenylsilane, triethylsilane, 
diethoxymethylsilane and polymethylhydrosiloxane showed no reactivity. The use of 
trichlorosilane resulted in the formation of 368a in an 8% conversion (Scheme 145). 
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O
OO
O O
H
MeO MeO
367a 368a : 8% conv.
Cl3SiH (3 equiv)
Et3N (2 equiv)
THF, r.t., 2 h
then H2O
 
Scheme 145 Reduction of 367a by trichlorosilane 
 
Lower yields were observed on decreasing the equivalents of phenylsilane (Table 11), a 
yield of less than 50% was observed on using equimolar amounts of 5-monoalkyl MA 
derivative 367a and phenylsilane suggesting that 2 equivalents of phenylsilane is required 
for this transformation. 
 
Table 11 Effect of phenylsilane equivalents on yield 
O
OO
O O
H
MeO MeO
367a 368a
PhSiH3 (1-3 equiv)
Et3N (2 equiv)
THF, r.t., 2 h
then H2O
 
entry equivalents of PhSiH3 yield, %b
1 1 41 
2 2 67 
3 3 84 
a Reaction conditions : 367a (1 equiv), phenylsilane (1-3 equiv), triethylamine (2 equiv), THF, r.t., 2 
hours. b Isolated yields. 
 
4.2.2 Exploring the Scope of the Reaction 
 
A range of 5-monoalkyl MA derivatives 367 were synthesised in excellent yields from 
alkylidene MA derivatives 328 by reduction with NaBH4 in high yield.16 Optically active 
substrate 329o was accessed by the reductive coupling MA and Boc-L-Proline 406.17  
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O
O
O
O
R
328
O
O
O
O
R
367 : 84-98%
NaBH4 (2 equiv)
DCM:AcOH (10:1)
0 oC-r.t., 2 h
N
Boc
CO2H
i) Meldum's acid (1 equiv)
DCC (1.1 equiv)
DMAP (1.5 equiv)
DCM, 0 oC-r.t., 24 h
ii) NaBH4 (2 equiv)
DCM, 0 oC-r.t., 2 h
O
O
O
O
N
Boc
406 367o : 78%  
Scheme 146 Synthesis of 5-monoalkyl MAs 
 
The 5-monoalkyl MA derivatives were exposed to the mild reductive conditions described 
above resulting in the synthesis of the desired β-substituted propionaldehydes (Table 12), 
with the exception of 367m (entry 8). An insoluble salt, which underwent no further 
transformation, was formed on addition of triethylamine to 367m, a contrast to its 
regioisomer 367l which proceeds smoothly (entry 7). 
 
Moderate to high yields were observed for a range of functionalities. Electron poor 368j 
was isolated in the highest yield (entry 2), however, only a moderate yield was observed 
with aryl halide 368n (entry 9). A yield of 74% was observed for benzyloxy substituted 
368k (entry 6); this aldehyde was accessed in only 45% yield from the corresponding 
alkylidene MA derivative 328k using molybdenum-catalysed reductive conditions (cf. 
3.3.3).  
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Table 12 Triethylamine promoted reduction of 5-monoalkyl MA derivatives 367 
R H
O
368
O
OR
O
O
PhSiH3 (3 equiv)
Et3N (2 equiv)
367
THF, r.t., 2 h
 
entry R producta yield, %c
1 4-(OMe)C6H4 368a 84 
2 2,3-(OCH2O)C6H3 368e 78 
3 C6H5CHCH 368f 80 
4 3,4-(OMe)2C6H3 368g 61 
5 4-(NO2)C6H4 368j 92 
6 4-(OBn)C6H4 368k 74b
7 2-naphthyl 368l 65 
8 1-naphthyl 368m 0 
9 4-BrC6H4 368n 56 
10 
N
Boc  
368o 75 
a Reaction conditions: 367 (1 equiv), phenylsilane (3 equiv), triethylamine (2 equiv), THF, r.t., 2 h.  
b Reaction was stirred for 4 h. c Isolated yields. 
 
Pleasingly, chiral γ-amino aldehyde 368o was isolated in good yield (entry 10). This γ-
amino aldehyde could be used in the synthesis of a range of potent and selective indole 
based 5-HT6 receptor agonists and antagonists 40718 via a palladium-catalysed indole 
formation with o-haloanilines (Scheme 147).19  
N
H
H
N
N
R
N
R
O
HNH2
X
H
N
Pd-catalysed
annulation
S
Ar
O O
S
Ar
O O
+
407 408 368o  
Scheme 147 Proposed synthetic route to biologically active indole derivatives from 368o 
 
In addition to 5-monoalkylated MA derivatives, 5,5’-disubstituted MA derivative 380 was 
exposed to these reductive conditions. Analysis of the reaction mixture showed that, even 
 115
Chapter 4 
after a prolonged period of heating, 5,5’-disubstituted MA derivative 380 underwent no 
reduction, only unreacted 380 was observed in the reaction mixture (Scheme 148). 
 
O
O
O
O
380
MeO
Me
i) PhSiH3 (3 equiv)
Et3N (2 equiv)
THF, 16 h, 80 oC
ii) H2O
H
O
381 : 0%
MeO
Me
 
Scheme 148 Reduction of 5,5’-dialkyl MA 380 
 
4.2.2.1 Synthesis of Aminoaldehydes 
 
Following the formation of chiral γ-amino aldehyde 368o, N-Boc-L-phenylalanine 
derivative 367p was synthesised by the same method as 367o (Scheme 149).20
 
i) Meldum's acid (1 equiv)
DCC (1.1 equiv)
DMAP (1.5 equiv)
DCM, 0 oC-r.t., 24 h
ii) NaBH (2 equiv)
DCM, 0 oC-r.t., 2 h
O
O
O
O
409 367p : 84%
BocHN CO2H
Ph
BocHN
Ph
 
Scheme 149 Synthesis of 367p 
 
Exposure of this secondary carbamate to the reductive conditions described above did not 
result in the formation of any amino aldehyde: crude 1H NMR analysis showed no peaks 
between 9 and 10 ppm. Following purification by flash column chromatography, one and 
two dimensional NMR studies showed the primary product of the reaction was chiral 2-
pyrrolidinone 410; no other products were isolated from the reaction mixture (Scheme 
150). 
O
O
BocHN
Ph
O
O
PhSiH3 (3 equiv)
Et3N (2 equiv)
THF, r.t., 20 h N
Boc
O
Ph
367p 410 : 45% yield  
Scheme 150 Reduction of 367p 
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No reaction was observed when either triethylamine or phenylsilane were removed from 
the reaction mixture. It is proposed that the reaction is initiated by the nucleophilic attack of 
the nitrogen on the electrophilic ester of the MA group; subsequent elimination of acetone 
and carbon dioxide results in the formation of enolate 411 (Scheme 151). The eliminated 
acetone, activated by the Lewis acidic silane species, then undergoes condensation at the 3-
position to give 410. 
 
O
O
BocHN
Ph
O
O
367p
N
Boc
O
Ph
- acetone, CO2
acetone
- H2O N
Boc
O
Ph
410411  
Scheme 151 Propose route to 410 
 
4.2.2.2 Reduction of Michael Acceptors 
 
Reduction of alkylidene MA derivative 328a by triethylamine and phenylsilane was 
achieved with prolonged heating, and aldehyde 368a was isolated in a 36% yield (Scheme 
152). This transformation is unsurprising in light of high electrophilicity of 328a21 and the 
ability of silanes to reduce Michael acceptors in the presence of Lewis bases (removal of 
triethylamine from the reaction mixture resulted in no reaction).15 When less reactive 
dimethyl itaconate was exposed to the same reductive conditions no conversion to dimethyl 
2-methyl succinate was observed.  
 
O
OO
O O
H
MeO MeO
328a 368a : 36%
PhSiH3 (3 equiv)
Et3N (2 equiv)
THF, 80 oC, 16 h
then H2O
 
Scheme 152 Triethylamine promoted tandem hydrosilylation of 328a 
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4.2.3 Mechanistic Studies 
 
As with the molybdenum-catalysed reduction of arylidene MA derivatives, deuterium 
labelling studies were carried out to gain insight into the reaction mechanism. Deuterium 
was used as a nucleophile and an electrophile in the form of trideuteriophenylsilane22 and 
deuterium oxide.  
 
Reduction of 367a with trideuteriophenylsilane followed by hydrolysis with water 
proceeded smoothly with the product isolated in 85% yield. 1H NMR analysis showed no 
aldehyde peak at 9.80 ppm (Figure 16) and a singlet at 9.75 ppm was observed in the 2H 
NMR (Figure 15), no other peaks were observed in the 2H NMR. Furthermore, a triplet at 
201.9 ppm was observed in the 13C NMR and bands at 2079 cm-1 (C-D) and 1712 cm-1 
(C=O) were observed in the IR spectra confirming the formation of a deuteroaldehyde. The 
1H NMR also showed a 2H triplets at 2.91 ppm and 2.74 (J = 7.5 Hz); a 2H multiplet is 
observed at 2.77-2.72 ppm in the 1H NMR spectra of 268a (Figure 17). This analysis 
suggests the formation of the deuterioaldehyde 412a (Scheme 153), this was confirmed by 
1H-, 2D-, and 13C NMR, mass spectrometry and IR analysis. 
 
O
OO
O O
D
MeO MeO
367a 412a : 85%
PhSiD3 (3 equiv)
Et3N (2 equiv)
THF, r.t., 2 h
then H2O
 
Scheme 153 Reduction of 367a using trideuterophenylsilane 
 
Figure 15 2D NMR of 1-deutero-3-(4-methoxyphenyl)propanal 412a  
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Figure 16 1H NMR of 1-deutero-3-(4-methoxyphenyl)propanal 412a 
 
Figure 17 1H NMR of 3-(4-methoxyphenyl)propanal 368a 
 
Reduction of 367a with phenylsilane, followed by hydrolysis with deuterium oxide gave 
the same mixture of products as the molybdenum-catalysed reduction of alkylidene MA 
derivative 328a hydrolysed with deuterium oxide (cf. 3.3.6.1). Again incomplete 
deuteration at the α-carbon occurred, however, the α,α’-dideuterated product 383a was the 
major product of the reaction. 
 
MeO O
O
O
O
376a
MeO
O
383a
H
D D
MeO
O
384a
H
D H
MeO
O
368a
H
H H
PhSiH3 (3 equiv)
Et3N (2 equiv)
THF, r.t., 2 h
thenD2O
383a:384a:368a : 74:20:6
82%
 
Scheme 154 Reduction of 367a quenched by deuterium oxide 
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4.2.4 Proposed Mechanism 
 
There are two possible reaction pathways for the amine promoted reduction of 5-monoalkyl 
Meldrum’s acid derivatives. Both proposed pathways are initiated by the deprotonation of 
367 on addition of triethylamine and subsequent silylation by phenylsilane to give 386 
(Scheme 155). In pathway a the cycloreversion of 386 gives α-oxoketene 387 which 
undergoes hydrosilylation to intermediate 388 and this remains in solution until 
decarboxylative protonation at the end of the reaction (decarboxylation confirmed by 
limewater test). In pathway b the ester moiety of 386 is hydrosilylated to give 395; this then 
undergoes cycloreversion to give, like pathway a, 388. 
 
O
O
R
O
O
367
O
O
R
O
OSiR3
386
cycloreversion
- acetone hydrosilylation
C
OR
OSiR3
O
O
R
R3SiO
OSiR3
O
OR
OSiR3
H OSiR3
R
O
H
368
395387
388
cycloreversion
- acetone
hydrosilylation
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a
pathway
b
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protonation
H2O
H
CO2
H H
Et3N, PhSiH3
 
Scheme 155 Proposed reaction pathways for the triethylamine promoted reduction of 5-monoalkyl MAs 
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Attempts to isolate intermediate 388 were unsucceful. However, 1NMR analysis of the 
reaction mixture prior to protonation showed loss of acetone is occurring prior to 
decarboxylative protonation. 
 
4.3 Application of Aldehyde Synthesis in Multi-Step Syntheses 
 
Multiple-step syntheses carried out in one pot are of interest as they can increase efficiency 
by avoiding repeated isolation and purification processes. It was envisaged that the mild, 
expeditious synthesis of β-substituted propionaldehydes, described above, could be used as 
the first step in a one-pot multi-step synthesis due to the synthetic utility of the newly 
formed aldehyde functionality.  
 
To explore the synthetic utility of the amine promoted β-substituted propionaldehyde 
synthesis, a one-pot malonate reduction/reductive amination was proposed to access γ-
substituted propylamines 414 directly from 5-monoalkyl Meldrum’s acid derivatives 
(Scheme 156). Decarboxylative protonation would reveal the protected aldehyde 
functionality; this would undergo imine formation on addition of a primary or secondary 
amine. Reduction of the imine would result in the formation of the desired γ-substituted 
propylamines. 
 
R
O
OSiR3
H OSiR3
388
O
O
O
O
R
PhSiH3 (3 equiv)
Et3N (2 equiv)
decarboxylative-
protonation
R H
O
367 368
R'R"NH R N
R"
R'
R N
R"
R'
414413
"H2"
 
Scheme 156 Envisaged process for γ-substituted propylamine synthesis from 367 
 
Methanol proved to be a suitable proton source giving the aldehyde before imine formation 
on addition of a suitable amine. Imine reduction was, as expected, achieved with both Pd/C 
with 1 atmosphere of molecular hydrogen23 and NaBH(OAc)324 (Table 13, entries 1 and 2). 
Higher yields were observed with the palladium-catalysed hydrogenation.  
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Table 13 One-pot reduction/reductive amination of 367a 
O
OMeO O
O
i) PhSiH3 (3 equiv)
Et3N (2 equiv)
THF, r.t. 2 h
ii) MeOH, amine
iii) Pd/C, H2
NR'R"
MeO
367a 414  
entry amine producta yield, %b
1 
HN
415a  
MeO
N
414aa  
63 
2 
HN
415a  
MeO
N
414aa  
31c
3 
HN
415b  
MeO
N
414ab  
52 
4 NH2
415c  
MeO
N
H
414ac  
48 
5 
HN
O
415d  
MeO
N
O
414ad  
41 
6 
HN
415e  
MeO
N
414ae  
50 
7 
HN
415f  
MeO
N
414af  
52 
8 
H2N
415g  
MeO
N
H
414ag  
37 
a Reaction conditions : (i) Substrate 367a (1 equiv), phenylsilane (3 equiv), triethylamine (2 equiv), THF, 
r.t., 2 h, (ii) methanol, amine (2 equiv), r.t. 1 h, (iii) Pd/C, H2 (g) (1 atm), r.t. 16 h. b Isolated yields. 
c NaBH(OAc)3 (2 equiv) used. 
 
This one-pot process was carried out with a range of primary and secondary amines and 
alkylidene MA derivative 367a, products were isolated in moderate yields (Table 13). 
 122
Chapter 4 
Despite high steric hindrance, diisopropylamine gave the highest yield of 63%, a pleasing 
yield for this multi-step process (entry 1). Yields varied little for other secondary amines 
(entries 3, 6 and 7) with the exception of the less nucleophilic morpholine 415d (entry 5). A 
poor yield was observed with the use of benzylamine 415g (entry 8); it is likely that this is 
a consequence of the dialkylation of the amine. Aniline 415c gives the reductive amination 
product in 48% yield (entry 4) 
 
Table 14 One-pot reduction/reductive amination of 5-monoalkyl MAs 
R O
OO
O
i) PhSiH3, Et3N,
THF, r.t. 2h
ii) MeOH,DIPA
iii) Pd/C, H2
R N
367 414 or 416  
entry substrate producta yield, %b
1 
O
O
O
OMeO
367g
MeO
 
MeO
N
MeO
414ga  
56 
2 
O
O
O
OBnO
367k  
HO
N
416ka  
57 
3 
O
O
O
OBnO
367k  
BnO
N
414ka  
32c
4 
O
O
O
O
367l  
N
414la  
41 
5 
O
O
O
O
N
Boc
367o  
NN
Boc
414oa  
61 
a Reaction conditions : (i) Substrate 367 (1 equiv), phenylsilane (3 equiv), triethylamine (2 equiv), THF, 
r.t., 2 h, (ii) methanol, diisopropylamine (2 equiv), r.t. 1 h, (iii) Pd/C, H2 (g) (1 atm), r.t. 16 h. b Isolated 
yields. c NaBH(OAc)3 (2 equiv) used. 
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This one-pot process tolerated a range of 5-monoalkyl MA derivatives (Table 14). Of note 
is the synthesis of 416ka and 414ka from the common substrate 367k, by adjusting the 
reductive conditions the benzyl protecting group can be either removed or left unchanged 
(entries 2 and 3, Table 14). The trend in reactivity for this multi-step process is the same as 
the synthesis of β-substituted propionaldehydes with the exception of 414la which was 
isolated in a poor 41% yield (entry 4). 
 
4.4 Conclusion 
 
A triethylamine promoted reduction of 5-monoalkyl MA derivatives to β-substituted 
aldehydes by phenylsilane has been reported. Good yields have been observed with a range 
of substrates using these mild, expeditious reductive conditions. Evidence towards a 
proposed mechanism has been acquired through deuterium labelling studies and a 
limewater test.  
 
This reductive system has been used in a one-pot reductive aldehyde formation/reductive 
amination for the synthesis of γ-substituted propylamines directly from 5-monoalkyl MA 
derivatives. Moderate yields were observed for this one-pot process. 
 
Under more forcing conditions it was possible to access β-aryl aldehydes directly from 
alkylidene MA derivatives; an amine promoted conjugate reduction is the initiating step of 
this reaction. 
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Chapter 5 - Experimental 
 
5.1 General Information 
 
Commercially available solvents and reagents were obtained from Sigma Aldrich Company 
Ltd, Lancaster Synthesis Ltd, Fisher Scientific Ltd and Strem Chemicals UK and were used 
without further purification. Solvents and were deoxygenated where necessary by purging 
with nitrogen. ‘Petrol’ refers to the fraction of petroleum ether boiling in the range of 40-60 
oC. For catalytic experiments, HPLC-grade solvent was passed through an Innovative 
Technology Pure-Solv solvent purification system. Microwave reactions were performed 
using a CEM Discover 300W laboratory microwave instrument.
 
NMR spectra were recorded on Bruker AV 250, AV300 or AV 500 spectrometers at 298 K 
unless otherwise stated. Chemical shifts (δ) are expressed in parts per million (ppm). 1H 
NMR spectra were referenced internally to residual protio-solvent (CHCl3 at 7.26 ppm), 13C 
NMR spectra were referenced to deuterio-solvent resonance (CDCl3 at 77.0 ppm) and 2H 
NMR were referenced to deuterio-solvent (CDCl3 at 7.26 ppm). Assignments were 
supported by 13C PENDANT NMR and homo- and heteronuclear, one- and two-
dimensional experiments as appropriate. The multiplicities of the spectroscopic data are 
presented in the following manner: singlet (s), broad singlet (br s), doublet (d), doublet of 
doublets (dd), double of doublet of doublets (ddd), doublet of doublet of triplets (ddt), 
triplet (t), triplet of doublets (td), quartet (q), quintet (quin), septet (sept) and multiplet (m). 
Coupling constants (J) are expressed in Hertz (Hz), The assignment of aromatic proton 
resonances for para disubstituted benzene rings has been simplified by assuming an AB 
system, however, the characteristic features of an AA’BB’system were observed in the 
NMR spectra. 
 
IR spectra were recorded on either a Nicolet-Nexus FTIR spectrometer, over the range 
4000-600 cm-1 and averaged over 32 scans, using KBr discs or NaCl plates. Melting points 
were determined using a Buchi 535 melting point apparatus and are uncorrected. 
Electrospray Ionisation (ESI) and Electron Impact (EI) mass spectra were obtained at the 
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EPSRC National Mass Spectrometry Service Centre at Swansea University or on a Bruker 
MicroTOF spectrometer at the mass spectrometry service at the University of Bath. 
 
High Performance Liquid Chromatography (HPLC) was performed on an Agilent 1100 
Series system, using a Chiralpak OJ column by Daicel Chemical Industries Ltd. Elemental 
analyses were recorded on a Micromass Autospec Spectrometer at the University of Bath. 
 
5.2 Molybdenum-Catalysed Conjugate Reduction 
 
5.2.1: Dimethyl 2-methylsuccinate 230 
MeO
O
OMe
O
PhSiH3 (1.5 equiv)
Mo(CO)6 (5 mol%)
NMO (10 mol%)
THF, MW, 80 oC, 5 min
MeO
O
OMe
O  
An oven dried microwave vial was charged with a solution dimethyl itaconate (79.1 mg, 
0.5 mmol), molybdenum hexacarbonyl (6.6 mg, 0.025 mmol, 5 mol%) and N-
methylmorpholine N-oxide monohydrate (5.9 mg, 0.044 mmol, 9 mol%) in tetrahydrofuran 
(1.0 mL). Phenylsilane (92 µL, 0.75 mmol) was added to the solution and the vial was 
sealed under an atmosphere of nitrogen. The solution was heated to 80 oC (100 W) in a 
microwave reactor for 5 minutes and allowed to cool to room temperature. After cooling to 
room temperature, water (0.5 mL) was added to the reaction mixture and the resulting 
solution was stirred at ambient temperature for 15 minutes. The solution was diluted with 
diethyl ether (25 mL) and washed with water (2 x 25 mL) followed by saturated brine (25 
mL). The organic phase was extracted, dried over MgSO4 and concentrated in vacuo. 
Methanol (20 mL) was added to the residue, the solution was filtered through celite and 
concentrated in vacuo to afford the desired compound as a colourless oil (147.4 mg, 95%). 
1H NMR (300 MHz, CDCl3) δ 3.70 (3H, s, OCH3), 3.68 (3H, s, OCH3), 3.00-2.89 (1H, m, 
MeO2CCH), 2.74 (1H, dd, J1 = 16.2 Hz, J2 = 8.3 Hz, CH2CO2Me), 2.41 (1H, dd, J1 = 16.2 
Hz, J2 = 6.0 Hz, CH2CO2Me), 1.22 (3H, d, J = 7.2 Hz); 13C NMR (75.5 MHz, CDCl3) δ 
176.1, 172.7, 52.5, 52.4, 37.9, 36.0, 17.4; HRMS (ESI) calcd for C7H12NaO4 [M+Na]+ : m/z 
183.0628, found 183.0623. Data identical to literature values.1
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5.3 Synthesis of α-Substituted Acrylic Esters 
 
5.3.1: General Procedure for the Synthesis of α-Substituted Acrylic Esters  
O
tBuO Br
N
H
PG OR
O
+
NaH
THF, 0 o-r.t., 24 h
O
tBuO N
PG
OR
O  
N-Protected gylcine methyl or ethyl ester 254 was added to a stirred solution of sodium 
hydride (60% dispersion in mineral oil) in tetrahydrofuran at 0 oC. The subsequent solution 
was stirred for 1 hour at 0 oC. tert-Butyl 2-(bromomethyl)acrylate 255 was then added to 
the reaction mixture and the resulting solution was stirred at ambient temperature for 24 
hours. The reaction mixture was quenched with water and dissolved in diethyl ether. The 
organic phase was washed with water and saturated brine. The organic phase was extracted, 
dried over MgSO4, concentrated in vacuo and purified by flash column chromatography. 
 
5.3.2: tert-butyl 2-((benzyl(2-ethoxy-2-oxoethyl)amino)methyl)acrylate 222 
O
tBuO N
Bn
OEt
O  
N-Benzyl glycine ethyl ester 254a (1.93 g, 10.0 mmol), sodium hydride (0.48 g, 12.0 
mmol), tert-butyl 2-(bromomethyl)acrylate 255 (2.42 g, 11.0 mmol) and tetrahydrofuran 
(50 mL) were reacted under the standard protocol and purified by flash column 
chromatography (9:1 petrol:ethyl acetate) to give the desired compound as a colourless oil 
(2.15 g, 64%); Rf (9:1 petrol:ethyl acetate) 0.24; IR (neat, cm-1) v 2978, 2932 (C-H), 1736, 
1711 (C=O), 1636 (C=C); 1H NMR (300 MHz, CDCl3) δ 7.32-7.17 (5H, m, Ar-H), 6.13 
(1H, s, C=CH2), 5.76 (1H, s, C=CH2), 4.11 (2H, q, J = 7.2 Hz, OCH2CH3), 3.80 (2H, s, 
NCH2Ph), 3.50 (2H, s, NCH2C=C), 3.28 (2H, s, NCH2CO2Et), 1.46 (9H, s, C(CH3)3), 1.22 
(3H, t, J = 7.2 Hz, OCH2CH3); 13C NMR (75.5 MHz, CDCl3) δ 171.9, 166.7, 139.9, 139.4, 
129.2, 128.7, 127.5, 125.7, 81.0, 60.6, 57.8, 55.0, 53.9, 28.5, 14.7; HRMS (ESI) calcd for 
C19H27NNaO4 [M+Na]+ : m/z 356.1838, found 356.1833; Anal. calcd for C19H27NO4: C 
68.4, H 8.16, N 4.20, found: C 68.5, H 8.27, N 4.25. 
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5.3.3: tert-butyl 2-((tert-butoxycarbonyl(2-ethoxy-2-oxoethyl)amino)methyl)acrylate 
256 
O
tBuO N
Boc
OEt
O  
N-Boc glycine ethyl ester 254b (2.25 g, 15 mmol), sodium hydride (0.72 g, 18 mmol), tert-
butyl 2-(bromomethyl)acetate 255 (3.63 g, 16.5 mmol) and tetrahydrofuran (75 mL) were 
reacted under standard conditions and purified by flash column chromatography (9:1 
petrol:ethyl acetate) to give the desired compound, a colourless oil, as a 1:1 mixture of 
rotamers (4.11 g, 80%); Rf (9:1 petrol:ethyl acetate) 0.27; IR (neat, cm-1) v 2980, 2935 (C-
H), 1753, 1706 (C=O), 1638 (C=C); 1H NMR (300 MHz, CDCl3) δ 6.19 and 617 (1H, s, 
C=CH2), 5.67 and 5.60 (1H, s, C=CH2), 4.17 and 4.16 (2H, q, J = 7.2 Hz, OCH2CH3), 4.11 
and 4.06 (2H, s, NCH2C=C), 3.99 and 3.88 (2H, s, NCH2CO2Et), 1.48 and 1.47 (9H, s, 
C(CH3)3), 1.44 and 1.42 (9H, s, C(CH3)3), 1.26 and 1.25 (3H, t, J = 7.2 Hz, OCH2CH3); 13C 
NMR (75.5 MHz, CDCl3) δ 170.4 and 170.3, 165.9, 156.2 and 155.5, 138.4 and 138.1, 
126.1 and 125.3, 81.6 and 81.4, 80.9 and 80.8, 61.3, 50.0 and 49.5, 49.3 and 49.2, 28.7 and 
28.6, 28.4, 14.6 and 14.5; HRMS (ESI) calcd for C17H30NO6 [M+H]+ : m/z 344.2073, found 
344.2063. 
 
5.3.4: tert-butyl 2-((allyl(2-methoxy-2-oxoethyl)amino)methyl)acrylate 257 
O
tBuO N
OMe
O
 
N-Allyl glycine methyl ester 254c (1.29 g, 10 mmol), sodium hydride (0.48 g, 12.0 mmol), 
tert-butyl 2-(bromomethyl)acetate 255 (2.42 g, 11.0 mmol) and tetrahydrofuran (50 mL) 
were reacted under standard conditions and purified by flash column chromatography (9:1 
petrol:ethyl acetate) to give the desired compound as a colourless oil (1.43 g, 53%); Rf (9:1 
petrol:ethyl acetate) 0.22; IR (neat, cm-1) v 2979, 2954, 2941, 2845 (C-H), 1741, 1715 
(C=O), 1641 (C=C); 1H NMR (300 MHz, CDCl3) δ 6.14 (1H, s, C=CH2), 5.81 (1H, ddt, J1 
= 17.3 Hz, J2 = 10.2 Hz, J3 = 6.4 Hz, NCH2CHCH2), 5.71 (1H, s, C=CH2), 5.18 (1H, ddt, J1 
= 17.3 Hz, J2 = 1.9 Hz, J3 = 1.5 Hz, NCH2CHCH2), 5.13 (1H, ddt, J1 = 10.2 Hz, J2 = 1.9 
Hz, J3 = 1.1 Hz, NCH2CHCH2), 3.67 (3H, s, CO2CH3), 3.44 (2H, s, NCH2C=C), 3.35 (2H, 
s, NCH2CO2Me), 3.26 (2H, ddd, J1 = 6.4 Hz, J2 = 1.5 Hz, J3 = 1.1 Hz, NCH2CHCH2), 1.48 
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(9H, s, C(CH3)3); 13C NMR (75.5 MHz, CDCl3) δ 172.4, 166.6, 139.7, 136.0, 125.9, 118.1, 
81.1, 57.3, 54.6, 54.11, 51.7, 28.5; HRMS (ESI) calcd for C14H23NNaO4 [M+Na]+ : m/z 
292.1525, found 292.1519. 
 
5.3.5: tert-butyl 2-(((2-ethoxy-2-oxoethyl)methylamino)methyl)acrylate 218 
O
tBuO N
Me
OEt
O  
Sarcosine ethyl ester hydrochloride 254d (694 mg, 4.53 mmol), sodium hydride (422 mg, 
10.5 mmol), tert-butyl 2-(bromomethyl)acetate 255 (1 g, 4.53 mmol) and tetrahydrofuran 
(50 mL) were reacted under standard conditions and purified by flash column 
chromatography (4:1 petrol:ethyl acetate) to give the desired compound as a colourless oil 
(932 mg, 80%); Rf (4:1 petrol:ethyl acetate) 0.27; IR (neat, cm-1) v 2980 (C-H), 1740, 1713 
(C=O), 1636 (C=C); 1H (300 MHz, CDCl3) δ 6.08 (1H, s, C=CHH), 5.61 (1H, s, C=CHH), 
4.07 (2H, q, J = 7.2 Hz, OCH2CH3), 3.28 (2H, s, NCH2C=C), 3.20 (2H, s, CH2CO2Et), 2.30 
(3H, s, NCH3), 1.40 (9H, s, C(CH3)3), 1.18 (3H, t, J = 7.2 Hz, OCH2CH3); 13C NMR (75.5 
MHz, CDCl3) δ 171.3, 166.4, 139.2, 126.0, 80.9, 60.5, 58.1, 57.1, 42.3, 28.3, 14.6; HRMS 
(ESI) calcd for C13H23NNaO4 [M+Na]+ : m/z 280.1524, found 280.1522. 
 
5.3.6: (R)-ethyl 2-(1-phenylethylamino)acetate 274 
HN
Ph
OEt
O
 
(R)-1-Phenylethylamine 272 (1.05 mL, 8.25 mmol) was added to a stirred solution of 
sodium hydride (60% dispersion in mineral oil) (330 mg, 8.25 mmol) in tetrahydrofuran 
(25 mL) at 0 oC. The subsequent solution was stirred for 1 hour at 0 oC. Ethyl 2-
bromoacetate 273 (457 µL, 4.13 mmol) was then added to the reaction mixture and the 
resulting solution was stirred at ambient temperature for 24 hours. The reaction mixture 
was quenched with water and dissolved in diethyl ether (50 mL). The organic phase was 
washed with water (50 mL) and saturated brine (50 mL). The organic phase was extracted, 
dried over MgSO4, concentrated in vacuo and purified by flash column chromatography 
(4:1 petrol:ethylacetate) to give the desired compound as a colourless oil (746 mg, 87%); Rf 
(4:1 petrol:ethyl acetate) 0.20;  1H NMR (300 MHz, CDCl3) δ 7.31 (5H, m, ArH), 4.13 (2H, 
q, J = 7.2 Hz, CO2CH2CH3), 3.77 (1H, q, J = 6.4 Hz, NCH), 3.27 (1H, d, J = 17.3 Hz, 
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NCH2CO2Et), 3.19 (1H, d, J = 17.3 Hz, NCH2CO2Et), 1.90 (1H, s, NH), 1.36 (3H, d, J = 
6.4 Hz, NCHCH3), 1.22 (3H, t, J = 7.2 Hz, CO2CH2CH3); 13C (75.5 MHz, CDCl3) δ 173.0, 
145.0, 128.9, 127.6, 127.2, 61.1, 58.1, 49.3, 24.6, 14.6; HRMS (ESI) calcd for 
C12H17NnaO2 [M+Na]+ : m/z 230.1152, found 230.1142. Data identical to literature values.2
 
5.3.7: (R)-tert-butyl 2-(((2-ethoxy-2-oxoethyl)(1-phenylethyl)amino)methyl)acrylate 
275 
N
OEt
O
Ph
O
tBuO
 
2-((R)-1-Phenylethylamino)acetate 274 (711 mg, 3.43 mmol), sodium hydroxide (137 mg, 
3.43 mmol), tert-butyl 2-(bromomethyl)acetate 255 (663 mg, 3.43 mmol) and 
tetrahydrofuran (20 mL) were reacted under standard conditions and purified by flash 
column chromatography (10:1 petrol:ethyl acetate) to give the desired compound as a 
colourless oil (544 mg, 46%); Rf (10:1 petrol:ethyl acetate) 0.24; [ ]24Dα  -1.3 (c = 0.8, 
CDCl3); IR (neat, cm-1) v 2980, 2935 (C-H), 1735, 1708 (C=O), 1639 (C=C); 1H NMR 
(300 MHz, CHCl3) δ 7.40-7.19 (5H, m, Ar), 6.13 (1H, s, C=CHH), 5.87 (1H, s, C=CHH), 
4.12 (2H, q, J = 7.2 Hz, OCH2CH3), 4.10 (1H, q, J = 6.8 Hz, NCH), 3.49 (1H, d, J = 16.2 
Hz, NCH2C=C), 3.45 (1H, d, J = 16.2 Hz, NCH2C=C), 3.40 (1H, d, J = 17.3 Hz, 
NCH2CO2Et), 3.25 (1H, d, J = 17.3 Hz, NCH2CO2Et), 1.48 (9H, s, C(CH3)3), 1.36 (3H, d, J 
= 6.8 Hz, CHCH3), 1.24 (3H, t, 7.2 Hz, OCH2CH3); 13C NMR (75.5 MHz, CDCl3) δ 172.5, 
166.7, 144.7, 140.4, 128.6, 127.9, 127.3, 125.4, 81.0, 60.7, 60.6, 52.1, 51.8, 28.5, 19.3, 
14.6; HRMS (ESI) calcd for C20H29NO4Na [M+Na]+ : m/z 370.1994, found 370.1994. 
 
5.3.8: (1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 2-(tert-butoxycarbonylamino)acetate 
290 
BocHN CO2H
(+)-Menthol
DCC, DMAP
DCM, r.t., 24 h
BocHN
O
O
 
To a stirred solution of N-Boc glycine 289 (3.50 g, 20.2 mmol) in dichloromethane (110 
mL) was added dicyclohexylcarbodiimide (4.18 g, 20.2 mmol), and dimethylaminopyridine 
(110 mg, 0.9 mmol) at 0 oC. The resulting solution was stirred for 1 hour before the 
addition of (+)-menthol (3.78 g, 24.2 mmol) and then stirred for a further 24 hours after 
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reaching ambient temperature. The reaction mixture was dissolved in DCM (100 mL) and 
washed with water (200 mL) and saturated brine (200 mL); the organic phase was extracted 
and concentrated in vacuo. The residue was dissolved in ethyl acetate and filtered through 
celite, the filtrate was concentrated in vacuo and purified by flash column chromatography 
(12:1 petrol:diethyl ether) to give the desired product as a colourless oil (5.09 g, 80%); Rf 
(12:1 petrol:diethyl ether) 0.21; [ ]24Dα  +75.3 (c = 0.9, CHCl3); IR (neat, cm-1) v IR 3034 (N-
H), 2958, 2871 (C-H), 1740, 1701 (C=O); 1H NMR (300 MHz, CDCl3) δ 5.02 (1H, br s, 
NH), 4.74 (1H, td, J1 = 10.9 Hz, J2 = 4.5 Hz, OCH), 3.87 (2H, d, J = 5.3 Hz, NCH2), 2.01-
1.94 (1H, m, mentholate), 1.90-1.75 (1H, m, mentholate), 1.73-1.63 (2H, m, mentholate), 
1.53-1.32 (2H, m, mentholate), 1.44 (9H, s, C(CH3)3), 1.11-0.79 (3H, m, mentholate), 0.89 
(3H, d, J = 6.5 Hz, CHC(CH3)2), 0.87 (3H, d, J = 6.5 Hz, CHC(CH3)2), 0.74 (3H, d, J = 6.8 
Hz, CHCH3); 13C NMR (75.5 MHz, CDCl3) δ 170.3, 156.0, 80.2, 75.8, 47.3, 43.0, 41.2, 
34.5, 31.8, 28.7, 26.6, 23.8, 22.4, 21.1, 16.7; HRMS (ESI) calcd for C17H32NO4 [M+H]+ : 
m/z 314.2331, found 314.2330. 
 
5.3.9: (1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 2-(benzylamino)acetate 291 
BocHN
O
O
BnHN
O
O
i) BnBr, NaH
THF, 0 oC - r.t.
16 h
ii) TFA, DCM
0 oC, 3 h
 
 (1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl 2-(tert-butoxycarbonylamino)acetate 289 (3.0 
g, 9.57 mmol) was added to a stirred solution of sodium hydride (60% dispersion in mineral 
oil) (460 mg, 11.48 mmol) in tetrahydrofuran (100 mL) at 0 oC. The resulting solution was 
stirred at 0 oC for 1 hour then benzyl bromide (1.71 mL, 14.36 mmol) was added and the 
solution stirred at ambient temperature for 24 hours. The reaction mixture was dissolved in 
diethyl ether (100 mL) and washed with saturated sodium hydrogen carbonate solution (2 x 
150 mL), water (150 mL) and saturated brine (150 mL). The organic phase was extracted 
and concentrated in vacuo and the residue was reacted further without isolation of the 
product. The residue was dissolved in dichloromethane (30 mL) and stirred at 0 oC. 
Trifluoacetic acid (7.5 mL) added to the solution drop wise, the reaction mixture was then 
stirred at ambient temperature for 3 hours. The reaction mixture was concentrated in vacuo 
and the residue dissolved in diethyl ether (100 mL). The organic phase was washed with 
saturated sodium hydrogen carbonate solution (3 x 100 mL), water (100 mL) and brine 
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(100 mL). The organic phase was extracted, concentrated in vacuo and purified by flash 
column chromatography (10:1 petrol:ethyl acetate) to give the desired compound as a 
colourless oil (1.34 g, 46%); Rf (10:1 petrol:ethyl acetate) 0.28; [ ]24Dα  +34.6 (c = 7.5, 
CHCl3);  IR (neat, cm-1) v 3030 (N-H), 2957, 2870 (C-H), 1732 (C=O); 1H NMR (300 
MHz, CDCl3) δ 7.30-7.19 (5H, m, Ar), 4.74 (1H, td, J1 = 10.9 Hz, J2 = 4.5 Hz, OCH), 3.77 
(2H, s, NCH2Ph), 3.35 (2H, s, NCH2CO2Xc), 2.01-1.96 (1H, m, mentholate), 1.91 (1H, br s, 
NH), 1.87-1.74 (1H, m, mentholate), 1.70-1.61 (2H, m, mentholate), 1.39-1.29 (1H, m, 
mentholate), 1.11-0.80 (4H, m, mentholate), 0.88 (3H, d, J = 6.5 Hz, CH(CH3)2), 0.86 (3H, 
d, (J = 6.5 Hz, CH(CH3)2), 0.75 (3H, d, J = 7.2 Hz, CHCH3); 13C NMR (75.5 MHz, CDCl3) 
δ 172.4, 140.0, 128.8, 128.7, 127.5, 75.1, 53.7, 50.7, 47.4, 41.4, 34.6, 31.8, 26.7, 23.8, 22.4, 
21.1, 16.7; HRMS (ESI) calcd for C19H30NO2 [M+H]+ : m/z 304.2277, found 304.2270. 
 
5.3.10: tert-butyl 2-((benzyl(2-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)-2-
oxoethyl)amino)methyl)acrylate 292 
BnHN
O
O
N
O
OBn
tBuO
O
THF, 0 oC to r.t.
O
tBuO Br
NaH
 
(1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl 2-(benzylamino)acetate 291 (500 mg, 1.65 
mmol) was added to a solution of sodium hydride (60% dispersion in mineral oil) (72.5 mg, 
1.81 mmol) in tetrahydrofuran (20 mL) at 0 oC. The subsequent solution was stirred for at 0 
oC for 1 hour before the addition of tert-butyl 2-(bromomethyl)acrylate 255 (750 mg, 1.81 
mmol). The reaction mixture was stirred at ambient temperature for 24 hours. The reaction 
mixture was dissolved in diethyl ether (50 mL) and washed with saturated sodium 
hydrogen carbonate solution (2 x 50 mL), water (50 mL) and brine (50 mL). The organic 
phase was extracted, dried over MgSO4 and concentrated in vacuo. The mixture was 
purified by flash column chromatography (15:1 petrol:diethyl ether) to give the desired 
product as a colourless oil (185 mg, 66% yield); Rf (15:1 petrol:diethyl ether) 0.25; [ ]24Dα  
+56.1 (c = 1.8, CHCl3); IR (neat, cm-1) v 2957, 2870 (C-H), 1738, 1712 (C=O), 1637 
(C=C); 1H NMR (300 MHz, CDCl3) δ 7.38-7.23 (5H, m, Ar), 6.19 (1H, d, J = 6.19 Hz, 
C=CHH), 5.81 (1H, d, J = 1.9 Hz, C=CHH), 4.78 (1H, td, J1 = 10.9 Hz, J2 = 4.5 Hz, OCH), 
3.87 (2H, s, NCH2Ph), 3.58 (2H, s, NCH2C=C), 3.32 (2H, s, NCH2CO2Xc), 2.07-2.00 (1H, 
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m, mentholate), 1.94-1.79 (1H, m, mentholate), 1.74-1.67 (2H, m, mentholate), 1.61-1.47 
(1H, m, mentholate), 1.53 (9H, s, C(CH3)3), 1.44-1.34 (1H, m, mentholate), 1.17-0.88 (3H, 
m, mentholate), 0.94 (3H, d, J = 6.5 Hz, CH(CH3)2), 0.92 (3H, d, J = 6.5 Hz, CH(CH3)2), 
0.81 (3H, d, J = 6.8 Hz, CHCH3); 13C NMR (75.5 MHz, CDCl3) δ 170.0, 165.2, 138.7, 
138.0, 127.7, 127.2, 126.0, 124.3, 124.0, 79.5, 73.1, 56.4, 53.7, 52.6, 46.0, 40.0, 33.2, 29.9, 
27.1, 25.2, 21.3, 19.7, 15.3; HRMS (ESI) calcd for C27H42NO4 [M+H]+ : m/z 444.3114, 
found 444.3099; Anal. calcd for C27H41NO4: C 73.1, H 9.32, N 3.16, found: C 73.4, H 9.41, 
N 3.27. 
 
5.3.11: 2-(benzyl(2-(tert-butoxycarbonyl)allyl)amino)acetic acid 295 
BnHN CO2H
NaH
THF, 0 oC to r.t.
O
tBuO Br
N
Bn
tBuO
O
CO2H
 
N-Benzylglycine 294 (250 mg, 1.51 mmol) was added to a solution of sodium hydride 
(60% dispersion in mineral oil) (121 mg, 3.26 mmol) in tetrahydrofuran (15 mL) at 0 oC. 
The resulting solution was stirred at 0 oC for 1 hour before the addition of tert-butyl 2-
(bromomethyl)acrylate 255 (266 mg, 1.38 mmol). The reaction mixture was allowed to stir 
for 24 hours at ambient temperature. The reaction mixture was dissolved in DCM (50 mL) 
and acidified with 1 M HCl(aq) (10 mL). The organic phase was extracted, dried over 
MgSO4 and concentrated in vacuo. The residue was purified by column chromatography 
(10:1 ethyl acetate:methanol) to give the desired product as a colourless viscous oil (115 
mg, 25%); Rf (10:1 ethyl acetate:methanol) 0.15; IR (neat, cm-1) v 3238 (O-H), 2981, 2934 
(C-H), 1702 (C=O), 1636 (C=C); 1H NMR (300 MHz, CDCl3) δ 10.40 (1H, br s, CO2H), 
7.35-7.22 (5H, m, Ar), 6.28 (1H, s, C=CHH), 5.79 (1H, s, C=CHH), 3.70 (2H, s, 
NCH2C=C), 3.45 (2H, s, NCH2Ph), 3.25 (2H, s, NCH2CO2H), 1.54 (9H, s, C(CH3)3); 13C 
NMR (75.5 MHz, CDCl3) δ 172.3, 166.4, 137.8, 137.0, 129.9, 129.4, 129.2, 128.3, 82.6, 
58.1, 57.7, 55.7, 28.4; HRMS (ESI) calcd for C17H22NO4 [M-H]- : m/z 304.1549, found 
304.1535. 
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5.3.12: General Procedure for the Coupling of Chiral Auxiliaries and 295 
N
Bn
tBuO
O
N
Xc
OBn
tBuO
O
CO2H
XcH (1.1 equiv)
DCC (1 equiv)
DMAP (5mol%)
DCM, 0 oC - r.t.
16 h  
To a stirred solution of 2-(benzyl(2-(tert-butoxycarbonyl)allyl)amino)acetic acid 295 (611 
mg, 2 mmol) in dichloromethane (10 mL) was added dicyclohexycarbodiimide (413 mg, 2 
mmol) and N,N-dimethylaminopyridine (12.2 mg, 0.1 mmol, 5 mol%). The resulting 
solution was stirred at 0 oC for 1 hour before the addition of alcohol (2.2 mmol). The 
reaction mixture was stirred at ambient temperature for 16 hours. The reaction mixture was 
dissolved in DCM (100 mL) and washed with water (2 x 100 mL) and saturated brine 
solution (100 mL). The organic phase was extracted, dried over MgSO4 and concentrated in 
vacuo. The mixture was purified by flash column chromatography. 
 
5.3.13: (R)-tert-butyl 2-((benzyl(2-(4,4-dimethyl-2-oxotetrahydrofuran-3-yloxy)-2-
oxoethyl)amino)methyl)acrylate 296 
N
O
OBn
tBuO
O
O
O
 
(R)-Pantolactone 298 (286 mg, 2.2 mmol) was reacted under the general procedure and 
purified by flash column chromatography (10:1 petrol:ethyl acetate) to give the desired 
compound as a colourless oil (500 mg, 60%); Rf (10:1 petrol:ethyl acetate) 0.09; [ ]24Dα  +2.0 
(c 1.6, CHCl3); IR (neat, cm-1) v 2977, 2933 (C-H), 1794, 1756, 1709 (C=O), 1636 (C=C); 
1H NMR (300 MHz, CDCl3) δ 7.37-7.22 (5H, m, Ar), 6.19 (1H, d, J = 1.9 Hz, C=CHH), 
5.80 (1H, d, J = 1.9 Hz, C=CHH), 5.41 (1H, s, OCH), 4.05 (2H, s, NCH2COXc), 3.88 (2H, 
s, NCH2Ph), 3.59 (2H, s, NCH2C=C), 3.54 (1H, d, J = 17.3 Hz, OCH2C(CH3)2), 3.46 (1H, 
d, J = 17.3 Hz, OCH2C(CH3)2), 1.52 (9H, s, C(CH3)3), 1.23 (3H, s, C(CH3)2), 1.10 (3H, s, 
C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 171.1, 169.2, 165.2, 138.4, 137.6, 127.8, 127.3, 
126.2, 124.4, 79.7, 75.2, 73.9, 56.3, 53.6, 52.0, 39.1, 27.1, 22.0, 19.0; HRMS (ESI) calcd 
for C23H31NNaO6 [M+Na] : m/z 440.2049, found 440.2044. 
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5.3.14: (S)-tert-butyl 2-((benzyl(2-oxo-2-(1-phenylethoxy)ethyl)amino)methyl)acrylate 
297 
N
O
OBn
tBuO
O
Ph  
(S)-1-Phenylethanol 299 (266 µL, 2.2 mmol) was reacted under the general procedure and 
purified by flash column chromatography (15:1 petrol:ethyl acetate) to give the desired 
compound as a colourless oil (398 mg, 49%); Rf (10:1 petrol:ethyl acetate) 0.30; [ ]24Dα  -29.7 
(c 1.7, CHCl3); IR (neat, cm-1) v 2981, 2933 (C-H), 1745, 1711 (C=O), 1636 (C=C); 1H 
NMR (300 MHz, CDCl3) δ 7.39-7.20 (10H, m, Ar), 6.14 (1H, s, C=CHH), 5.93 (1H, q, J = 
6.8 Hz, OCH(Ph)Me), 5.75 (1H, s, C=CHH), 3.81 (2H, s, NCH2Ph), 3.53 (2H, s, 
NCH2C=C), 3.37 (1H, d, J = 17.3 Hz, NCH2COXc), 3.31 (1H, d, J = 17.3 Hz, NCH2COXc), 
1.54 (3H, d, J = 6.8 Hz, CHCH3), 1.49 (9H, s, C(CH3)3); 13C NMR (75.5 MHz, CDCl3) δ 
171.1, 166.7, 142.0, 140.0, 139.4, 129.2, 129.0, 128.6, 128.3, 127.5, 126.5, 125.6, 81.0, 
72.7, 57.8, 55.1, 54.1, 28.5, 22.7; HRMS (ESI) calcd for C25H31NNaO4 [M+Na]+ : m/z 
432.2151, found 432.2146. 
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5.4 Molybdenum-Catalysed Reductive Dieckmann Condensation 
 
5.4.1: General Procedure for the Molybdenum-Catalysed Reductive Dieckmann 
Condensation 
O
tBuO N
PG
OR
O
PhSiH3 (1.5 equiv)
Mo(CO)6 (5 mol%)
NMO (10mol%)
THF, 80 oC, 16 h N
PG
O
OtBu
O
 
To a solution of molybdenum hexacarbonyl (6.6 mg, 0.025 mmol, 5 mol%) and N-
methylmorpholine N-oxide monohydrate (5.9 mg, 0.044 mmol, 9 mol%) in tetrahydrofuran 
(3 mL) was added β-substituted acrylate (0.5 mmol) followed by phenylsilane (92 µL, 0.75 
mmol). The reaction mixture was stirred at 80 oC for 16 hours. After cooling to room 
temperature the reaction mixture was dissolved in diethyl ether (25 mL) and washed with 
water (2 x 25 mL) and saturated brine (25 mL). The organic phase was extracted, dried over 
MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography. 
 
5.4.2: tert-butyl 1-benzyl-3-methyl-4-oxopyrrolidine-3-carboxylate 258 
N
Bn
O
OtBu
O
 
tert-Butyl 2-((benzyl(2-ethoxy-2-oxoethyl)amino)methyl)acrylate 222 (167 mg, 0.5 mmol) 
was reacted under the general procedure and purified by flash column chromatography 
(12:1 petrol:diethyl ether) to give the desired product as a colourless oil (128 mg, 88%); Rf 
(12:1 petrol:diethyl ether) 0.19; IR (neat, cm-1) v 2979, 2935, 2797 (C-H), 1766, 1729 
(C=O); 1H NMR (300 MHz, CDCl3) δ 7.34-7.24 (5H, m, Ar), 3.71 (2H, s, NCH2Ph), 3.33 
(1H, d, J = 9.4 Hz, NCH2C(Me)CO2tBu), 3.20 (1H, d, J = 17.0 Hz, NCH2C=O), 3.00 (1H, 
d, J = 17.0 Hz, NCH2C=O), 2.68 (1H, d, J = 9.4 Hz, NCH2C(Me)CO2tBu), 1.44 (9H, s, 
C(CH3)3), 1.35 (3H, s, CH3); 13C NMR (75.5 Hz, CDCl3) δ 210.9, 170.7, 138.0, 128.9, 
128.8, 127.8, 82.4, 62.9, 61.3, 60.3, 58.4, 28.3, 18.2; HRMS (ESI) calcd for C17H23NNaO3 
[M+Na]+ : m/z 312.1576, found 312.1560; Anal. calcd for C17H23NO3: C 70.6, H 8.01, N 
4.84, found: C 70.4, H 8.09, N 4.81; Diacel Chiralcel OJ, hexane/propan-2-ol (99:1), 0.5 
mL min-1, tR = 15.3 and 16.6 mins. 
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5.4.3: di-tert-butyl 3-methyl-4-oxopyrrolidine-1,3-dicarboxylate 249 
N
Boc
O
OtBu
O
 
tert-Butyl 2-((tert-butoxycarbonyl(2-ethoxy-2-oxoethyl)amino)methyl)acrylate 256 (172 
mg, 0.5 mmol) was reacted under the general procedure and purified by flash column 
chromatography (10:1 petrol:ethyl acetate) to give the desired product, a colourless oil, a 
1:1 mixture of rotamers (91.4 mg, 61%); Rf (10:1 petrol:ethyl acetate) 0.28; IR (neat, cm-1) 
v 2977, 2928 (C-H), 1753, 1723, 1699 (C=O); 1H NMR (300 MHz, CDCl3) δ 4.18 and 4.16 
(1H, d, J = 12.1 Hz, NCH2C(Me)CO2tBu), 4.03 and 3.98 (1H, d, J = 19.2 Hz, NCH2C=O), 
3.71 (1H, d, J = 19.2 Hz, NCH2C=O), 3.36 (1H, d, J = 12.1 Hz, NCH2C(Me)CO2tBu), 1.45 
(9H, s, C(CH3)3), 1.40 (9H, s, C(CH3)3), 1.30 (3H, s, CH3); 13C NMR (75.5 Hz, CDCl3) δ 
209.0 and 208.3, 169.5, 154.5, 83.2, 81.0, 57.5 and 56.9, 55.1 and 54.4, 53.1 and 52.6, 28.8, 
28.1, 17.7; HRMS (ESI) calcd for C15H25NNaO5 [M+Na]+ m/z 322.1630, found 322.1632. 
 
5.4.4: tert-butyl 1-allyl-3-methyl-4-oxopyrrolidine-3-carboxylate 259 
N
O
OtBu
O
 
tert-Butyl 2-((allyl(2-methoxy-2-oxoethyl)amino)methyl)acrylate 257 (134.7 mg, 0.5 
mmol) was reacted under the general procedure and purified by flash column 
chromatography (20:1 petrol:ethyl acetate) to give the desired product as a colourless oil 
(61.0 mg, 51%); Rf (20 petrol:ethyl acetate) 0.26; IR (neat, cm-1) v 2983, 2936, 2800 (C-H), 
1764, 1725 (C=O); 1H NMR (300 MHz, CDCl3) δ 5.84 (1H, ddt, J1 = 17.0 Hz, J2 = 10.2 
Hz, J3 = 6.4 Hz, NCH2CH=CH2), 5.23 (1H, dd, J1 = 17.0 Hz, J2 = 1.9 Hz, NCH2CH=CH2), 
5.15 (1H, dd, J1 = 10.2 Hz, J2 = 1.9 Hz, NCH2CH=CH2), 3.28 (1H, d, J = 9.4 Hz, 
NCH2C(Me)CO2tBu), 3.15 (2H, d, J = 6.4 Hz, NCH2CH=CH2), 3.12 (1H, d, J = 17.0 Hz, 
NCH2C=O), 3.0 (1H, d, J = 17.0 Hz, NCH2C=O), 2.70 (1H, d, J = 9.4 Hz, 
NCH2C(Me)CO2tBu), 1.42 (9H, s, C(CH3)3), 1.33 (3H, s, CH3); 13C NMR (75.5 MHz, 
CDCl3) δ 211.0, 170.7, 134.8, 118.1, 82.4, 62.9, 61.2, 59.1, 58.2, 28.2, 18.4; HRMS (ESI) 
calcd for C13H21NNaO3 [M+Na] : m/z 262.1419, found 262.1417. 
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5.4.5: tert-butyl 1,3-dimethyl-4-oxopyrrolidine-3-carboxylate 260 
N
Me
O
OtBu
O
 
tert-Butyl 2-(((2-ethoxy-2-oxoethyl)methylamino)methyl)acrylate 218 (129 mg, 0.5 mmol) 
was reacted under the general procedure and purified by flash column chromatography (4:1 
petrol:ethyl acetate) to give the desired product as a colourless oil (71.8 mg, 67%); Rf (4:1 
petrol:ethyl acetate) 0.26; IR (neat, cm-1) v 2979, 2937, 2783 (C-H), 1766, 1729 (C=O); 1H 
NMR (300 MHz, CDCl3) δ 3.23 (1H, d, J = 9.4 Hz, NCH2C(Me)CO2tBu), 3.10 (1H, d, J = 
17.0 Hz, NCH2C=O), 2.99 (1H, d, J =17.0 Hz, NCH2C=O), 2.68 (1H, d, J = 9.4 Hz, 
NCH2C(Me)CO2tBu), 2.40 (3H, s, NCH3), 1.43 (9H, s, C(CH3)3), 1.33 (3H, s, CH3); 13C 
NMR (75.5, CDCl3) δ 211.3, 170.5, 82.4, 65.2, 63.2, 58.8, 43.0, 28.2, 18.6; HRMS (ESI) 
calcd for C11H19NNaO3 [M+Na]+ : m/z 236.1263, found 236.1259. 
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5.5 Asymmetric Molybdenum-Catalysed Reductive Dieckmann 
Condensation 
 
5.5.1: Ligation of molybdenum 
Me OMe
Bn
Me
H
iBu
266 : (+)-dolefin
O
tBuO N
Bn
OEt
O
222
PhSiH3 (1.5 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
266 (0.75 mol%)
THF, 80 oC, 16 h N
Bn
O
CO2tBu
258 : 88%, 0% ee
 
A solution of molybdenum hexacarbonyl (6.6 mg, 0.025 mmol), N-methylmorphonline N-
oxide monohydrate (5.9 mg, 0.044 mmol) and (+)-dolefin 266 (15.5 mg, 0.05 mmol) was 
stirred in tetrahydrofuran (1 mL) for 45 minutes at 80 oC. After cooling to ambient 
temperature tert-butyl 2-((benzyl(2-ethoxy-2-oxoethyl)amino)methyl)acrylate 222 (167 mg, 
0.5 mmol) and phenylsilane (92 µL, 0.75 mmol). The reaction mixture was stirred at 80 oC 
for 16 hours. After cooling to room temperature the reaction mixture was dissolved in 
diethyl ether (25 mL) and washed with water (2 x 25 mL) and saturated brine (25 mL). The 
organic phase was extracted, dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography (12:1 petrol:diethyl ether) to give the desired 
product 258 as a colourless oil (127 mg, 88%); HPLC Diacel Chiralpak OJ, hexane/propan-
2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR = 15.3 min, tR = 16.5 min, 0% ee. 
Spectroscopic data identical to that previously reported (cf. 5.9.1). 
 
5.5.2: tert-butyl 3-methyl-4-oxo-1-((R)-1-phenylethyl)pyrrolidine-3-carboxylate 276 
N
O
OtBu
O
 
To a solution of molybdenum hexacarbonyl (6.6 mg, 0.025 mmol, 5 mol%) and N-
methylmorpholine N-oxide monohydrate (5.9 mg, 0.044 mmol, 9 mol%) in tetrahydrofuran 
(3 mL) was added (R)-tert-butyl 2-(((2-ethoxy-2-oxoethyl)(1-phenylethyl)amino) 
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methyl)acrylate 275 (174 mg, 0.5 mmol) followed by phenylsilane (92 µL, 0.75 mmol). 
The reaction mixture was stirred at 80 oC for 16 hours. After cooling to room temperature 
the reaction mixture was dissolved in diethyl ether (25 mL) and washed with water (2 x 25 
mL) and saturated brine (25 mL). The organic phase was extracted, dried over MgSO4 and 
concentrated in vacuo. The residue was purified by flash column chromatography (12:1 
petrol:ethyl acetate) to give the desired product, a colourless oil, as an inseparable 1:1 
mixture of diastereomers (140.1 mg, 92%); Rf (12:1 petrol:ethyl acetate) 0.22; IR (neat, cm-
1) v 2976, 2934 (C-H), 1764, 1728 (C=O). 1H NMR (300 MHz, CDCl3) δ 7.33-7.22 (5H, m, 
Ar), 3.36 (0.5H, q, J = 6.8 Hz, NCH), 3.33 (0.5H, q, J = 6.8 Hz, NCH), 3.30 (0.5H, d, J = 
17.0 Hz, NCH2CO), 3.27 (0.5H, d, J = 9.4 Hz, NCH2C(Me)CO2tBu), 3.23 (0.5H, d, J = 9.4 
Hz, NCH2C(Me)CO2tBu), 3.07 (1H, s, NCH2CO), 2.87 (0.5H, d, J = 17.0 Hz, NCH2CO), 
2.58 (0.5H, d, J = 9.4 Hz, NCH2C(Me)CO2tBu), 2.54 (0.5H, d, J = 9.4 Hz, 
NCH2C(Me)CO2tBu), 1.44 (4.5H, s, C(CH3)3), 1.43 (4.5H, s, C(CH3)3), 1.36 (1.5H, d, J = 
6.8 Hz, NCHCH3), 1.35 (1.5H, d, J = 6.8 Hz, NCHCH3), 1.32 (1.5H, s, C(CO2tBu)CH3), 
1.29 (1.5H, s, C(CO2tBu)CH3); 13C NMR (75.5 MHz, CDCl3) δ 211.1 (2C), 170.8 and 
170.7, 144.3 (2C), 128.9 (2C), 127.7 (2C), 127.4 (2C), 82.3 and 82.2, 65.3 and 65.2, 61.7 
and 61.6, 60.5 and 60.4, 58.3 (2C), 28.5 and 28.3, 22.8 (2C), 18.1 and 17.9; HRMS (ESI) 
calcd for C18H26NO3 [M+H]+ : m/z 304.1913, found 304.1912. 
 
5.5.3: Reductive Dieckmann Condensation of 292 
N
O
OBn
tBuO
O
292
N
O
CO2tBu
PhSiH3 (1.5 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
THF, reflux, 16 h
258 : 79% yield
44% ee
Bn
+
HO
293 : 60%
 
To a solution of molybdenum hexacarbonyl (6.6 mg, 0.025 mmol, 5 mol%) and N-
methylmorpholine N-oxide monohydrate (5.9 mg, 0.044 mmol, 9 mol%) in tetrahydrofuran 
(3 mL) was added tert-butyl 2-((benzyl(2-((1S,2R,5S)-2-isopropyl-5-
methylcyclohexyloxy)-2-oxoethyl)amino)methyl) acrylate 292 (222 mg, 0.5 mmol) 
followed by phenylsilane (92 µL, 0.75 mmol). The reaction mixture was stirred at 80 oC for 
16 hours. After cooling to room temperature the reaction mixture was dissolved in diethyl 
ether (25 mL) and washed with water (2 x 25 mL) and saturated brine (25 mL). The organic 
phase was extracted, dried over MgSO4 and concentrated in vacuo. The residue was 
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purified by flash column chromatography (12:1 petrol:diethyl ether) to give the desired 
product 258 as a colourless oil (115 mg, 79%), followed by (+)-menthol 293 as colourless 
crystals (93.3 mg, 60%).  
Data for 258: HPLC Diacel Chiralpak OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 
30 oC): tR (minor) = 18.4 min, tR (major) = 20.4 min, 44% ee. All other spectroscopic data 
identical to that previously reported (cf. 5.9.1). 
Data for 293: 1H NMR (300 MHz, CDCl3) δ 3.38-3.30 (1H, m), 2.15 (1H, sept.d, J1 = 6.8 
Hz, J2 = 2.6 Hz), 1.95-1.88 (2H, m), 1.64-1.53 (2H, m), 1.45-1.29 (1H, m), 1.11-1.02 (1H, 
m), 0.99-0.81 (3H, m), 0.88 (3H, d, J = 6.8 Hz), 0.87 (3H, d, J = 6.8 Hz), 0.76 (3H, d, J = 
7.2 Hz); 13C NMR (75.5 MHz, CDCl3) δ 71.3, 50.0, 45.0, 34.5, 31.6, 25.6, 23.0, 22.1, 20.9, 
16.0. 293 is commercially available. 
 
5.5.4: Reductive Dieckmann Condensation of 296 
N
O
CO2tBu
Bn
N
O
OBn
tBuO
O
PhSiH3 (1.5 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
THF, reflux, 16 hO
O
258296  
To a solution of molybdenum hexacarbonyl (5.4 mg, 0.02 mmol, 5 mol%) and N-
methylmorpholine N-oxide monohydrate (4.8 mg, 0.033 mmol, 9 mol%) in tetrahydrofuran 
(3 mL) was added (R)-tert-butyl 2-((benzyl(2-(4,4-dimethyl-2-oxotetrahydrofuran-3-
yloxy)-2-oxoethyl)amino)methyl)acrylate 296 (170 mg, 0.41 mmol) followed by 
phenylsilane (75 µL, 0.62 mmol). The reaction mixture was stirred at 80 oC for 16 hours. 
After cooling to room temperature the reaction mixture was dissolved in diethyl ether (25 
mL) and washed with water (2 x 25 mL) and saturated brine (25 mL). The organic phase 
was extracted, dried over MgSO4 and concentrated in vacuo. The residue was purified by 
flash column chromatography (12:1 petrol:diethyl ether) to give the desired product 258 as 
a colourless oil (76.4 mg, 65%); HPLC Diacel Chiralpak OJ, hexane/propan-2-ol (99:1), 
0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.8 min, tR (major) = 17.3 min, 9% ee. 
Spectroscopic data identical to that previously reported (cf. 5.9.1). 
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5.5.5: Reductive Dieckmann Condensation of 297 
N
O
CO2tBu
Bn
N
O
OBn
tBuO
O
PhSiH3 (1.5 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
THF, reflux, 16 h
258297
Me
Ph
 
To a solution of molybdenum hexacarbonyl (6.6 mg, 0.025 mmol, 5 mol%) and N-
methylmorpholine N-oxide monohydrate (5.9 mg, 0.044 mmol, 9 mol%) in tetrahydrofuran 
(3 mL) was added tert-butyl (S)-tert-butyl 2-((benzyl(2-oxo-2-(1-
phenylethoxy)ethyl)amino)methyl)acrylate 292 (205 mg, 0.5 mmol) followed by 
phenylsilane (92 µL, 0.75 mmol). The reaction mixture was stirred at 80 oC for 16 hours. 
After cooling to room temperature the reaction mixture was dissolved in diethyl ether (25 
mL) and washed with water (2 x 25 mL) and saturated brine (25 mL). The organic phase 
was extracted, dried over MgSO4 and concentrated in vacuo. The residue was purified by 
flash column chromatography (12:1 petrol:diethyl ether) to give the desired product 258 as 
a colourless oil (94.9 mg, 66%); HPLC Diacel Chiralpak OJ, hexane/propan-2-ol (99:1), 
0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.3 min, tR (major) = 16.7 min, 2% ee. 
Spectroscopic data identical to that previously reported (cf. 5.9.1). 
 
5.5.6: Reductive Dieckmann Condensation of 292 Mediated by Diphenylsilane 
N
O
OBn
tBuO
O
292
N
O
CO2tBu
Ph2SiH2 (1.5 equiv)
Mo(CO)6 (5mol%)
NMO (10 mol%)
THF, reflux, 16 h
258 : 85% yield
20% ee
Bn
+
HO
293 : 62%
 
To a solution of molybdenum hexacarbonyl (6.6 mg, 0.025 mmol, 5 mol%) and N-
methylmorpholine N-oxide monohydrate (5.9 mg, 0.044 mmol, 9 mol%) in tetrahydrofuran 
(3 mL) was added tert-butyl 2-((benzyl(2-((1S,2R,5S)-2-isopropyl-5-
methylcyclohexyloxy)-2-oxoethyl)amino)methyl) acrylate 292 (222 mg, 0.5 mmol) 
followed by diphenylsilane (139 µL, 0.75 mmol). The reaction mixture was stirred at 80 oC 
for 16 hours. After cooling to room temperature the reaction mixture was dissolved in 
diethyl ether (25 mL) and washed with water (2 x 25 mL) and saturated brine (25 mL). The 
organic phase was extracted, dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography (12:1 petrol:diethyl ether) to give the desired 
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product 258 as a colourless oil (127 mg, 85%), followed by (+)-menthol 293 as colourless 
crystals (96.8 mg, 62%).  
Data for 258: HPLC Diacel Chiralpak OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 
30 oC): tR (minor) = 16.1 min, tR (major) = 17.6 min, 20% ee. All other spectroscopic data 
identical to that previously reported (cf. 5.9.1). 
Data for 293: All data identical to that previously reported (cf. 5.5.3). 
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5.6 Palladium-Catalysed Deallylation 
 
5.6.1: (1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 2-(benzylamino)acetate 291 
N
Bn O
Pd(PPh3)4 (2 mol%)
ZnCl2 (50 mol%)
Ph2SiH2 (1.5 eq)
CHCl3, r.t., o/n
Xc
HN
Bn O
XctBuO
O
 
To a solution of tert-butyl 2-((benzyl(2-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)-
2-oxoethyl)amino)methyl) acrylate 292 (88.7 mg, 0.2 mmol) in chloroform (2 mL) was 
added diphenylsilane (76 µL, 0.3 mmol), zinc chloride (13.6 mg, 0.1 mmol) and Pd(PPh3)4 
(4.6 mg, 0.004 mmol). The reaction mixture was stirred at ambient temperature for 20 
hours. The reaction mixture was filtered through a short silica column and concentrated in 
vacuo to give the desired product as a colourless oil (84.9 mg, 96% yield). Spectroscopic 
data identical to that previously reported (cf. 5.3.8). 
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5.7 Rhodium-Catalysed Reduction 
 
5.7.1: tert-butyl 3-(benzyl(2-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)-2-
oxoethyl)amino)-2-methylpropanoate 305 and tert-butyl 3-(benzyl(2-((1S,2R,5S)-2-
isopropyl-5-methylcyclohexyloxy)-2-oxoethyl)amino)-2-methylacrylate 306 
[Rh(cod)Cl]2 (2.5 mol%)
PPh3 (11 mol%)
PhMe2SiH (1.5 eq)
DCE, 60 oC, 16 h
N
Bn O
XctBuO
O
292
N
Bn O
XctBuO
O
306
N
Bn O
XctBuO
O
305
+
 
A solution of [Rh(cod)Cl]2 (2.5 mg, 0.01 mmol, 5 mol% Rh) and triphenylphosphine (6.8 
mg, 0.026 mmol 13 mol%) in dichloromethane (2 mL) was stirred under an atmosphere of 
argon for 30 minutes. tert-Butyl 2-((benzyl(2-((1S,2R,5S)-2-isopropyl-5-
methylcyclohexyloxy)-2-oxoethyl)amino)methyl) acrylate 292 (88.7 mg, 0.2 mmol) was 
added to the solution, followed by dimethylphenylsilane (46 µL, 0.3 mmol) and the 
resultant mixture was stirred at 60 oC for 16 hours. After cooling to room temperature, 
water (0.5 mL) was added and was left to stir for 15 minutes before the reaction mixture 
was dissolved in DCM, dried over MgSO4, concentrate in vacuo. The residue was purified 
by flash column chromatography (17:1 petrol:diethyl ether) to give 305 as a colourless oil 
(8.1 mg, 9%) followed by 306 as a colourless oil (34.5 mg, 40%). 
Data for 305: Rf (17:1 petrol:diethyl ether) 0.28; IR (neat, cm-1) v 2955, 2979 (C-H), 1730 
(C=O); 1H NMR (300 MHz, CDCl3) δ 7.36-7.21 (5H, m, Ar), 4.72 (1H, td, J1 = 10.9 Hz, J2 
= 4.5 Hz, OCH), 3.83 (2H, s, NCH2Ph), 3.27 (2H, s, NCH2COXc), 3.00 (1H, dd, J1 = 12.8 
Hz, J2 = 9.0 Hz, NCH2CH(Me)CO2tBu), 2.78 (1H, dd, J1 = 12.8 Hz, J2 = 6.4 Hz, 
NCH2CH(Me)CO2tBu), 2.64-2.52 (1H, m, CH(Me)CO2tBu), 2.03-1.96 (1H, m, 
mentholate), 1.87-1.75 (1H, m, mentholate), 1.71-1.63 (2H, m, mentholate), 1.50-1.21 (3H, 
m, mentholate), 1.45 (9H, s, C(CH3)3, 1.03 (3H, d, J = 7.2 Hz, tBuO2CCHCH3), 1.04-0.83 
(2H, m, mentholate), 0.91 (3H, d, J = 6.5 Hz, CH(CH3)2), 0.88 (3H, d, J = 6.5 Hz, 
CH(CH3)2), 0.77 (3H, d, J = 6.8 Hz, CHCH3); 13C NMR (75.5 MHz, CDCl3) δ 176.9, 
166.0, 137.0, 129.4, 128.6, 127.5, 80.6, 74.6, 60.1, 59.8, 56.2, 47.4, 41.5, 40.5, 34.6, 31.8, 
28.5, 26.6, 23.7, 22.4, 21.2, 16.6, 15.7; HRMS (ESI) calcd for C27H44NO4 [M+H]+ : m/z 
446.3270, found 446.3271. 
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Data for 306: Rf (17:1 petrol:diethyl ether) 0.09; [ ]24Dα  +55.5 (c 1.4, CHCl3); IR (neat, cm-1) 
v 2956, 2929, 2870 (C-H), 1740, 1683 (C=O), 1628, 1605 (C=C); 1H NMR (300 MHz, 
CDCl3) δ 7.40 (1H, s, C=CHN) 7.39-7.23 (5H, m, Ar), 4.74 (1H, td, J1 = 10.9 Hz, J2 = 4.5 
Hz, OCH), 4.48 (2H, s, NCH2Ph), 3.87 (2H, s, NCH2COXc), 3.00 (1H, dd, J1 = 12.8 Hz, J2 
= 9.0 Hz, NCH2CH(Me)CO2tBu), 2.78 (1H, dd, J1 = 12.8 Hz, J2 = 6.4 Hz, 
NCH2CH(Me)CO2tBu), 2.64-2.52 (1H, m, CH(Me)CO2tBu), 2.01-1.94 (1H, m, 
mentholate), 1.85 (3H, s, CH3C=C), 1.87-1.74 (1H, m, mentholate), 1.70-1.64 (2H, m, 
mentholate), 1.55-1.26 (2H, m, mentholate), 1.46 (9H, s, C(CH3)3, 1.11-0.83 (3H, m, 
mentholate), 0.91 (3H, d, J = 6.5 Hz, CH(CH3)2), 0.88 (3H, d, J = 6.5 Hz, CH(CH3)2), 0.75 
(3H, d, J = 6.8 Hz, CHCH3); 13C NMR (75.5 MHz, CDCl3) δ 170.5, 170.1, 148.0, 137.5, 
129.2, 129.0, 128.1, 97.4, 79.1, 75.9, 58.9, 52.8, 47.4, 41.2, 34.5, 31.8, 28.8, 26.6, 23.7, 
22.4, 21.1, 16.6, 11.7; HRMS (ESI) calcd for C27H44NO4 [M+H]+ : m/z 444.3114, found 
446.3124. 
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5.8 Cobalt-Catalysed Reductive Dieckmann Condensation 
 
5.8.1: tert-butyl 1-benzyl-3-methyl-4-oxopyrrolidine-3-carboxylate 258 
Co(acac)2 (5 mol%)
Et2Zn (2 equiv)
N
Bn O
Xc
THF, r.t., 16 h N
Bn
CO2tBu
OO
tBuO
OXc =
 
A solution of Co(acac)2 (2.7 mg, 0.01 mmol, 5 mol%) and tert-butyl 2-((benzyl(2-
((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)-2-oxoethyl)amino)methyl)acrylate 292 
(88.7 mg, 0.2 mmol) in tetrahydrofuran (3 mL) was stirred at room temperature for 15 
minutes before cooling to 0 oC. Diethylzinc (1 M in hexanes) (400 µL, 0.4 mmol) was 
added to the solution, the reaction mixture was stirred at ambient temperature for 16 hours. 
1 M HCl(aq) (1 mL) was added to the reaction mixture and the resulting solution was stirred 
for 15 minutes. The reaction mixture was dissolved in diethyl ether (25 mL) and washed 
with saturated sodium hydrogen carbonate (2 x 25 mL), water (25 mL) and saturated brine 
(25 mL). The organic phase was extracted, dried over MgSO4 and concentrated in vacuo. 
The residue was purified by flashed column chromatography (12:1 petrol:diethyl ether) to 
give 258 as a colourless oil (25.6 mg, 44%); HPLC Diacel Chiralpak OJ, hexane/propan-2-
ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.4 min, tR (major) = 16.6 min, 29% 
ee. All other spectroscopic data identical to that previously reported (cf. 5.9.1). 
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5.9 Nickel-Catalysed Reductive Dieckmann Condensation 
 
5.9.1: tert-butyl 1-benzyl-4-oxo-3-propylpyrrolidine-3-carboxylate 310 and tert-butyl 
1-benzyl-4-oxo-3-propylpyrrolidine-3-carboxylate 258 
Ni(acac)2 (5mol%)
Et2Zn (2 equiv)
N
Bn
CO2tBu
O
N
Bn
CO2tBu
nPrO
258
THF, r.t., 16 h
N
Bn O
Xc
O
tBuO
292 310
+
 
A solution of Ni(acac)2 (2.7 mg, 0.01 mmol, 5 mmol%) and tert-butyl 2-((benzyl(2-
((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)-2-oxoethyl)amino)methyl)acrylate 292 
(88.7 mg, 0.2 mmol) in tetrahydrofuran (3 mL) was stirred at room temperature for 15 
minutes before cooling to 0 oC. Diethylzinc (1 M in hexanes) (400 µL, 0.4 mmol) was 
added to the solution, the reaction mixture was stirred at ambient temperature for 16 hours. 
1 M HCl(aq) (1 mL) was added to the reaction mixture and the resulting solution was stirred 
for 15 minutes. The reaction mixture was dissolved in diethyl ether (25 mL) and washed 
with saturated sodium hydrogen carbonate (2 x 25 mL), water (25 mL) and saturated brine 
(25 mL). The organic phase was extracted, dried over MgSO4 and concentrated in vacuo. 
The residue was purified by flashed column chromatography (12:1 petrol:diethyl ether) to 
give tert-butyl 1-benzyl-4-oxo-3-propylpyrrolidine-3-carboxylate 310 as a colourless oil 
(18.3 mg, 29% yield) followed by 258 as a colourless oil (38.7 mg, 67%).  
Data for 310: Rf (12:1 petrol:diethyl ether) 0.24; IR (neat, cm-1) v 2963, 2933, 2874, 2797 
(C-H), 1762, 1725 (C=O); 1H NMR (300 MHz, CDCl3) δ 7.31-7.20 (5H, m, Ar-H), 3.70 
(1H, d, J = 13.2 Hz, NCH2Ph), 3.64 (1H, d, J = 13.2 Hz, NCH2), 3.37 (1H, d, J = 9.4 Hz, 
NCH2C(nPr)CO2tBu), 3.19 (1H, d, J = 17.0 Hz, NCH2CO), 2.88 (1H, d, J = 17.0 Hz, 
NCH2CO), 2.64 (1H, d, J = 9.4 Hz, NCH2C(nPr)CO2tBu), 1.81 (1H, ddd, J = 13.9 Hz, 12.4 
Hz, 4.5 Hz, C(CO2tBu)CH2CH2CH3), 1.64 (1H, ddd, J = 13.9 Hz, 12.4 Hz, 4.5 Hz, 
C(CO2tBu)CH2CH2CH3), 1.51-1.34 (1H, m, C(CO2tBu)CH2CH2CH3), 1.42 (9H, s, 
C(CH3)3), 1.27-1.12 (1H, m, C(CO2tBu)CH2CH2CH3), 0.87 (3H, t, J = 7.2 Hz, 
C(CO2tBu)CH2CH2CH3); 13C NMR (75.5 MHz, CDCl3) δ 210.1, 169.6, 138.0, 129.3, 
128.8, 127.7, 82.3, 62.6, 61.6, 60.4, 60.3, 35.1, 28.3, 18.7, 14.9; HRMS (ESI) calcd for 
C19H28NO3 [M+H]+ : m/z 318.2069, found 318.2074. 
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Data for 258: HPLC Diacel Chiralpak OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 
30 oC): tR (minor) = 14.6 min, tR (major) = 15.6 min, 18% ee. All other spectroscopic data 
identical to that previously reported (cf. 5.9.1). 
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5.10 Copper-Catalysed Reductive Dieckmann Condensation 
 
5.10.1: Reductive Dieckmann Condensation of 292 Mediated by 
Tetramethyldisiloxane 
tBuO
O
N
Bn O
Cu(OAc)2 (5 mol%)
rac-BINAP (5 mol%)
TMDS (1.5 equiv)
THF, 50 oC, 16 h N
Bn
CO2tBu
O
Xc
 
A solution of Cu(OAc)2 (1.8 mg, 0.01 mmol, 5 mol%) and rac-BINAP (6.4 mg, 0.01 mmol, 
5 mol%) in tetrahydrofuran (1 mL) was stirred at ambient temperature for 15 minutes 
before the addition of tetramethyldisiloxane (53 µL, 0.3 mmol). The resulting solution was 
stirred for a further 10 minutes, after which, a solution of tert-butyl 2-((benzyl(2-
((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)-2-oxoethyl)amino)methyl) acrylate 292 
(88.7 mg, 0.2 mmol) in tetrahydrofuran (2 mL) was added via syringe. The reaction was 
stirred at 50 oC for 16 hours. The crude reaction mixture was concentrated in vacuo and 
purified by flash column chromatography (12:1 petrol:diethyl ether) to give 258 as a 
colourless oil (11.5 mg, 20%); HPLC Diacel Chiralpak OJ, hexane/propan-2-ol (99:1), 0.5 
mL/min (220 nm, 30 oC): tR (minor) = 17.2 min, tR (major)= 18.6 min, 41% ee. All other 
spectroscopic data identical to that previously reported (cf. 5.9.1). 
 
5.10.2: Reductive Dieckmann Condensation of 292 Using Achiral Bisphosphine 
Ligands 
tBuO
O
N
Bn O
Cu(OAc)2 (5 mol%)
Ligand (5 mol%)
PMHS (1.5 equiv)
THF, 50 oC, 16 h N
Bn
CO2tBu
O
Xc
 
A solution of Cu(OAc)2 (1.8 mg, 0.01 mmol, 5 mol%) and achiral bisphosphine ligand 
(0.01 mmol, 5 mol%) in tetrahydrofuran (1 mL) was stirred at ambient temperature for 15 
minutes before the addition of polymethylhydrosiloxane (20 µL, 0.3 mmol). The resulting 
solution was stirred for a further 10 minutes, after which, a solution of tert-butyl 2-
((benzyl(2-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)-2-oxoethyl)amino)methyl) 
acrylate 292 (88.7 mg, 0.2 mmol) in tetrahydrofuran (2 mL) was added via syringe. The 
reaction was stirred at 50 oC for 16 hours. The crude reaction mixture was concentrated in 
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vacuo and purified by flash column chromatography (12:1 petrol:diethyl ether) to give 258 
as a colourless oil. 
 
5.10.2.1: dppf 
 
dppf (5.7 mg, 0.01 mmol) was reacted under the standard procedure to give the desired 
product as a colourless oil (24.8 mg, 43% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 17.3 min, tR (major) 
= 19.0 min, 36% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.2.2: rac-BINAP 
 
rac-BINAP (6.2 mg, 0.01 mmol) was reacted under the standard procedure to give the 
desired product as a colourless oil (34.3 mg, 59% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 14.8 min, tR (major) 
= 16.0 min, 48% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.2.3: dppm 
 
dppm (3.8 mg, 0.01 mmol) was reacted under the standard procedure to give the desired 
product as a colourless oil (12.3 mg, 21% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 17.1 min, tR (major) 
= 18.7 min, 44% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.2.4: dppe 
 
dppe (4.0 mg, 0.01 mmol) was reacted under the standard procedure to give the desired 
product as a colourless oil (39.4 mg, 68% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.0 min, tR (major) 
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= 16.2 min, 50% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.2.5: dppp 
 
dppp (4.1 mg, 0.01 mmol) was reacted under the standard procedure to give the desired 
product as a colourless oil (52.1 mg, 73% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.0 min, tR (major) 
= 16.2 min, 46% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.2.6: dppb 
 
dppb (4.3 mg, 0.01 mmol) was reacted under the standard procedure to give the desired 
product as a colourless oil (11.8 mg, 20% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 17.5 min, tR (major) 
= 19.2 min, 43% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.2.7: dcpe 
 
dcpe (4.2 mg, 0.01 mmol) was reacted under the standard procedure to give the desired 
product as a colourless oil (45.3 mg, 78% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.1 min, tR (major) 
= 16.2 min, 40% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.2.8: Xantphos 
 
Xantphos 311 (5.8 mg, 0.01 mmol) was reacted under the standard procedure to give the 
desired product as a colourless oil (36.1 mg, 62% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.2 min, tR (major) 
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= 16.4 min, 30% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.3: Reductive Dieckmann Condensation of 292 Using Chiral Bisphosphine 
Ligands 
tBuO
O
N
Bn O
Cu(OAc)2 (5 mol%)
Ligand* (5 mol%)
PMHS
THF, 50 oC, 16 h N
Bn
CO2tBu
O
Xc
 
A solution of Cu(OAc)2 (1.8 mg, 0.01 mmol, 5 mol%) and chiral bisphosphine ligand (0.01 
mmol, 5 mol%) in tetrahydrofuran (1 mL) was stirred at ambient temperature for 15 
minutes before the addition of polymethylhydrosiloxane (20 µL, 0.3 mmol). The resulting 
solution was stirred for a further 10 minutes, after which, a solution of tert-butyl 2-
((benzyl(2-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)-2-oxoethyl)amino)methyl) 
acrylate 292 (88.7 mg, 0.2 mmol) in tetrahydrofuran (2 mL) was added via syringe. The 
reaction was stirred at 50 oC for 16 hours. The crude reaction mixture was concentrated in 
vacuo and purified by flash column chromatography (12:1 petrol:diethyl ether) to give 258 
as a colourless oil. 
 
5.10.3.1: (R)-BINAP 
 
(R)-BINAP (R)-52 (6.2 mg, 0.01 mmol) was reacted under the standard procedure to give 
the desired product as a colourless oil (15.5 mg, 27% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.4 min, tR (major) 
= 16.8 min, 79% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.3.2: (S)-BINAP 
 
(S)-BINAP (S)-52 (6.2 mg, 0.01 mmol) was reacted under the standard procedure to give 
the desired product as a colourless oil (36.1 mg, 62% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.5 min, tR (major) 
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= 16.8 min, 14% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.3.3: (R)-Tol-BINAP 
 
(R)-Tol-BINAP 312 (6.8 mg, 0.01 mmol) was reacted under the standard procedure to give 
the desired product as a colourless oil (26.1 mg, 45% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.1 min, tR (major) 
= 16.3 min, 75% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.3.4: (R)-Xylyl-BINAP 
 
(R)-Xylyl-BINAP 313 (7.4 mg, 0.01 mmol) was reacted under the standard procedure to 
give the desired product as a colourless oil (46.0 mg, 79% yield); HPLC Diacel Chiralpak 
OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 14.8 min, tR 
(major) = 15.9 min, 35% ee. All other spectroscopic data identical to that previously 
reported (cf. 5.9.1). 
 
5.10.3.5: (R,R)-iPr-DuPhos 
 
(R,R)-iPr-DuPhos 315 (4.2 mg, 0.01 mmol) was reacted under the standard procedure to 
give the desired product as a colourless oil (38.2 mg, 66% yield); HPLC Diacel Chiralpak 
OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 17.7 min, tR 
(major) = 19.4 min, 46% ee. All other spectroscopic data identical to that previously 
reported (cf. 5.9.1). 
 
5.10.3.6: (R,R)-Me-DuPhos 
 
(R,R)-Me-Duphos 314 (3.1 mg, 0.01 mmol) was reacted under the standard procedure to 
give the desired product as a colourless oil (39.5 mg, 68% yield); HPLC Diacel Chiralpak 
OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.2 min, tR 
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(major) = 16.3 min, 86% ee. All other spectroscopic data identical to that previously 
reported (cf. 5.9.1). 
 
5.10.3.7: (R)-(S)-Josiphos 
 
(R)-(S)-Josiphos 316 (6.4 mg, 0.01 mmol) was reacted under the standard procedure to 
give the desired product as a colourless oil (49.7 mg, 86% yield); HPLC Diacel Chiralpak 
OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 16.0 min, tR 
(major) = 17.3 min, 45% ee. All other spectroscopic data identical to that previously 
reported (cf. 5.9.1). 
 
5.10.3.8: (S)-(R)-Josiphos 
 
(S)-(R)-Josiphos 317 (6.4 mg, 0.01 mmol) was reacted under the standard procedure to 
give the desired product as a colourless oil (57.6 mg, 99% yield); HPLC Diacel Chiralpak 
OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 137 min, tR 
(major) = 14.8 min, 48% ee. All other spectroscopic data identical to that previously 
reported (cf. 5.9.1). 
 
5.10.3.9: (R)-PhanePhos 
 
(R)-PhanePhos 318 (5.8 mg, 0.01 mmol) was reacted under the standard procedure to give 
the desired product as a colourless oil (30.4 mg, 53% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.3 min, tR (major) 
= 16.7 min, 15% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.3.10: (R)-SYNPHOS 
 
(R)-SYNPHOS 317 (6.4 mg, 0.01 mmol) was reacted under the standard procedure to give 
the desired product as a colourless oil (30.3 mg, 52% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 14.8 min, tR (major) 
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= 16.0 min, 65% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.3.11: (R)-P-Phos 
 
(R)-P-Phos 319 (6.4 mg, 0.01 mmol) was reacted under the standard procedure to give the 
desired product as a colourless oil (44.9 mg, 78% yield); HPLC Diacel Chiralpak OJ, 
hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 17.7 min, tR (major) 
= 19.5 min, 63% ee. All other spectroscopic data identical to that previously reported (cf. 
5.9.1). 
 
5.10.3.12: (R)-Xylyl-P-Phos 
 
(R)-Xylyl-P-Phos 320 (7.6 mg, 0.01 mmol) was reacted under the standard procedure to 
give the desired product as a colourless oil (33.7 mg, 58% yield); HPLC Diacel Chiralpak 
OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.2 min, tR 
(major) = 16.4 min, 91% ee. All other spectroscopic data identical to that previously 
reported (cf. 5.9.1). 
 
5.10.4: Room Temperature Reductive Dieckmann Condensation of 292 
tBuO
O
N
Xc
O
Cu(OAc)2 (5 mol%)
(R)-Xylyl-P-Phos (5 mol%)
PMHS
THF, r.t., 3 h N
Bn
CO2tBu
O
Bn
 
A solution of Cu(OAc)2 (1.8 mg, 0.01 mmol, 5 mol%) and (R)-Xylyl-P-Phos 320 (6.4 mg, 
0.01 mmol, 5 mol%) in tetrahydrofuran (1 mL) was stirred at ambient temperature for 15 
minutes before the addition of polymethylhydrosiloxane (20 µL, 0.3 mmol). The resulting 
solution was stirred for a further 10 minutes, after which, a solution of tert-butyl 2-
((benzyl(2-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)-2-oxoethyl)amino)methyl) 
acrylate 292 (88.7 mg, 0.2 mmol) in tetrahydrofuran (2 mL) was added via syringe. The 
reaction was stirred at ambient temperature for 3 hours. The crude reaction mixture was 
concentrated in vacuo and purified by flash column chromatography (12:1 petrol:diethyl 
ether) to give 258 as a colourless oil (27.1 mg, 47%); HPLC Diacel Chiralpak OJ, 
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hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.2 min, tR (major) 
= 16.4 min, 93% ee; [ ]24Dα  +19.6 (c = 1.1, CHCl3). All other spectroscopic data identical to 
that previously reported (cf. 5.9.1). 
 
5.10.5: Reductive Dieckmann Condensation of 222 Using Chiral Bisphosphine 
Ligands 
tBuO
O
N
Bn O
Cu(OAc)2 (5 mol%)
Ligand* (5 mol%)
PMHS
THF, 50 oC, 16 h N
Bn
CO2tBu
O
OEt
 
A solution of Cu(OAc)2 (1.8 mg, 0.01 mmol, 5 mol%) and chiral bisphosphine ligand (0.01 
mmol, 5 mol%) in tetrahydrofuran (1 mL) was stirred at ambient temperature for 15 
minutes before the addition of polymethylhydrosiloxane (20 µL, 0.3 mmol). The resulting 
solution was stirred for a further 10 minutes, after which, a solution of tert-butyl 2-
((benzyl(2-ethoxy-2-oxoethyl)amino)methyl) acrylate 222 (66.7 mg, 0.2 mmol) in 
tetrahydrofuran (2 mL) was added via syringe. The reaction was stirred at 50 oC for 16 
hours. The crude reaction mixture was concentrated in vacuo and purified by flash column 
chromatography (12:1 petrol:diethyl ether) to give 258 as a colourless oil. 
 
5.10.5.1: (R,R)-iPr-DuPhos 
 
(R,R)-iPr-DuPhos 315 (4.2 mg, 0.01 mmol) was reacted under the standard procedure to 
give the desired product as a colourless oil (15.3 mg, 26% yield); HPLC Diacel Chiralpak 
OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.0 min, tR 
(major) = 16.3 min, 20% ee. All other spectroscopic data identical to that previously 
reported (cf. 5.9.1). 
 
5.10.5.2: (R,R)-Me-DuPhos 
 
(R,R)-Me-Duphos 314 (3.1 mg, 0.01 mmol) was reacted under the standard procedure to 
give the desired product as a colourless oil (45.6 mg, 79% yield); HPLC Diacel Chiralpak 
OJ, hexane/propan-2-ol (99:1), 0.5 mL/min (220 nm, 30 oC): tR (minor) = 15.3 min, tR 
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(major) = 16.6 min, 15% ee. All other spectroscopic data identical to that previously 
reported (cf. 5.9.1). 
 
 159
Chapter 5 
5.11 General Procedure for the Synthesis of Alkylidene Meldrum’s Acid 
Derivatives 
O
O
O
O
R
CHO +
O
O
O
O
H2O
75 oC, 2 h
R
 
To a solution of Meldrum’s acid (1.1 equiv) in water was added aldehyde (1.0 equiv). The 
resulting solution was stirred at 75 oC for 2 hours. After cooling the reaction mixture was 
filtered via Buckner filtration and washed with water (100 mL) and petrol (100 mL). The 
resulting solid was recrystallised from hot ethanol to give the desired compound. 
 
5.11.1: 5-(4-methoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328a  
MeO O
O
O
O  
Meldrum’s acid (4.66 g, 32.3 mmol), p-anisaldehyde (3.58 mL, 29.4 mmol) and water (50 
mL) were reacted the standard procedure to give the desired compound as a yellow 
crystalline solid (5.58g, 72%); mp (EtOH) 125-126 oC (lit = 127-128 oC)3; 1H NMR (300 
MHz, CDCl3) δ 8.34 (1H, s, C=CH), 8.19 (2H, d, J = 9.0 Hz, ArH), 6.95 (2H, d, J = 9.0 Hz, 
ArH), 3.88 (3H, s, OCH3), 1.76 (6H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 165.0, 
164.4, 160.8, 158.3, 138.0, 125.1, 115.0, 111.3, 104.5, 56.1, 27.9; HRMS (ESI) calcd for 
C14H14NaO5 [M+Na]+ : m/z 285.0739, found 285.0725. Data identical to literature values.4
 
5.11.2: 5-(4-(Methylthio)benzylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione 328b 
MeS O
O
O
O  
Meldrum’s acid (1.59 g, 11.0 mmol) and 4-(methylthio)benzaldehyde (1.52 g, 10.0 mmol) 
and water (20 mL) were reacted under the standard protocol to desired compound as a 
yellow crystalline solid (2.10 g, 75%); mp (EtOH) 126-128 °C; IR (KBr, cm-1) ν 3099, 
2986, 2939 (C-H); 1750, 1711 (C=O); 1577 (C=C); 1H NMR (300 MHz, CDCl3) δ 8.39 
(1H, s, C=CH); 8.11 (2H, d, J 6.8 Hz, ArH); 7.32 (2H, d, J 6. 8 Hz, ArH); 2.58 (3H, s, 
SCH3), 1.83 (6H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 163.6, 160.1, 157.4, 148.4, 
134.6, 127.7, 124.7, 112.4, 104.2, 27.5, 14.4; HRMS (ESI) calcd for C14H18NO4S 
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[M+NH4]+ : m/z 296.0951, found 296.0951; Anal. calcd for C14H14O4S: C 60.4, H 5.07, 
found: C 60.7, H 5.16. 
 
5.11.3: 5-(4-dimethylaminobenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328c  
Me2N O
O
O
O  
Meldrum’s acid (793 mg, 5.5 mmol), 4-dimethylaminobenzaldehyde (746 mg, 5.0 mmol) 
in water (10 mL) was reacted under standard protocol to give the desired compound as a 
orange crystalline solid (1.26 g, 92%); mp (EtOH) 174-175 oC; 1H NMR (300 MHz, 
CDCl3) δ 8.31 (1H, s, C=CH), 8.25 (2H, d, J = 9.4 Hz, ArH), 6.70 (2H, d, J = 9.4 Hz, ArH), 
3.15 (6H, s, N(CH3)2), 1.76 (6H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 165.6, 161.9, 
158.4, 155.0, 139.4, 120.5, 111.6, 105.4, 103.8, 40.5, 27.7; HRMS (ESI) calcd for 
C15H18NO4 [M+H]+ : m/z 276.1236, found 276.1230. Data identical to literature values.5
 
5.11.4: 5-(benzo-[1,3]dioxol-5-ylmethylene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328d 
O
O
O
O
O
O  
Meldrum’s acid (1.25 g, 10.4 mmol), piperonal (1.50 g, 10.0 mmol) in water (20 mL) was 
reacted under standard protocol to give the desired compound as a yellow crystalline solid 
(2.54 g, 82 %); mp (EtOH) 178-180 oC (lit = 179-180 oC)6; 1H NMR (300 MHz, CDCl3) δ 
8.31 (1H, s, C=CH), 8.06 (1H, d, J = 1.9 Hz, ArH), 7.54 (1H, dd, J1 = 8.3 Hz, J2 = 1.9 Hz, 
ArH), 6.90 (1H, d, J = 8.3 Hz, ArH), 6.09 (2H, s, OCH2O), 1.78 (6H, s, C(CH3)2); 13C 
NMR (75.5 MHz, CDCl3) δ 164.3, 160.7, 158.3, 153.6, 148.7, 134.6, 126.8, 112.8, 111.7, 
108.9, 104.7, 102.8, 27.9; HRMS (EI) calcd for C14H12NaO6 [M+Na]+ : m/z 299.0532, 
found 299.0534. Data identical to literature values.6
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5.11.5: 5-(benzo-[1,3]dioxol-4-ylmethylene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328e  
O
O
O
O
O
O
 
Meldrum’s acid (1.25 g, 10.4 mmol), 2,3-(methylenedioxy)benzaldehyde (1.50 g, 10.0 
mmol) in water (20 mL) was reacted under the standard protocol to give the desired 
compound as a yellow crystalline solid (2.03 g, 73%); mp (EtOH) 172-174 oC; IR (KBr, 
cm-1) v 1740, 1710 (C=O), 1561 (C=C), 1382, 1248 (C-O); 1H NMR (300 MHz, CDCl3) δ 
8.43 (1H, s, C=CH), 7.50 (1H, dd, J1 = 7.5 Hz, J2 = 1.5 Hz, ArH), 6.95 (1H, dd, J1 = 7.5 
Hz, J2 = 1.5 Hz, ArH), 6.88 (1H, t, J = 7.5 Hz, ArH), 6.06 (2H, s, OCH2O), 1.80 (6H, s, 
C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 163.2, 160.0, 149.8, 149.6, 148.2, 124.1, 122.1, 
166.4, 115.4, 113.1, 105.1, 102.1, 28.0; HRMS (ESI) calcd for C14H12NaO6 [M+Na]+ : m/z 
299.0532, found 299.0530; Anal. calcd for C14H12O6: C 60.9, H 4.38, found: C 70.0, H 
4.42. 
 
5.11.6: 2,2-dimethyl-5-(3-phenyl-allylidene)-[1,3]dioxane-4,6-dione 328f  
O
O
O
O  
Meldrum’s acid (793 mg, 5.5 mmol), cinnamaldehyde (629 µL, 5.0 mmol) and water (10 
mL) was reacted under the standard protocol to give the desired product as a yellow 
crystalline solid (1.12 g, 87%); mp (EtOH) 98-99 oC (lit 101 oC)7; 1H NMR (300 MHz, 
CDCl3) δ 8.32 (1H, dd, J1 = 15.1 Hz, J2 = 12.1 Hz, PhCHCH), 8.19 (1H, d, J = 12.1 Hz, 
C=CH), 7.68-7.64 (2H, m, ArH), 7.46-7.39 (4H, m, ArH and PhCH), 1.76 (6H, s, CH3); 13C 
NMR (75.5 MHz, CDCl3) δ 163.4, 161.2, 158.4, 154.9, 135.3, 132.2, 129.7, 129.6, 124.9, 
111.8, 105.2, 28.1; HRMS (ESI) calcd for C15H14NaO4 [M+Na]+ : m/z 281.0790, found 
281.0792. Data identical to literature values.7
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5.11.7: 5-(3,4-dimethoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328g  
O
O
O
O
MeO
MeO  
Meldrum’s acid (1.59 g, 11.0 mmol), 3,4-dimethoxybenzaldehyde (1.66 g, 10 mmol) and 
water (20 mL) was reacted under the standard protocol to give the desired product as a 
yellow/orange crystalline solid (2.38 g, 81 %); mp (EtOH) 160-161 oC (lit = 156-158 oC)4; 
1H NMR (300 MHz, CDCl3) δ 8.34 (1H, s, C=CH), 8.28 (1H, d, J= 2.3 Hz, ArH), 7.62 (1H, 
dd, J1 = 8.3 Hz, J2 = 2.3 Hz, ArH), 6.92 (1H, d, J = 8.3 Hz, ArH), 3.97 (3H, s, OCH3), 3.94 
(3H, s, OCH3), 1.77 (6H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 164.5, 161.0, 158.6, 
155.1, 149.1, 133.1, 125.5, 116.1, 111.1, 111.0, 104.6, 56.6, 56.4, 27.9; HRMS (EI) calcd 
for C15H17O6 [M+H]+ : m/z 293.1020, found 293.1017. Data identical to literature values.4
 
5.11.8: 5-(2,5-dimethoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328h  
O
O
O
O
OMe
OMe  
Meldrum’s acid (1.59 g, 11.0 mmol), 2,5-dimethoxybenzaldehyde (1.66 g, 10 mmol) and 
water (20 mL) was reacted under standard protocol to give the desired compound as an 
orange crystalline solid (2.15 g, 73 %); mp (EtOH) 124-125 oC (lit = 120-121 oC)8 1H NMR 
(300 MHz, CDCl3) δ 8.72 (1H, s, C=CH), 7.67 (1H, d, J = 3.0 Hz, ArH), 7.08 (1H, dd, J1 = 
9.0 Hz, J2 = 3.0 Hz, ArH), 6.90 (1H, d, J = 9.0 Hz, ArH), 3.85 (3H, s, OCH3), 3.79 (3H, s, 
OCH3), 1.80 (6H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 163.7, 160.5, 154.8, 153.3, 
152.8, 122.5, 121.9, 116.5, 115.4, 112.4, 104.8, 56.5, 56.3, 27.9; HRMS (EI) calcd for 
C15H16NaO6 [M+Na]+ : m/z 315.0845, found 315.0856. Data identical to literature values.8
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5.11.9: 5-(2,3,4-trimethoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328i  
O
O
O
O
OMe
MeO
MeO  
Meldrum’s acid (793 mg, 5.5 mmol), 2,3,4-trimethoxybenzaldehyde (9.81 g, 5.5 mmol) and 
water (10 mL) was reacted under standard protocol to give the desired compound as a 
yellow crystalline solid (1.11 g, 69 %); mp (EtOH) 127-128 oC (lit = 123-124)9; 1H NMR 
(300 MHz, CDCl3) δ 8.72 (1H, s, C=CH), 8.16 (1H, d, J = 9.0 Hz, ArH), 6.72 (1H, d, J = 
9.0 Hz, ArH), 3.99 (3H, s, OCH3), 3.94 (3H, s, OCH3), 3.84 (3H, s, OCH3), 1.78 (6H, s, 
C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 164.1, 161.0, 159.6, 156.4, 153.0, 141.8, 129.6, 
119.4, 112.6, 107.3, 104.6, 62.5, 61.4, 56.7, 27.9; HRMS (EI) calcd for C16H18NaO7 
[M+Na]+ : m/z 345.0950, found 345.0931. Data identical to literature values.9
 
5.11.10: 5-(4-nitrobenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328j  
O2N O
O
O
O  
Meldrum’s acid (4.66 g, 32.3 mmol), 4-nitrobenzaldehyde (4.44 g, 29.4 mmol) and water 
(50 mL) was reacted under the standard protocol to give the desired product as a pale 
orange solid (6.78 g, 83 %); mp (EtOH) 140-142 oC (lit 142-143 oC)3; 1H NMR (300 MHz, 
CDCl3) δ 8.45 (1H, s, C=CH), 8.30 (2H, d, J = 8.7 Hz, ArH), 8.06 (2H, d, J = 8.7 Hz, ArH), 
1.84 (6H, s, C(CH3)2); 13C NMR (75.5 MHz, DMSO-d6) δ 162.0, 159.3, 154.2, 149.0, 
138.9, 132.8, 123.5, 119.5, 105.5, 27.6; HRMS (ESI) calcd for C13H11NNaO6 [M+Na]+ : 
m/z 300.0484, found 300.0482. Data identical to literature values.3
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5.11.11: 5-(4-benzyloxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione  328k 
O
O
O
OBnO  
Meldrum’s acid (6.34 g, 44.0 mmol), 4-benzyloxybenzaldehyde (8.49 g, 40.0 mmol) and 
water (100 mL) was reacted under the standard protocol to give the desired compound as a 
yellow crystalline solid (6.43 g, 48%); mp (EtOH) 118-120 oC; IR (KBr, cm-1) v 1721, 
1754 (C=O), 1216 (C-O); 1H NMR (250 MHz, CDCl3) δ 8.37 (1H, s, C=CH), 8.22 (2H, d, 
J = 8.9 Hz, ArH), 7.45–7.31 (5H, m, ArH), 7.03 (2H, d, J = 8.9 Hz, ArH), 5.17 (2H, s, 
OCH2Ph), 1.78 (6H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 164.5, 164.2, 160.9, 
158.3, 138.0, 136.1, 129.2, 128.8, 12.9, 125.3, 115.6, 111.4, 104.6, 70.8, 27.9; HRMS (ESI) 
calcd for C20H18NaO5 [M+Na]+: m/z 361.1052, found 361.1048; Anal. calcd for C20H18O5: 
C 71.0, H 5.36, found: C 70.8, H 5.44.  
 
5.11.12: 2,2-dimethyl-5-(naphthalene-2-ylmethylene)-1,3,-dioxane-4,6-dione 328l 
O
O
O
O  
Meldrum’s acid (793 mg, 5.5 mmol), 2-naphthaldehyde (781 mg, 5.0 mmol) and water (10 
mL) was reacted under the standard protocol to give the desired product as a pale yellow 
crystalline solid (462 mg, 33 %); mp (EtOH) 148-150 oC; IR (KBr, cm-1) v 1760, 1731, 
(C=O) 1607 (C=C); 1H NMR (300 MHz, CDCl3) δ 8.58 (1H, s, C=CH), 8.54 (1H, s, ArH), 
8.13 (1H, dd, J1 = 8.7 Hz, J2 = 1.9 Hz, ArH), 7.94 (1H, d, J = 7.9 Hz, ArH), 7.88 (1H, d, J 
= 8.7 Hz, ArH), 7.86 (1H, d, J = 7.9 Hz, ArH), 7.63 (1H, ddd, J1 = 7.9 Hz, J2 = 6.8 Hz, J3 = 
1.5 Hz, ArH), 7.55 (1H, ddd, J1 = 7.9 Hz, J2 = 6.8 Hz, J3 = 1.5 Hz, ArH), 1.84 (6H, s, 
C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 163.9, 160.4, 158.6, 137.5, 136.0, 133.0, 130.2, 
129.9, 129.8, 128.7, 128.5, 128.2, 127.4, 114.8, 105.0, 28.1; HRMS (ESI) calcd for 
C17H14NaO4 [M+Na]+ : m/z 305.0790, found 305.0786; Anal. calcd for C17H12O4: C 72.3, H 
5.00, found: C 72.5, H 5.40. 
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5.11.13: 2,2-dimethyl-5-(naphthalen-1-ylmethylene)-1,3-dioxane-4,6-dione 328m 
O
O
O
O
 
Meldrum’s acid (4.66 g, 32.3 mmol), 1-naphthaldehyde (4.0 mL, 29.4 mmol) and water (50 
mL) was reacted under the standard protocol to give the desired product as a pale yellow 
crystalline solid (6.4 g, 77 %); mp (EtOH) 140-141 oC; IR (KBr, cm-1) v 1728 (C=O), 1608 
(C=C); 1H NMR (300 MHz, CDCl3) δ 9.22 (1H, s, C=CH), 8.03-7.90 (4H, m, ArH), 7.65-
7.51 (3H, m, ArH), 1.86 (6H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 163.2, 159.9, 
156.9, 133.7, 133.7, 132.1, 130.4, 129.6, 129.4, 128.2, 127.1, 125.3, 124.0, 117.4, 105.2, 
28.2; HRMS (ESI) calcd for C17H18NO4 [M+NH4]+ : m/z 300.1230, found 300.1234. 
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5.12 General Procedure for the Synthesis of 5-Monoalkyl Meldrum’s 
Acid Derivatives 
O
O
O
O
R O
O
O
O
R
NaBH4 (2 equiv)
DCM:AcOH (10:1)
0 oC-r.t., 2 h  
To a solution of 5-arylidene Meldrum’s acid derivative and glacial acetic acid in 
dichloromethane at 0 oC was added sodium borohydride portion wise. The resulting 
solution was allowed to reach ambient temperature and stirred for 2 hour. The solution was 
dissolved in dichloromethane and washed with brine and water. The organic phase was 
extracted, dried over MgSO4 and concentrated in vacuo to give the desired product. 
 
5.12.1: 5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a  
MeO O
O
O
O  
5-(4-methoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328a (1.00 g, 3.82 mmol), 
glacial acetic acid (4.0 mL), sodium borohydride (0.43 g, 11.4 mmol) and  dichloromethane 
(25 mL) was reacted under the standard procedure to give the desired product as a white 
solid (994 mg, 98%); mp (EtOAc) 82-85 oC (lit = 85-86 oC)10; IR (KBr, cm-1) v 3006, 2961, 
2915 (C-H), 1787, 1746 (C=O); 1H NMR (300 MHz, CDCl3) δ 7.24 (2H, d, J = 8.7 Hz, 
ArH), 6.82 (2H, d, J = 8.7 Hz, ArH), 3.77 (3H, s, OCH3), 3.72 (1H, t, J = 4.9 Hz, CH2CH), 
3.44 (2H, d, J = 4.9 Hz, ArCH2), 1.72 (3H, s, CH3), 1.48 (3H, s, CH3); 13C NMR (75.5 
MHz, CDCl3) δ 165.9, 159.1, 131.4, 129.4, 114.3, 105.6, 55.6, 48.7, 31.9, 28.9, 27.8; 
HRMS (ESI) calcd for C14H15O5 [M-H]- : m/z 263.0919, found 263.0912. Anal. calcd for 
C14H16O5: C 63.6, H 6.10, found: C 63.1, H 6.06. Data identical to literature data.10
 
 167
Chapter 5 
5.12.2: 5-(benzo[d][1,3]dioxol-4-ylmethyl)-2,2-dimethyl-1,3-dioxane-4,6-dione 367e 
O
O
O
O
O
O
 
5-(benzo[d][1,3]dioxol-4-ylmethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione 328e (615 mg, 
2.23 mmol), glacial acetic acid (2.0 mL), dichloromethane (10 mL) and sodium 
borohydride (168 mg, 4.45 mmol) was reacted under the standard protocol to give the 
desired compound as a white solid (569 mg, 92%); mp (EtOAc) 127-128 oC; IR (KBr, cm-
1) v 1755, 1725 (C=O), 1276 (C-O); 1H NMR (300 MHz, CDCl3) δ 6.81 (1H, d, J = 2.3 Hz, 
ArH), 6.77 (1H, d, J = 6.8 Hz, ArH), 6.72 (1H, dd, J1 = 6.8 Hz, J2 = 2.3 Hz, ArH), 5.92 
(2H, s, O-CH2-O), 4.00 (1H, t, J = 5.7 Hz, CH2CH), 3.40 (2H, d, J = 5.7 Hz, ArCH2), 1.79 
(3H, s, C(CH3)2), 1.71 (3H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 165.4, 147.6, 
145.6, 123.6, 122.2, 119.5, 107.8, 105.5, 101.1, 46.4, 29.0, 27.0, 26.7; HRMS (ESI) calcd 
for C14H13O6 [M-H]- : m/z 277.0712, found 277.0694. Anal. calcd for C14H12O6: C 60.9, H 
4.40, found: C 59.9, H 4.30. 
 
5.12.3: 5-cinnamyl-2,2-dimethyl-1,3-dioxane-4,6-dione 367f  
O
O
O
O
Ph
 
2,2-dimethyl-5-(3-phenyl-allylidene)-[1,3]dioxane-4,6-dione 328f (233 mg, 0.90 mmol), 
glacial acetic acid (1.0 mL), dichloromethane (10 mL) and sodium borohydride (0.10 g, 
2.71 mmol) was reacted under standard protocol to give the desired compound as a white 
solid (203 mg, 87%); mp (EtOAc) 85-86 oC; 1H NMR (250 MHz, CDCl3) δ 7.41-7.21 (5H, 
m, Ar), 6.63 (1H, d, J = 15.8 Hz, PhCH), 6.29 (1H, dt, J1 = 15.8 Hz, J2 = 7.3 Hz, 
PhCHCH), 3.70 (1H, t, J = 5.1 Hz, CH2CH), 3.05 (2H, dd, J1 = 7.3 Hz, J2 = 5.1 Hz, 
CHCH2CH), 1.81 (3H, s, C(CH3)2), 1.77 (3H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 
165.4, 137.2, 135.1, 128.9, 128.0, 126.7, 124.3, 105.5, 47.0, 30.0, 28.8, 27.3; HRMS (ESI) 
calcd for C15H15O4 [M-H]- : m/z 259.0970, found 259.0970. Data identical to literature 
values.11
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5.12.4: 5-(3,4-dimethoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367g  
O
O
O
OMeO
MeO
 
5-(3,4-dimethoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328g (585 mg, 2.0 
mmol), glacial acetic acid (2.0 mL), dichloromethane (15 mL) and sodium borohydride 
(151 mg, 4.0 mmol) was reacted under the standard protocol to give the desired compound 
as a white solid (495 mg, 84%); mp (EtOAc) 138-140 oC (lit = 136-137 oC)12; 1H NMR 
(300 MHz, CDCl3) δ 6.84 (1H, d, J = 9.0 Hz, ArH), 6.83 (1H, s, ArH), 6.76 (1H, d, J = 9.0 
Hz, ArH), 3.84 (3H, s, OCH3), 3.83 (3H, s, OCH3), 3.74 (1H, t, J = 4.9 Hz, CH2CH), 3.43 
(2H, d, J = 4.9 Hz, CH2CH), 1.71 (3H, s, CH3), 1.47 (3H, s, CH3); 13C NMR (75.5 MHz, 
CDCl3) δ 165.9, 149.1, 148.5, 129.9, 122.4, 113.5, 111.5, 105.6, 56.3, 56.2, 48.7, 32.3, 
28.9, 27.8; HRMS (ESI) calcd for C15H18NaO6 [M+Na]+ : m/z 317.1001, found 317.0989. 
Data identical to literature values.12
 
5.12.5: 5-(4-nitrobenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367j  
O
O
O
OO2N  
5-(4-nitrobenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328j (1.00 g, 3.61 mmol), 
glacial acetic acid (4.0 mL), dichloromethane (25 mL) and sodium borohydride (0.43 g, 
11.4 mmol) was reacted under the standard protocol to give the desired compound as a pale 
yellow solid (881 mg, 87%); mp (EtOAc) 111-112 oC; IR (KBr, cm-1) v 1758, 1730 (C=O), 
1517, 1342 (N-O); 1H NMR (300 MHz, CDCl3) δ 8.13 (2H, d, J = 8.7 Hz, ArH), 7.53 (2H, 
d, J = 8.7 Hz, ArH), 3.83 (1H, t, J = 5.3 Hz, CH2CH), 3.44 (2H, d, J = 5.3 Hz, CH2CH), 
1.79 (3H, s, C(CH3)2), 1.67 (3H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 165.0, 147.5, 
145.1, 131.3, 124.1, 105.8, 48.1, 31.8, 28.8, 27.4; HRMS (ESI) calcd for C13H12NO6 [M-
H]- : m/z 278.0665, found 278.0674; Anal. calcd for C13H13NO6: C 55.9, H 4.69, N 5.02, 
found: C 55.7, H 4.75, N 4.98. 
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5.12.6: 5-(4-benzyloxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367k 
O
O
O
OBnO  
5-(4-benzyloxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328k (2.26 g, 6.68 
mmol), glacial acetic acid (8.0 mL), dichloromethane (50 mL) and sodium borohydride 
(0.75 g, 20.0 mmol) was reacted under the standard protocol to give the desired compound 
as a white solid (2.10 g, 93%); mp (EtOAc) 92-94 oC; IR (KBr, cm-1) v 3020, 2945, 2872 
(C-H), 1785, 1748 (C=O); 1217 (C-O); 1H NMR (300 MHz, CDCl3) δ 7.43-7.29 (5H, m, 
ArH), 7.24 (2H, d, J = 8.7 Hz, ArH), 6.89 (2H, d, J = 8.7 Hz, ArH), 5.03 (2H, s, O-CH2-
Ph), 3.73 (1H, t, J = 4.9 Hz, CH2CH), 3.44 (2H, d, J = 4.9 Hz, CH2CH), 1.72 (3H, s, 
C(CH3)2), 1.46 (3H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 165.9, 158.3, 137.3, 
131.4, 129.8, 129.0, 128.4, 127.9, 115.3, 105.7, 70.3, 48.7, 31.9, 28.9, 27.8; HRMS (ESI) 
calcd for C20H20NaO5 [M+Na]+ : m/z 363.1208, found 363.1203; Anal. calcd for C20H20O5, 
C 70.6, H 5.92, found: C 71.3, H 5.88. 
 
5.12.7: 2,2-dimethyl-5-(naphthalen-2-ylmethyl)-1,3-dioxane-4,6-dione 367l 
O
O
O
O  
5-(naphthalene-2-methylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328l (201 mg, 0.71 
mmol), glacial acetic acid (1.0 mL), dichloromethane (10 mL) and sodium borohydride 
(80.7 mg, 2.13 mmol) was reacted under the standard protocol to give the desired 
compound as a white solid (190 mg, 94%); mp (EtOAc) 128-129 oC; IR (KBr, cm-1) v 
3050, 2984, 2870 (C-H), 1790, 1745 (C=O); 1H NMR (300 MHz, CDCl3) δ 7.82-7.77 (4H, 
m, ArH), 7.50-7.41 (3H, m, ArH), 3.84 (1H, t, J = 4.9 Hz, CH2CH), 3.65 (2H, d, J = 4.9 
Hz, CH2CH), 1.73 (3H, s, C(CH3)2), 1.50 (3H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 
165.7, 135.2, 133.8, 132.9, 129.0, 128.7, 128.3, 128.2, 128.0, 126.5, 126.3, 105.6, 48.7, 
32.6, 28.8, 27.6; HRMS (ESI) calcd for C17H15O4 [M-H]- : m/z 283.0970, found 283.0964. 
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5.12.8: 2,2-dimethyl-5-(naphthalen-1-ylmethyl)-1,3-dioxane-4,6-dione 367m 
O
O
O
O
 
5-(naphthalene-1-methylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328m (1.15 g, 4.09 
mmol), glacial acetic acid (2.5 mL), dichloromethane (25 mL) and sodium borohydride 
(464 mg, 12.3 mmol) was reacted under the standard protocol to give the desired compound 
as a white solid (1.12 g, 97%); mp (EtOAc) 135-137 oC; IR (KBr, cm-1) 3057, 3000, 2869 
(C-H); 1781, 1750 (C=O); 1H NMR (300 MHz, CDCl3) δ 8.08 (1H, dd, J1 = 8.3 Hz, J2 = 
1.1 Hz, ArH), 7.89 (1H, dd, J1 = 8.3 Hz, J2 = 1.5 Hz, ArH), 7.79 (1H, d, J = 8.3 Hz, ArH), 
7.65 (1H, dd, J1 = 7.2 Hz, J2 = 1.1 Hz, ArH), 7.57 (1H, ddd, J1 = 8.3 Hz, J2 = 6.8 Hz, J3 = 
1.5 Hz, ArH), 7.51 (1H, ddd, J1 = 8.3 Hz, J2 = 6.8 Hz, J3 = 1.5 Hz, ArH), 7.44 (1H, dd, J1 = 
8.3 Hz, J2 = 7.2 Hz, ArH), 3.93 (1H, t, J = 5.3 Hz, CHCH2Ar), 3.80 (2H, d, J = 5.3 Hz, 
CHCH2Ar), 1.70 (3H, s, C(CH3)2), 1.69 (3H, s, C(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 
165.7, 134.5, 134.4, 131.7, 129.6, 128.8, 128.3, 127.1, 126.2, 126.0, 123.2, 105.6, 48.2, 
29.2, 29.0, 26.9; HRMS (ESI) calcd for C17H15O4 [M-H]- : m/z 283.0970, found 283.0972. 
Data identical to literature values.13
 
5.12: 5-(4-benzyloxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367n  
O
O
O
OBr  
4-bromobenzaldehyde (537 mg, 2.9 mmol) was added to a solution of Meldrum’s acid (470 
mg, 3.19 mmol) in water (10 mL). The solution was stirred at 75 oC for 2 h. After cooling 
the precipitate was filtered via Buckner filtration and washed with water (100 mL) and 
petrol (100 mL) and dried. The resulting solid was dissolved in dichloromethane (10 mL), 
acetic acid (2 mL) was added and the solution cooled to 0 oC. Sodium borohydride (219 
mg, 5.8 mmol) was added portionwise, the solution allowed to warm to ambient 
temperature and was stirred for 2 h. The reaction mixture was dissolved in DCM (50 mL) 
and washed with water (3 x 50 mL) and brine (50 mL). The organic phase was separated, 
dried over MgSO4 and concentrated in vacuo to give the desired product as a white solid 
(426 mg, 47 %); mp (EtOAc) 143-144 oC (lit = 142-144 oC)14; 1H NMR (300 MHz, CDCl3) 
δ 7.41 (2H, d, J = 8.3 Hz, ArH), 7.21 (2H, d, J = 8.3 Hz, ArH), 3.73 (1H, t, J = 4.9 Hz, 
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CH2CH), 3.43 (2H, d, J = 4.9 Hz, CH2CH), 1.75 (3H, s, C(CH3)2), 1.59 (3H, s, C(CH3)2); 
13C NMR (75.5 MHz, CDCl3) δ 165.4, 136.5, 132.1, 121.7, 105.6, 48.3, 31.8, 28.8, 27.6; 
HRMS (ESI) calcd for C13H14BrO4 [M+H]+ : m/z 313.0075, found 313.0081. Data identical 
to literature values.14
 
5.13 The Reductive Coupling of N-Boc Protected Amino Acids and 
Meldrum’s Acid 
i) Meldrum's acid
DCC (1.1 equiv)
DMAP (1.5 equiv)
DCM, 0 oC-r.t., 24 h
ii) NaBH (2 equiv)
DCM, 0 oC-r.t., 2 h
O
O
O
O
R
R
CO2H
 
To a solution of N-Boc amino acid (20.0 mmol) and Meldrum’s acid (3.02 g, 20.9 mmol) in 
dichloromethane (100 mL) was added 4-(dimethylamino)pyridine (3.85 g, 31.5 mmol). The 
solution was cooled to 0 oC and a solution of N,N’-dicyclohexylcarbodiimide (4.74 g, 23.0 
mmol) in dichloromethane (50 mL) was added dropwise over 1 hour. After warming to 
room temperature the reaction mixture was left to stir for 20 hours. The reaction mixture 
was filtrated and the filtrate washed with 5% KHSO4 (3 x 100 mL) and saturated brine (1 x 
100 mL). The organic phase was extracted and dried over MgSO4 at 0 oC for 5 hours. The 
solution was filtered, glacial acetic acid (13.3 mL, 220 mmol) was added to the filtrate and 
the solution was cooled to 0 oC. Sodium borohydride (1.85 g, 50 mmol) was added portion 
wise over 1 hour before the reaction mixture was stirred for 16 hours at room temperature. 
The reaction mixture was washed with water (2 x 100 mL) and saturated brine (100 mL). 
The organic phase was extracted, dried over MgSO4 and concentrated in vacuo. The 
mixture was purified by flash column chromatography to a give the desired compound. 
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5.13.1: (S)-tert-butyl 2-((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)methyl)pyrrolidine-1-
carboxylate 367o  
O
O
O
O
N
Boc
 
N-Boc-L-proline (4.31 g, 20.0 mmol) was reacted under the standard protocol. The reaction 
mixture was purified by flash column chromatography (4:1 petrol:ethyl acetate) to a give 
the desired compound as a white solid (5.10 g, 78%); Rf (4:1 petrol:ethyl acetate) 0.32; mp 
122-123 oC; -22.6 (c 0.40, CHCl[ ]24α D 3); IR (KBr, cm-1) v 2976, 2915 (C-H), 1784, 1749, 
1675 (C=O); 1H NMR (300 MHz, CDCl3) δ 4.66 (1H, d, J = 4.5 Hz, NCH), 4.32 (1H, t, J = 
7.9 Hz, CH malonate), 3.33 (2H, m, NCH2), 2.32-2.23 (1H, CHCH2CH), 2.12-1.87 (4H, 
m), 1.83 (3H, s, C(CH3)2), 1.74 (3H, s, C(CH3)2), 1.72-1.62 (1H, m), 1.41 (9H, s, C(CH3)3); 
13C NMR (75.5 MHz, CDCl3) δ 165.5, 157.0, 105.3, 79.9, 55.8, 47.0, 45.6, 32.1, 32.0, 29.1, 
28.8, 26.0, 24.0; HRMS (ESI) calcd for C16H24NO6 [M-H]- : m/z 326.1604, found 
326.1590. 
 
5.13.2: (R)-tert-butyl 1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)-3-phenylpropan-2-
ylcarbamate 367p 
O
O
O
O
BocHN
Ph  
N-Boc-L-phenylalanine (5.32 g, 20.0 mmol) was reacted under the standard protocol. The 
reaction mixture was purified by flash column cohromatography (2:1 petrol:ethyl acetate) 
to a give the desired compound as a white solid (6.75 g, 90%); Rf (2:1 petrol:ethyl acetate) 
0.24;  +4.6 (c = 1.8, CHCl[ ]24Dα 3); 1H NMR (300 MHz, CDCl3) δ 7.37-7.17 (5H, m, ArH), 
4.57-4.42 (1H, m, CH Meldrum’s acid), 4.37-4.09 (1H, m, NHCH), 3.91 (1H, brs, NH), 
3.00-2.74 (2H, m, ArCH2), 2.38-2.03 (2H, m, CHCH2), 1.78 (3H, s, C(CH3)2), 1.74 (3H, s, 
C(CH3)2), 1.36 (9H, s, C(CH3)3); 13C NMR (75.5 MHz, CDCl3) δ 165.7, 165.6, 156.5, 
137.2, 129.3, 128.6, 126.7, 105.1, 79.6, 50.0, 44.2, 41.8, 31.4, 28.5, 28.2, 26.0. Data 
identical to literature values.15
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5.14 Alkylation of 5-Monoalkyl Meldrum’s Acid Derivatives 
 
5.14.1: 5-(4-methoxybenzyl)-2,2,5-trimethyl-1,3-dioxane-4,6-dione 380 
MeO O
O
O
O  
To a solution of 5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (529 mg, 
2 mmol) and potassium carbonate (304 mg, 2.2 mmol) in N,N’-dimethylformamide (5 mL) 
was added methyl iodide (125 µL, 2mmol). The reaction mixture was stirred at room 
temperate for 1 hour. The reaction mixture was dissolved in ethyl acetate (50 mL) and 
washed with water (3 x 50 mL) and saturated brine (50 mL). The organic phase was 
extracted, dried over MgSO4 and concentrated in vacuo to give the desired compound as a 
colourless solid (545 mg, 98%); mp (ethyl acetate) 86-88 oC (lit = 84 oC)16; 1H NMR (300 
MHz, CDCl3) δ 7.08 (2H, d, J = 9.0 Hz, ArH), 6.78 (2H, d, J = 9.0 Hz, ArH), 3.75 (3H, s, 
OCH3), 3.26 (2H, s, ArCH2), 1.72 (3H, s, C(CH3)2), 1.60 (3H, s, C(CH3)2), 0.97 (3H, s, 
CCH3); 13C NMR (75.5 MHz, CDCl3) δ 170.4, 159.5, 131.6, 127.8, 114.5, 105.6, 55.62, 
52.8, 44.6, 29.8, 28.8, 26.1; HRMS (ESI) calcd for C15H18NaO5 [M+Na]+ : m/z 301.1052, 
found 301.1051. Data identical to literature values values.16
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5.15 General Preparation of 3-Aryl Propionaldehydes 
 
Method A 
O
O
O
O
R
PhSiH3 (3 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
H
O
RTHF, 80 oC, 16 h
then H2O  
To a solution of alkylidene Meldrum’s acid derivative (0.5 mmol), molybdenum 
hexacarbonyl (6.6 mg, 5 mol%) and N-methylmorpholine N-oxide monohydrate (5.9 mg, 9 
mol%) in tetrahydrofuran (3.0 mL) was added phenylsilane (185 µL, 1.5 mmol). The 
resulting solution was stirred under an atmosphere of nitrogen at 80 oC for 16 h. After 
cooling to room temperature water (0.5 mL) was added and the solution stirred for 15 
minutes. The solution was dissolved in ether (50 mL) was washed with 1 M NaOH (3 x 50 
mL) followed by saturated brine (2 x 50 mL). The organic phase was extracted, dried over 
MgSO4 and concentrated in vacuo. The desired product was purified by flash column 
chromatography. 
 
Method B 
O
O
O
O
R
PhSiH3 (3 equiv)
Mo(CO)6 (5 mol%)
NMO (9 mol%)
H
O
RTHF, 80 oC, 16 h
then H2O  
To a solution of 5-monoalkyl Meldrum’s acid derivative (0.5 mmol), molybdenum 
hexacarbonyl (6.6 mg, 5 mol%) and N-methylmorpholine N-oxide monohydrate (5.9 mg, 9 
mol%) in tetrahydrofuran (3.0 mL) was added phenylsilane (185 µL, 1.5 mmol). The 
resulting solution was stirred under an atmosphere of nitrogen at 80 oC for 16 h. After 
cooling to room temperature water (0.5 mL) was added and the solution stirred for 15 
minutes. The solution was dissolved in ether (50 mL) was washed with 1 M NaOH (3 x 50 
mL) followed by saturated brine (2 x 50 mL). The organic phase was extracted, dried over 
MgSO4 and concentrated in vacuo. The desired product was purified by flash column 
chromatography. 
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Method C 
R H
O
O
OR
O
O
PhSiH3 (3 equiv)
Et3N (2 equiv)
THF, r.t., 2 h
then H2O  
To a solution of 5-alkyl Meldrum’s acid derivative (0.5 mmol) in tetrahydrofuran (3 mL) 
was added triethylamine (139 µL, 1.0 mmol) followed by phenylsilane (185 µL, 1.5 mmol). 
The resulting solution was stirred for 2 hours at room temperature. Water (0.5 mL) was 
added to the solution and stirred for 15 minutes. The reaction mixture was dissolved in 
diethyl ether (50 mL) and washed with water (2 x 50 mL) then with saturated brine (50 
mL). The organic phase was extracted, dried over MgSO4 and concentrated in vacuo and 
purified by column chromatography to give the desired product. 
 
Method D 
O
O
R
O
O
R
O
H
PhSiH3 (3 equiv)
Et3N (2 equiv)
THF, 80 oC, 16 h
then H2O  
To a solution of alkylidene Meldrum’s acid derivative (0.5 mmol) tetrahydrofuran (3.0 mL) 
was added triethylamine (139µL, 1.0 mmol) and phenylsilane (185 µL, 1.5 mmol). The 
resulting solution was stirred at 80 oC for 16 h. After cooling to room temperature water 
(0.5 mL) was added and the solution stirred for 15 minutes. The solution was dissolved in 
ether (25 mL) was washed with water (2 x 25 mL) followed by saturated brine (25 mL). 
The organic phase was extracted, dried over MgSO4 and concentrated in vacuo. The desired 
product was purified by flash column chromatography. 
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5.15.1: 3-(4-methoxyphenyl)-propanal 368a  
MeO
H
O
 
5-(4-methoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328a (131 mg, 0.5 mmol) 
was reacted using method A to give the desired product, purified by flash column 
chromatography (petrol:ethyl acetate 11:1), as a colourless oil (70.1 mg, 85%). 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) was 
reacted using method B to give the desired product, purified by flash column 
chromatography, as a colourless oil (59.4 mg, 72%). 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) was 
reacted using method C to give the desired product, purified by flash column 
chromatography, as a colourless oil (68.9 mg, 84%). 
5-(4-methoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328a (131 mg, 0.5 mmol) 
was reacted using method D to give the desired product, purified by flash column 
chromatography, as a colourless oil (29.4 mg, 36%). 
Rf (11:1 petrol:ethyl acetate) 0.21; IR (neat, cm-1) v 2840, 2730 (C-H), 1716 (C=O), 1246 
(C-O); 1H NMR (300 MHz, CDCl3) δ 9.80 (1H, t, J = 1.5 Hz, CHO), 7.11 (2H, d, J = 8.7 
Hz, ArH), 6.84 (2H, d, J = 8.7 Hz, ArH), 3.78 (3H, s, CH3), 2.91 (2H, t, J = 7.2 Hz, 
ArCH2), 2.77-2.72 (2H, m, CH2CHO); 13C NMR (75.5 MHz, CDCl3) δ 202.3, 158.5, 132.7, 
129.7, 114.4, 55.7, 46.0, 27.7; HRMS (ESI) calcd for C10H12NaO2 [M+Na]+ : m/z 
187.0735, found 187.0738. Data identical to literature values.17
 
5.15.2: 3-(4-thiomethylbenzene)-propanal 368b 
MeS
H
O
 
5-(4-thiomethylbenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328b (139 mg, 0.5 
mmol) was reacted using method A to give the desired product, purified by flash column 
chromatography (11:1 petrol:ethyl acetate), as a colourless oil (44 mg, 66%); Rf (11:1 
petrol:ethyl acetate) 0.24; IR (neat, cm-1) v 2824, 2727 (C-H); 1722 (C=O); 1H NMR (300 
MHz, CDCl3) δ 9.81 (1H, t, J = 1.5 Hz, CHO), 7.20 (2H, d, J = 8.7 Hz, Ar), 7.12 (2H, d, J 
= 8.7 Hz, Ar), 2.92 (2H, t, J = 7.2 Hz, ArCH2), 2.79-2.73 (2H, m, CH2CHO); 13C NMR 
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(75.5 MHz, CDCl3) δ 201.9, 137.7, 136.5, 129.3, 127.5, 45.7, 31.4, 28.0, 16.6, HRMS (EI) 
calcd for C10H16NOS [M+NH4]+ : m/z 198.0947, found 198.948; Anal. calcd for C10H12OS: 
C 66.6, H 6.71, found: C 66.3, H 6.88. 
 
5.15.3: 3-(4-dimethylaminobenzene)-propanal 368c 
Me2N
H
O
 
5-(4-dimethylaminobenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328c (126 mg, 0.5 
mmol) was reacted using method A to give the desired product, purified by flash column 
chromatography (10:1 petrol:ethyl acetate), as a colourless oil (71.8 mg, 81%); Rf (10:1 
petrol:ethyl acetate) 0.19; IR (neat, cm-1) v 2826, 2729 (C-H); 1722 (C=O); 1H NMR (250 
MHz, CDCl3) δ 9.82 (1H, t, J = 1.5 Hz, CHO), 7.07 (2H, d, J = 8.7 Hz, ArH), 6.70 (2H, d, J 
= 8.7 Hz, ArH), 2.92 (6H, s, N(CH3)2), 2.89 (2H, t, J = 7.2 Hz, ArCH2), 2.76-2.70 (2H, m, 
CH2CHO); 13C NMR (75.5 MHz, CDCl3) δ 202.7, 149.7, 129.3, 128.6, 113.4, 46.1, 41.2, 
27.6; HRMS (EI) calcd for C11H16NO [M+H]+ : m/z 178.1232, found 178.1228. 
 
5.15.4: 3-(benzo[1,3]dioxol-5-yl)propanal 368d  
O
H
O
O
 
5-(benzo[1,3]dioxol-5-ylmethyl)-2,2-dimethyl-1,3-dioxane-4,6-dione 328d (138.1 mg, 0.5 
mmol) was reacted using method A to give the desired product, purified by column 
chromatography (petrol : ethyl acetate 6:1), as a colourless oil (58.3 mg, 65%); Rf (6:1 
petrol:ethyl acetate) 0.29; 1H NMR (400 MHz, CDCl3) δ 9.79 (1H, t, J = 1.5 Hz, CHO), 
6.72 (1H, d, J = 7.8 Hz, ArH), 6.68-6.62 (2H, m, ArH), 5.91 (2H, s, OCH2O), 2.87 (2H, t, J 
= 7.3 Hz, ArCH2), 2.74-2.70 (2H, m, CH2CHO); 13C NMR (75.5 MHz, CDCl3) δ 202.2, 
148.1, 146.4, 134.5, 121.5, 109.2, 108.7, 101.3, 46.0, 28.3; HRMS (EI) calcd for 
C10H10NaO3 [M+Na]+ : m/z 201.0528, found 201.0532. Data identical to literature values.18
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5.15.5: 3-(benzo[1,3]-dioxol-4-yl)-propanal 368e  
H
OO
O
 
5-(benzo[d][1,3]dioxol-4-ylmethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione 328e (138 mg, 
0.5 mmol) was reacted using method A to give the desired product, purified by flash 
column chromatography (petrol : ethyl acetate 11:1), as a colourless oil (69.4 mg, 78%). 
5-(benzo[d][1,3]dioxol-4-ylmethyl)-2,2-dimethyl-1,3-dioxane-4,6-dione 367e (139 mg, 0.5 
mmol) was reacted using method C to give the desired product, purified by flash column 
chromatography, as a colourless oil (69.2 mg, 78%). 
Rf (11:1 petrol:ethyl acetate) 0.24; IR (neat, cm-1) v 2828, 2729 (C-H); 1724 (C=O); 1252 
(C-O); 1H NMR (300 MHz, CDCl3) δ 9.81 (1H, t, J = 1.3 Hz, CHO), 6.79-6.65 (3H, m, 
ArH), 5.93 (2H, s, -OCH2O-), 2.92 (2H, t, J = 7.3 Hz, ArCH2), 2.82-2.75 (2H, m, 
CH2CHO); 13C NMR (75.5 MHz, CDCl3) δ 202.0, 147.6, 145.8, 128.2, 122.8, 122.1, 107.4, 
101.0, 43.7, 22.7; HRMS (ESI) calcd for C10H10NaO3 [M+Na]+ : m/z 201.0528, found 
201.0524. 
 
5.15.6: (E)-5-phenylpent-4-enal 367f  
H
O
Ph  
2,2-dimethyl-5-(3-phenyl-allylidene)-[1,3]dioxane-4,6-dione 328f (129 mg, 0.5 mmol) was 
reacted using method A to give the desired product, purified by flash column 
chromatography (12:1 petrol:ethyl acetate), as a colourless oil (31.2 mg, 39%). 
5-cinnamyl-2,2-dimethyl-[1,3]dioxane-4,6-dione 367f (130 mg, 0.5 mmol) was reacted 
using method C to give the desired product, purified by flash column chromatography 
(petrol : ethyl acetate 12:1), as a colourless oil (64.2 mg, 80%). 
Rf (12:1 petrol:ethyl acetate) 0.26; 1H NMR (300 MHz, CDCl3) δ 9.83 (1H, t, J = 1.3 Hz, 
CHO), 7.36-7.28 (4H, m, ArH), 7.24-7.19 (1H, m, ArH), 6.4 (1H, dt, J1 = 15.8 Hz, J2 = 1.3 
Hz, PhCH), 6.21 (1H, dt, J1 = 15.8 Hz, J2 = 6.4 Hz, PhCHCH), 2.66-2.61 (2H, m, 
CHCHCH2), 2.59-2.51 (2H, m, CH2CHO); 13C NMR (75.5 MHz, CDCl3) δ 202.2, 137.6, 
131.5, 129.0, 128.6, 127.7, 126.5, 43.7, 25.9; HRMS (ESI) calcd for C11H12NaO [M+Na]+ : 
m/z 183.0786, found 183.0790. Data identical to literature values.19
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5.15.7: 3-(3,4-dimethoxyphenyl)-propanal 368g  
MeO
H
O
MeO
 
5-(3,4-dimethoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328g (146 mg, 0.5 
mmol) was  reacted using method A to give the desired product, purified by flash column 
chromatography (4:1 petrol:ethyl acetate), as a colourless oil (51.2 mg, 53%). 
5-(3,4-dimethoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367g (147 mg, 0.5 mmol) 
was reacted using method C to give the desired product, purified by flash column 
chromatography, as a colourless oil (59.5 mg, 61%). 
Rf (4:1 petrol:ethyl acetate) 0.30; 1H NMR (300 MHz, CDCl3) δ 9.79 (1H, t, J = 1.5 Hz, 
CHO), 6.80 (1H, d, J = 8.5 Hz, ArH), 6.74-6.71 (2H, m, ArH), 3.87 (3H, s, OCH3), 3.85 
(3H, s, OCH3), 2.90 (2H, t, J = 7.2 Hz, ArCH2), 2.78-2.71 (2H, m, CH2CHO); 13C NMR 
(75.5 MHz, CDCl3) δ 202.1, 149.4, 147.9, 133.3, 120.5, 112.1, 111.8, 56.3, 56.2, 45.9, 
28.2; HRMS (EI) calcd for C11H14NaO3 [M+Na]+ : m/z 217.0841, found 217.0840. Data 
identical to literature values.20
 
5.15.8: 3-(2,5-dimethoxyphenyl)-propanal 368h 
H
O
OMe
MeO
 
5-(2,5-dimethoxybenzylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione 328h (146 mg, 0.5 
mmol) was reacted using method A to give the desired product, purified by flash column 
chromatography (11:1 petrol:ethyl acetate), as a colourless oil (73.4 mg, 76%); Rf (11:1 
petrol:ethyl acetate) 0.20; IR (neat, cm-1) v 2836, 2729 (C-H); 1723 (C=O); 1225 (C-O); 1H 
NMR (300 MHz, CDCl3) δ 9.80 (1H, t, J = 1.5 Hz, CHO), 6.78-6.69 (3H, m, ArH), 3.77 
(3H, s, OCH3), 3.75 (3H, s, OCH3), 2.92 (2H, t, J = 7.2 Hz, ArCH2), 2.74-2.68 (2H, m, 
CH2CHO); 13C NMR (75.5 MHz, CDCl3) δ 202.7, 153.9, 152.0, 130.2, 116.8, 111.9, 111.5, 
56.1, 56.1, 44.3, 24.1; HRMS (EI) calcd for C11H15O3 [M+H]+ : m/z 195.1021, found 
195.1021. 
 
 180
Chapter 5 
5.15.9: 3-(2,3,4-trimethoxyphenyl)-propanal 367i 
MeO
H
O
MeO
OMe
 
5-(2,3,4-trimethoxybenzylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione 328i (161 mg, 0.5 
mmol) was reacted using method A to give the desired product, purified by column 
chromatography (11:1 petrol:ethyl acetate), as a colourless oil (53.3 mg, 48%); Rf (11:1 
petrol:ethyl acetate 0.26); IR (neat, cm-1) v 2826, 2728 (C-H); 1723 (C=O); 1248, 1232 (C-
O); 1H NMR (300 MHz, CDCl3) δ 9.78 (1H, t, J = 1.5 Hz, CHO), 6.80 (1H, d, J = 8.7 Hz, 
ArH), 6.57 (1H, d, J = 8.7 Hz, ArH), 3.87 (3H, s, OCH3), 3.84 (3H, s, OCH3), 3.81 (3H, s, 
OCH3), 2.86 (2H, t, J = 7.5 Hz, ArCH2), 2.72-2.66 (2H, m, CH2CHO); 13C NMR (75.5 
MHz, CDCl3) δ 202.7, 152.9, 152.2, 142.6, 126.6, 124.2, 107.5, 61.2, 61.1, 56.4, 45.1, 
23.2; HRMS (EI) calcd for C12H16NaO4 [M+Na]+ : m/z 247.0946, found 247.0937. 
 
5.15.10: 3-(4-nitrophenyl)-propanal 368j  
O2N
H
O
 
5-(4-nitrobenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328j (139 mg, 0.5 mmol) was 
reacted using method A to give the desired product, purified by flash column 
chromatography (6:1 petrol:ethyl acetate), as a colourless crystalline solid (32.8 mg, 37%). 
5-(4-nitrobenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367j (140 mg, 0.5 mmol) was 
reacted using method B to give the desired product, purified by flash column 
chromatography, as a colourless crystalline solid (81.6 mg, 91%). 
5-(4-nitrobenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367j (140 mg, 0.5 mmol) was 
reacted using method C to give the desired product, purified by flash column 
chromatography, as a colourless crystalline solid (82.2 mg, 92%). 
Rf (6:1 petrol:ethyl acetate) 0.19; mp (EtOH) 106-108 oC; 1H NMR (300 MHz, CDCl3) δ 
9.82 (1H, t, J = 1.1 Hz, CHO), 8.14 (2H, d, J = 8.7 Hz, ArH), 7.36 (2H, d, J = 8.7 Hz, 
ArH), 3.05 (2H, t, 7.2 Hz, ArCH2), 2.88-2.83 (2H, m, CH2CHO); 13C NMR (75.5 MHz, 
CDCl3) δ 200.6, 148.7, 147.0, 129.7, 124.2, 44.9, 28.2; HRMS (ESI) calcd for C9H10NO3 
[M+H]+ : m/z 180.0661, found 180.0660; Anal. calcd for C9H9NO3: C 60.3, H 5.06, N 7.82, 
found: C 60.0, H 5.25, N 7.69. Data identical to literature values.21
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5.15.11: 3-(4-benzyloxyphenyl)-propanal 368k  
BnO
H
O
 
5-(4-benzyloxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328k (169 mg, 0.5 
mmol) was reacted using method A to give the desired product, purified by flash column 
chromatography (9:1 petrol:ethyl acetate), as a white solid (54.4 mg, 45%). 
5-(4-benzyloxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367k (170 mg, 0.5 mmol) was 
reacted using method C to give the desired product, purified by flash column 
chromatography, as a white solid (88.5 mg, 74% yield). 
Rf (9:1 petrol:ethyl acetate) 0.27; mp (petrol) 87-88 oC; 1H NMR (300 MHz, CDCl3) δ 9.82 
(1H, t, J = 1.5 Hz, CHO), 7.45-7.29 (5H, m, ArH), 7.11 (2H, d, J = 8.7 Hz, ArH), 6.91 (2H, 
d, J = 8.7 Hz, ArH), 5.05 (2H, s, PhCH2O), 2.91 (2H, t, J = 7.5 Hz, ArCH2), 2.75 (2H, m, 
CH2CHO); 13C NMR (75.5 MHz, CDCl3) δ 202.1, 157.7, 137.5, 133.0, 129.7, 129.0, 128.3, 
127.9, 115.4, 70.5, 45.9, 27.7; HRMS (ESI) calcd for C16H16NaO2 [M+Na]+ : m/z 
263.1048, found m/z 263.1041; Anal. calcd for C16H16O2: C 80.0, H 6.71, found: C 80.8, H 
6.66. Data identical to literature values.22
 
5.15.12: 3-(2-naphthyl)-propanal 368l  
H
O
 
5-(2-nathphalen-2-methyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367l (139 mg, 0.5 mmol) 
was reacted using method C to give the desired product, purified by flash column 
chromatography (12:1 petrol:ethyl acetate), as a yellow oil (58.5 mg, 65%); Rf (12:1 
petrol:ethyl acetate) 0.24; 1H NMR (300 MHz, CDCl3) δ 9.85 (1H, t, J = 1.4 Hz, CHO), 
7.85-7.77 (3H, m, ArH), 7.65 (1H, s, ArH), 7.53-7.42 (2H, m, ArH), 7.34 (1H, dd, J1 = 8.5 
Hz, J2 = 1.9 Hz, ArH), 3.13 (2H, d, J = 7.6 Hz, ArCH2), 2.90-2.83 (2H, m, CH2CHO); 13C 
NMR (75.5 MHz, CDCl3) δ 201.9, 138.3, 134.0, 132.6, 128.7, 128.1, 127.9, 127.3, 126.9, 
126.6, 125.9, 45.6, 28.7; HRMS (ESI) calcd for C13H11O [M-H]- : m/z 183.0810, found 
183.0810. Data identical to literature values.23
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5.15.13: 3-(4-bromophenyl)-propanal 368n 
Br
H
O
 
5-(4-bromobenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367n (157 mg, 0.5 mmol) was 
reacted using method C to give the desired product, purified by flash column 
chromatography (12:1 petrol:ethyl acetate), as a colourless oil (84.3 mg, 79%); Rf (12:1 
petrol:ethyl acetate) 0.28; IR (neat, cm-1) 2826, 2728 (CHO); 1723 (C=O); 650 (C-Br); 1H 
NMR (250 MHz, CDCl3) δ 9.80 (1H, t, J = 1.3 Hz, CHO), 7.39 (2H, d, J = 8.5 Hz, ArH), 
7.07 (2H, d, J = 8.5 Hz, ArH), 2.91 (2H, t, J = 7.3 Hz, ArCH2), 2.77 (2H, m, CH2CHO); 13C 
NMR (75.5 MHz, CDCl3) δ 199.9, 138.3, 130.6, 129.0, 119.0, 44.0, 26.4; HRMS (ESI) 
calcd for C9H9BrNaO [M+Na]+ : m/z 234.9729, found 234.9735. 
 
5.15.14: (S)-tert-butyl 2-(3-oxopropyl)pyrrolidine-1-carboxylate 368o 
H
O
N
Boc
 
To a solution of (S)-tert-butyl 2-((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-
yl)methyl)pyrrolidine-1-carboxylate 367o (818.4 mg, 2.5 mmol) in tetrahydrofuran (15 mL) 
was added triethylamine (700 µL, 5 mmol) followed by phenylsilane (925 µL, 7.5 mmol). 
The solution was allowed to stir for 2 hours at room temperature before water (5 mL) was 
added. The reaction mixture was dissolved in diethyl ether (100 mL) and washed with 
water (2 x 100 mL) followed by saturated brine (100 mL). The organic phase was 
extracted, dried over MgSO4 and concentrated in vacuo. The residue was purified by flash 
column chromatography (10:1 petrol:ethyl acetate) to give the desired product, a mixture of 
rotamers, as a colourless oil (428 mg, 75%); Rf (10:1 petrol:ethyl acetate) 0.21; [ ]24Dα +160.3 
(c 0.56, CHCl3); IR (neat, cm-1) v 2880, 2722 (C-H), 1724, 1690 (C=O); 1H NMR (300 
MHz, CDCl3) δ 9.72 (1H, brs, CHO), 3.80 (1H, brs, BocNCH2), 3.38-3.20 (2H, m, 
BocNCH2 and BocNCH), 2.53-2.37 (2H, m, CH2CHO), 2.00-1.55 (6H, m), 1.41 (9H, s, 
C(CH3)3); 13C NMR (75.5 MHz, CDCl3) δ 202.6 and 202.2, 155.25, 79.8 and 79.5, 56.8, 
46.9 and 46.6, 41.2, 31.2 and 30.6, 28.9, 27.4, 24.1 and 23.3; HRMS (ESI) calcd for 
C12H21NNaO3 [M+Na]+ : m/z 250.1419, found : m/z 250.1417. 
 
 183
Chapter 5 
5.16 Synthesis of 3,5-Disubstituted Pyrrolidines 
 
5.16.1: (S)-tert-butyl 5-benzyl-2-oxo-3-(propan-2-ylidene)pyrrolidine-1-carboxylate 
410 
N
Boc
O
Ph
 
To a solution of (R)-tert-butyl 1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)-3-phenylpropan-
2-ylcarbamate 367p (189 mg, 0.5 mmol) in tetrahydrofuran (3 mL) was added 
triethylamine (139 µL, 1.0 mmol) followed by phenylsilane (185 µL, 1.5 mmol). The 
reaction mixture allowed to stir at ambient temperature for 20 hours. The reaction mixture 
was dissolved in ethyl acetate (50 mL) and washed with water (2 x 50 mL) and saturated 
brine (50 mL). The organic phase was extracted, dried over MgSO4 and concentrated in 
vacuo. The residue was purified by flash column chromatography (12:1 petrol:ethyl 
acetate) to give the desired compound as a colourless oil (71.4 mg, 45%); Rf (12:1 
petrol:ethyl acetate) 0.20; IR (neat, cm-1) v 2979, 2932 (C-H), 1772, 1707 (C=O), 1662 
(C=C); 1H NMR (300 MHz, CDCl3) δ 7.33-7.17 (5H, m, ArH), 4.34-4.26 (1H, m, NCH), 
3.18 (1H, dd, J1 = 13.2 Hz, J2 = 3.4 Hz, ArCH2), 2.53 (1H, dd, J1 = 13.2 Hz, J2 = 9.4 Hz, 
ArCH2), 2.47-2.37 (2H, m, CCH2CH), 2.21 (3H, s, C(CH3)2), 1.75 (3H, s, C(CH3)2), 1.59 
(9H, s, C(CH3)3); 13C NMR (75.5 MHz, CDCl3) δ 167.3, 151.3, 149.2, 137.7, 129.8, 129.0, 
127.1, 123.4, 82.9, 55.4, 41.3, 29.0, 28.6, 24.5, 20.3; HRMS (ESI) calcd for C19H25NNaO3 
[M+Na]+ : m/z 338.1732, found 338.1715. 
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5.17 Deuterium Labelling Studies 
 
5.17.1: 1,3-dideuterated-3-(4-methoxyphenyl) propionaldehyde 382a 
MeO
O
D
H D
 
To a solution of 5-(4-methoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 328a (131 
mg, 0.5 mmol), molybdenum hexacarbonyl (6.6 mg, 5 mol%) and N-methylmorpholine N-
oxide (5.9 mg, 0.044 mmol, 9mol%) in tetrahydrofuran (3 mL) was added 
trideuteriophenylsilane (185 µL, 1.5 mmol). The resulting solution was stirred under an 
atmosphere of nitrogen at 80 oC for 16 h. After cooling to room temperature water (0.5 mL) 
was added and the solution stirred for 15 minutes. The solution was dissolved in ether (50 
mL) was washed with 1 M NaOH (3 x 50 mL) followed by brine (2 x 50 mL). The organic 
phase was extracted, dried over MgSO4 and concentrated in vacuo. The desired product 
was isolated by flash column chromatography (11:1 petrol:ethyl acetate) as a colourless oil 
(65.1 mg, 79%); 100% deuterium incorportation; Rf (11:1 petrol:ethyl acetate) 0.21; IR 
(neat, cm-1) v 2081 (C-D), 1709 (C=O), 1246 (C-O); 1H NMR (300 MHz, CDCl3) δ 7.11 
(2H, d, J = 8.7 Hz, ArH), 6.84 (2H, d, J = 8.7 Hz, ArH), 3.79 (3H, s, OCH3), 2.92-2.86 (1H, 
m, CHD), 2.74 (2H, d, J = 7.9 Hz, CH2CDO); 2H NMR (77 MHz, DCM) δ 9.75 (s, CDO), 
2.84 (s, ArCHD); 13C NMR (75.5 MHz, CDCl3) δ 201.9 (t, J = 26.0 Hz), 158.5, 132.7, 
129.6, 114.4, 55.7, 45.7, 29.3 (t, J = 19.6 Hz); HRMS (EI) calcd for C10H14D2NO 
[M+NH4+]: m/z 189.0855, found: m/z 189.0855. 
 
5.17.2: Preparation of α,α-dideuterated-3-(4-methoxyphenyl) propionaldehyde 383a  
MeO
O
H
D D
    
Procedure A : To a solution of 5-(4-methoxybenzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-
dione 328a (131 mg, 0.5 mmol), molybdenum hexacarbonyl (6.6 mg, 5 mol%) and N-
methylmorpholine N-oxide monohydrate (5.9 mg, 0.044 mmol, 9mol%) in tetrahydrofuran 
(3 mL) was added phenylsilane (185 µL, 1.5 mmol). The resulting solution was stirred 
under an atmosphere of nitrogen at 80 oC for 16 h. After cooling to room temperature 
deuterium oxide (0.5 mL) was added and the solution stirred for 15 minutes. 
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Procedure B : To a solution of 5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 
367a (132 mg, 0.5 mmol) in tetrahydrofuran (3 mL) was added triethylamine (139 µL, 1.0 
mmol) and phenylsilane (183 µL, 1.5 mmol). The reaction mixture was allowed to stir for 
2h at room temperature under an atmosphere of nitrogen. Deuterium oxide (1.0 mL) was 
added to the reaction mixture and stirred for 15 minute.  
Work-up : The reaction mixture was dissolved in diethyl ether (50 mL) and washed with 
water (50 mL) and brine (50 mL). The organic phase was extracted, dried over MgSO4 and 
concentrated in vacuo. The desired product was isolated by flash column chromatography 
(11:1 petrol:ethyl acetate) as a colourless oil (Procedure A : 61.5 mg, 75%; Procedure B : 
68.0 mg, 82% yield); 73% deuterium incorporation;Rf (11:1 petrol:ethyl acetate) 0.21; IR 
(neat, cm-1) v 2836, 2725 (C-H), 1723 (C=O), 1249 (C-O); 1H NMR (300 MHz, CDCl3) δ 
9.81 (1H, s, CHO), 7.11 (2H, d, J = 8.7 Hz, ArH), 6.84 (2H, d, J = 8.7 Hz, ArH), 3.78 (3H, 
s, OCH3), 2.89 (2H, s, ArCH2); 2H NMR (77 MHz, DCM) δ 2.64 (s); 13C NMR (75.5 MHz, 
CDCl3) δ 202.3, 158.5, 132.7, 129.6, 114.4, 55.7, 45.5 (t, J = 28.5 Hz CD2), 27.6; HRMS 
(EI) calcd for C10H10D2NaO [M+Na]+: m/z 189.0855, found: m/z 189.0858. 
 
5.17.3: Preparation of 1-deuterated-3-(4-methoxyphenyl) propionaldehyde 412a 
O
D
MeO  
To a solution of 5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 467a (132 mg, 
0.5 mmol) in tetrahydrofuran (3 mL) was added triethylamine (139 µL, 1.0 mmol) and 
trideuterophenylsilane24 (190 µL, 1.5 mmol). The reaction mixture was allowed to stir for 
2h at room temperature under an atmosphere of nitrogen. Water (1.0 mL) was added to the 
reaction mixture and stirred for 15 minute. The reaction mixture was dissolved in diethyl 
ether (50 mL) and washed with water (50 mL) and brine (50 mL). The organic phase was 
extracted, dried over MgSO4 and concentrated in vacuo. The desired product was isolated 
by flash column chromatography (11:1 petrol:ethyl acetate) as a colourless oil (70.4 mg, 
85%); 100% deuterium incorporation; Rf (11:1 petrol:ethyl acetate) 0.21; IR (neat, cm-1) v 
2279 (C-D), 1712 (C=O), 1247 (C-O); 1H NMR (300 MHz, CDCl3) δ 7.11 (2H, d, J = 8.7 
Hz, ArH), 6.84 (2H, d, J = 8.7 Hz, ArH), 3.78 (3H, s, OCH3), 2.91 (2H, t, J = 7.5 Hz, 
ArCH2) 2.74 (2H, t, J = 7.5 Hz, CH2CDO); 2H NMR (77 MHz, DCM) δ 9.75 (s); 13C NMR 
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(75.5 MHz, CDCl3) δ 201.9 (t, J = 26.0 Hz), 158.5, 132.8, 129.6, 114.4, 55.7, 45.8, 27.7; 
HRMS (EI) calcd for C10H10DNaO [M+Na]+: m/z 187.0855, found: m/z 187.0854. 
 
5.18 One-Pot Aldehyde Formation Reductive Amination 
 
Method A: Using Pd/C, H2
R O
OO
O
iii) Pd/C, H2
R NR'R"
i) PhSiH3, Et3N,
THF, r.t. 2h
ii) MeOH, amine
 
To a solution of 5-monoalkyl Meldrum’s acid (0.5 mmol) in tetrahydrofuran (3 mL) was 
added triethylamine (139 µL, 1 mmol) followed by phenylsilane (185 µL, 1.5 mmol). The 
reaction mixture was stirred for 2 hours at room temperature. Methanol (1 mL) was added 
to the reaction mixture and stirred for 15 minutes before amine was added (1 mmol) and 
stirred for a further hour. 10% palladium on activated carbon (50 mg) was added and 
hydrogen gas bubbled through the solution. The reaction mixture was left for 16 hours. The 
reaction mixture was then passed through a pad of celite and concentrated in vacuo. The 
residue was dissolved in ethyl acetate (25 mL) and washed with 1M HCl(aq) (3 x 25 mL). 
The aqueous phase was basified with 1M NaOH(aq) and washed with DCM (3 x 50 mL). 
The combined organic phases were dried over MgSO4 and concentrated in vacuo. 
  
Method B: Using Na(OAc)3BH 
R O
OO
O
i) PhSiH3, Et3N,
THF, r.t. 2h
ii) MeOH, amine
iii) Na(OAc)3BH
R NR'R"
 
To a solution of 5-substituted Meldrum’s acid derivative (0.5 mmol) in tetrahydrofuran (3 
mL) was added triethylamine (139 µL, 1.0 mmol) followed by phenylsilane (185 µL, 1.5 
mmol). The reaction mixture was stirred for 2 hours at room temperature. Methanol (1 mL) 
was added to the reaction mixture and stirred for 15 minutes before amine was added (1 
mmol) and stirred for a further hour. Sodium triacetoxyborohydride (212 mg, 1.0 mmol) 
was added and the reaction mixture was left to stir for 16 hours. The reaction mixture was 
dissolved in ethyl acetate (25 mL) and the organic phase was then extracted with 1M HCl(aq) 
(3 x 25 mL). The combined aqueous phases basified with 1M NaOH(aq) and extracted with 
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DCM (3 x 50 mL). The combined organic phases were dried over MgSO4 and concentrated 
in vacuo. 
 
5.18.1: N,N-diisopropyl-3-(4-methoxybenzene)propan-1-amine 414aa 
MeO
N
 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) and 
diispropylamine 415a (140 µL, 1.0 mmol) were reacted using method A to give the desired 
product as a colourless oil (77.7 mg, 63%). 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) and 
diispropylamine 415a (140 µL, 1.0 mmol) were reacted using method B to give the desired 
product as a colourless oil (38.8 mg, 31%). 
IR (neat, cm-1) v 3001, 2968, 2875 (C-H), 1245 (C-O); 1H NMR (300 MHz, CDCl3) δ 7.11 
(2H, d, J = 8.7 Hz, ArH), 6.83 (2H, d, J = 8.7 Hz, ArH), 3.79 (3H, s, OCH3), 3.04 (2H, sept, 
J = 6.4 Hz, CH(CH3)2), 2.55 (2H, t, J = 7.5 Hz, ArCH2), 2.45 (2H, t, J = 7.5 Hz, CH2N), 
1.74 (2H, quin, J = 7.5 Hz, CH2CH2CH2), 1.01 (12H, d, J = 6.4 Hz, CH(CH3)2); 13C NMR 
(75.5 MHz, CDCl3) δ 156.5, 133.6, 128.2, 112.6, 54.2, 47.7, 44.0, 31.9, 31.7, 19.5; HRMS 
(ESI) calcd for C16H28NO [M+H]+ : m/z 250.2171, found 250.2177. 
 
5.18.2: N,N-dimethyl-3-(4-methoxybenzene))propan-1-amine 414ab  
MeO
N
 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) and 
dimethylamine (2M solution in THF) 415b (1 mL, 1.0 mmol) were reacted using method A 
to give the desired product, purified by flash column chromatography (98:2 ethyl 
acetate:methanol), as a colourless oil (50.0 mg, 52%); Rf (98:2 ethyl acetate:methanol) 
0.18; 1H NMR (300 MHz, CDCl3) δ 7.10 (2H, d, J = 8.7 Hz, ArH), 6.82 (2H, d, J = 8.7 Hz, 
ArH), 3.78 (3H, s, OCH3), 2.58 (2H, t, J = 7.5 Hz, ArCH2), 2.28 (2H, t, J = 7.5 Hz, NCH2), 
2.22 (6H, s, N(CH3)2), 1.76 (2H, quin, J = 7.5 Hz, CH2CH2CH2); 13C NMR (75.5 MHz, 
CDCl3) δ 158.1, 134.7, 129.6, 114.1, 59.7, 55.6, 45.9, 33.1, 30.1; HRMS (ESI) calcd for 
C12H20NO [M+H]+ : m/z 194.1545, found 194.1540. Data identical to literature values.25  
 
 188
Chapter 5 
5.18.3: N-phenyl-3-(4-methoxybenzene)propane-1-amine 414ac  
MeO
N
H
 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) and 
aniline 415c (91 µL, 1.0 mmol) were reacted using method A to give the desired product, 
purified by flash column chromatography (ethyl acetate), as a colourless oil (57.9 mg, 
48%); Rf (ethyl acetate) 0.22; 1H NMR (300 MHz, CDCl3) δ 7.23 (2H, dd, J1 = 8.7 Hz, J2 = 
7.5 Hz, ArH), 7.18 (2H, d, J = 8.7 Hz, ArH), 6.91 (2H, d, J = 8.7 Hz, ArH), 6.76 (1H, t, J = 
7.5 Hz, ArH), 6.64 (2H, d, J = 7.5 Hz, ArH), 3.85 (3H, s, OCH3), 3.32 (1H, brs, NH), 3.18 
(2H, t, J = 7.2 Hz, ArCH2), 2.74 (2H, t, J = 7.2 Hz, NCH2), 1.97 (2H, quin, J = 7.2 Hz, 
CH2CH2CH2); 13C NMR (75.5 MHz, CDCl3) δ 156.8, 147.3, 132.7, 128.3, 128.2, 116.1, 
112.8, 111.7, 54.2, 42.3, 31.4, 30.2; HRMS (ESI) calcd for C16H20NO [M+H]+ : m/z 
242.1545, found 242.1528. Data identical to literature values.26  
 
5.18.4: 4-(3-(4-methoxyphenyl)propyl)morpholine 414ad 
MeO
N
O
 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) and 
morpholine 415d (88 µL, 1.0 mmol) were reacted using method A to give the desired 
product, purified by flash column chromatography (ethyl acetate), as a colourless oil (48.0 
mg, 41%); Rf (ethyl acetate) 0.23; IR (neat, cm-1) v 3011, 2944, 2859, 2813 (C-H), 1246, 
1117 (C-O); 1H NMR (300 MHz, CDCl3) δ 7.09 (2H, d, J = 8.7 Hz, ArH), 6.81 (2H, d, J = 
8.7 Hz, ArH), 3.77 (3H, s, OCH3), 3.70 (4H, t, J = 4.5 Hz, O(CH2)2), 2.58 (2H, t, J = 7.5 
Hz, ArCH2), 2.42 (4H, t, J = 4.5 Hz, N(CH2)2), 2.34 (2H, t, J = 7.5 Hz, NCH2) 1.77 (2H, 
quin, J = 7.5 Hz, CH2CH2CH2); 13C NMR (75.5 MHz, CDCl3) δ 158.2, 134.5, 129.7, 114.1, 
67.4, 58.7, 55.6, 54.1, 33.1, 28.9; HRMS (ESI) calcd for C14H22NO2 [M+H]+ : m/z 
236.1651, found 236.1638. 
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5.18.5: 1-(3-(4-methoxyphenyl)propyl)piperidine 414ae 
MeO
N
 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) and 
piperidine 415e (0.1 mL, 1.0 mmol) were reacted using method A to give the desired 
product, purified by flash column chromatography (ethyl acetate), as a colourless oil (57.9 
mg, 50%); Rf (ethyl acetate) 0.24; IR (neat, cm-1) v 2938, 2855, 2804, 2769 (C-H), 1245 (C-
O); 1H NMR (300 MHz, CDCl3) δ 7.09 (2H, d, J = 8.7 Hz, ArH), 6.81 (2H, d, J = 8.7 Hz, 
ArH), 3.77 (3H, s, OCH3), 2.56 (2H, t, J = 7.9 Hz, ArCH2), 2.38-2.28 (6H, m, N(CH2)3) 
1.79 (2H, quin, J = 7.9 Hz, CH2CH2CH2), 1.58 (4H, quin, J = 5.7 Hz, CH2), 1.46-1.38 (2H, 
m, CH2); 13C NMR (75.5 MHz, CDCl3) δ 158.1, 134.8, 129.6, 114.1, 59.3, 55.6, 55.0, 33.4, 
29.3, 26.4, 24.9; HRMS (ESI) calcd for C15H24NO [M+H]+ : m/z 234.1858, found 
234.1857. 
 
5.18.6: N-benzyl-N-methyl-3-(4-methoxybenzene)propane-1-amine 414af 
MeO
N
 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) and 
N-benzyl-N-methylamine 415f (0.1 mL, 1.0 mmol) were reacted using method A to give 
the desired product, purified by flash column chromatography (ethyl acetate), as a 
colourless oil (68.1 mg, 52%); Rf (ethyl acetate) 0.18; IR (neat, cm-1) v 3028, 2939, 2836, 
2790 (C-H), 1246 (C-O); 1H NMR (250 MHz, CDCl3) δ 7.36-7.27 (5H, m, ArH), 7.10 (2H, 
d, J = 8.5 Hz, ArH), 6.83 (2H, d, J = 8.5 Hz, ArH), 3.80 (3H, s, OCH3), 3.52 (2H, s, 
NCH2Ph), 2.60 (2H, t, J = 7.6 Hz, ArCH2), 2.43 (2H, t, J = 7.6 Hz, CH2N), 2.21 (3H, s, 
NCH3), 1.83 (2H, quin, J = 7.9 Hz, CH2CH2CH2); 13C NMR (75.5 MHz, CDCl3) δ 158.1, 
140.0, 134.9, 129.7, 129.5, 128.6, 127.3, 114.1, 62.7, 57.2, 55.7, 42.6, 33.1, 29.8; HRMS 
(EI) calcd for C18H24NO [M+H]+ : m/z 270.1858, found 270.1853. 
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5.18.7: N-benzyl-3-(4-methoxybenzene)propane-1-amine 414ag 
MeO
N
H
 
5-(4-methoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367a (132 mg, 0.5 mmol) and 
benzylamine 415g (0.11 mL, 1.0 mmol) were reacted using method A to give the desired 
product (47.8 mg, 37%); IR (neat, cm-1) v 3064 (N-H), 3030, 3004, 2955, 2836 (C-H) 1249 
(C-O); 1H NMR (250 MHz, CDCl3) δ 7.28-7.14 (5H, m, ArH), 7.01 (2H, d, J = 8.8 Hz, 
ArH), 6.74 (2H, d, J = 8.8 Hz, ArH), 3.70 (5H, s, OCH3 and NCH2Ph), 2.58 (2H, t, J = 7.3 
Hz, ArCH2), 2.52 (2H, t, J = 7.3 Hz, CH2N), 2.25 (1H, brs, NH), 1.72 (2H, quin, J = 7.3 
Hz, CH2CH2CH2); 13C NMR (75.5 MHz, CDCl3) δ 156.7, 139.4, 133.2, 128.2, 127.4, 
127.1, 125.9, 112.7, 54.2, 53.0, 47.9, 31.7, 30.9; HRMS (EI) calcd for C17H22NO [M+H]+ : 
m/z 256.1701, found 256.1686. 
 
5.18.8: N,N-diisopropyl-3-(3,4-dimethoxyphenyl)propan-1-amine 414ga 
MeO
N
MeO
 
5-(3,4-dimethoxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367g (147 mg, 0.5 mmol) 
and diisopropylamine 415a (140 µL, 1.0 mmol) was reacted using method A to give the 
desired product, purified by flash column chromatography (4:1 petrol:ethyl acetate), as a 
colourless oil (81.2 mg, 56%); Rf (4:1 petrol:ethyl acetate) 0.27; IR (neat, cm-1) v 2963,  
2902, 2877 (C-H), 1261, 1235 (C-O); 1H NMR (300 MHz, CDCl3) δ 6.80-6.70 (3H, m, 
ArH), 3.87 (3H, s, OCH3), 3.86 (3H, s, OCH3), 3.03 (2H, sept, J = 6.4 Hz, NCH(CH3)2), 
2.55 (2H, t, J = 7.9 Hz, ArCH2), 2.44 (2H, t, J = 7.9 Hz, CH2N), 1.74 (2H, quin, J = 7.5 Hz, 
CH2CH2CH2), 1.00 (12H, d, J = 6.4 Hz, NCH(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 
149.2, 147.4, 135.6, 120.5, 112.0, 111.5, 56.3, 56.2, 48.8, 45.5, 33.6, 21.0, 18.6; HRMS 
(ESI) calcd for C17H30NO2 [M+H]+ : m/z 280.2277, found 280.2259. 
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5.18.9: N,N-diisopropyl-3-(4-hydroxyphenyl)propan-1-amine 416ka 
HO
N
 
5-(4-benzyloxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367k (170 mg, 0.5 mmol) and 
diisopropylamine 415a (140 µL, 1.0 mmol) was reacted using method A to give the desired 
product as a colourless oil (67.3 mg, 57%); IR (neat, cm-1) v 3414 (O-H), 2945, 2853 (C-
H); 1H NMR (300 MHz, CDCl3) δ 7.00 (2H, d, J = 8.7 Hz, ArH), 6.75 (2H, d, J = 8.7 Hz, 
ArH), 3.09 (2H, sept, J = 6.4 Hz, NCH(CH3)2), 2.50 (2H, t, J = 7.5 Hz, ArCH2), 2.47 (2H, t, 
J = 7.5 Hz, CH2N), 1.77 (2H, quin, J = 7.5 Hz, CH2CH2CH2), 1.04 (12H, d, J = 6.4 Hz, 
NCH(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 154.6, 134.2, 129.7, 116.2, 49.3, 45.6, 33.3, 
33.0, 20.8; HRMS (ESI) calcd for C15H26NO [M+H]+ : m/z 236.2014, found 236.2004. 
 
5.18.10: N,N-diisopropyl-3-(4-benzyloxyphenyl)propan-1-amine 414ka 
BnO
N
 
5-(4-benzyloxybenzyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367k (170 mg, 0.5 mmol) and 
diisopropylamine 415a (140 µL, 1.0 mmol) was reacted using method B to give the desired 
product as a colourless oil (52.8 mg, 32%); IR (neat, cm-1) v 2968, 2855 (C-H) 1238 (C-O); 
1H NMR (300 MHz, CDCl3) δ 7.46-7.30 (5H, m, ArH), 7.12 (2H, d, J = 8.7 Hz, ArH), 6.91 
(2H, d, J = 8.7 Hz, ArH), 5.05 (2H, s, PhCH2O), 3.05 (2H, sept, J = 6.4 Hz, NCH(CH3)2), 
2.56 (2H, t, J = 7.9 Hz, ArCH2), 2.46 (2H, t, J = 7.9 Hz, CH2N), 1.76 (2H, quin, J = 7.9 Hz, 
CH2CH2CH2), 1.03 (12H, d, J = 6.4 Hz, NCH(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 
155.8, 136.2, 133.9, 128.2, 127.5, 126.8, 126.45, 113.6, 69.0, 49.0, 47.9, 44.0, 31.7, 19.5; 
HRMS (ESI) calcd for C22H32NO [M+H]+ : m/z 326.2484, found 326.2483. 
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5.18.11: N,N-diisopropyl-3-(2-Naphthyl)propan-1-amine 414la 
N
 
5-(2-nathphalen-2-methyl)-2,2-dimethyl-[1,3]dioxane-4,6-dione 367l (139 mg, 0.5 mmol) 
and diisopropylamine 415a (140 µL, 1.0 mmol) was reacted using method A to give the 
desired product, purified by flash column chromatography (4:1 petrol:ethyl acetate), as a 
yellow oil (55.1 mg, 41%); Rf (4:1 petrol:ethyl acetate) 0.25; IR (neat, cm-1) v 2978, 2912, 
1845, (C-H); 1H NMR (300 MHz, CDCl3) δ 7.84-7.65 (3H, m, ArH), 7.65 (1H, s, ArH), 
7.50-7.40 (2H, m, ArH), 7.37 (1H, dd, J1 = 8.7 Hz, J2 = 1.9 Hz, ArH), 3.06 (2H, sept, J = 
6.6 Hz, NCH(CH3)2), 2.80 (2H, t, J = 7.5 Hz, ArCH2), 2.52 (2H, t, J = 7.5 Hz, CH2N), 1.87 
(2H, quin, J = 7.5 Hz, CH2CH2CH2), 1.04 (12H, d, J = 6.6 Hz, NCH(CH3)2); 13C NMR 
(75.5 MHz, CDCl3) δ 140.7, 134.1, 132.4, 128.2, 128.0, 127.8, 126.7, 126.4, 126.2, 125.4, 
49.0, 45.4, 34.3, 33.1, 21.1; HRMS (ESI) calcd for C19H28N [M+H]+ : m/z 270.2222, found 
: m/z 270.2204. 
 
5.18.12: (R)-tert-butyl 2-(3-(diisopropylamino)propyl)pyrrolidine-1-carboxylate 414o 
NN
Boc
 
(S)-tert-butyl 2-((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)methyl)pyrrolidine-1-carboxylate 
367o (164 mg, 0.5 mmol) and diisopropylamine 415a (140 µL, 1.0 mmol) was reacted 
using method A to give the desired product, purified by flash column chromatography 
(ethyl acetate), as a colourless oil (95.1 mg, 61%); Rf (ethyl acetate) 0.28; +383.3 (c 
0.06, CHCl
[ ]24Dα
3); IR (neat, cm-1) 2971, 2875 (C-H), 1680 (C=O); 1H NMR (300 MHz, CDCl3) 
δ 3.70 (1H, brs, BocNCH2), 3.40-3.25 (2H, m, BocNCH2 and BocNCH), 2.99 (2H, sept, J = 
6.4 Hz, NCH(CH3)2), 2.45 (2H, m NCH2), 2.00-1.59 (5H, m), 1.46 (9H, s, C(CH3)3), 1.44-
1.18 (3H, m), 1.00 (12H, d, J = 6.4 Hz, N(CH(CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 
155.1, 79.3, 57.7, 48.9, 46.5, 45.8, 32.9, 31.1, 29.0, 24.2, 23.5, 21.1; HRMS (ESI) calcd for 
C18H37N2O2 [M+H]+ : m/z 313.2855, found : m/z 313.2844. 
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